<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD002125.pub2" GROUP_ID="MENSTR" ID="930899082400025691" MERGED_FROM="" MODIFIED="2009-11-06 02:21:05 +0100" MODIFIED_BY="Jane Clarke" NOTES="&lt;p&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.3.1&lt;br&gt;Exported from Review Manager 4.2.3&lt;br&gt;Exported from Review Manager 4.2.2&lt;br&gt;Exported from Review Manager 4.2.3&lt;br&gt;Exported from Review Manager 4.2.2&lt;br&gt;Short title (no longer in use): Surgery for tubal disease before IVF&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2009-11-06 14:10:20 +1300" NOTES_MODIFIED_BY="jane clarke" REVIEW_NO="NJ 472" REVMAN_SUB_VERSION="5.0.22" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2009-11-06 02:21:05 +0100" MODIFIED_BY="Jane Clarke">
<TITLE>Surgical treatment for tubal disease in women due to undergo in vitro fertilisation</TITLE>
<CONTACT MODIFIED="2009-11-06 02:21:05 +0100" MODIFIED_BY="Jane Clarke"><PERSON ID="9027" ROLE="AUTHOR"><PREFIX>A/Prof</PREFIX><FIRST_NAME>Neil</FIRST_NAME><LAST_NAME>Johnson</LAST_NAME><POSITION>Associate Professor</POSITION><EMAIL_1>n.johnson@auckland.ac.nz</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics &amp; Gynaecology</DEPARTMENT><ORGANISATION>University of Auckland</ORGANISATION><ADDRESS_1>PO Box 92019</ADDRESS_1><CITY>Auckland</CITY><ZIP>1003</ZIP><COUNTRY CODE="NZ">New Zealand</COUNTRY><PHONE_1>+64 9 3737599 ext: 89488</PHONE_1><FAX_1>+64 9 3035969</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2009-11-06 02:21:05 +0100" MODIFIED_BY="Jane Clarke"><PERSON ID="9027" ROLE="AUTHOR"><PREFIX>A/Prof</PREFIX><FIRST_NAME>Neil</FIRST_NAME><LAST_NAME>Johnson</LAST_NAME><POSITION>Associate Professor</POSITION><EMAIL_1>n.johnson@auckland.ac.nz</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics &amp; Gynaecology</DEPARTMENT><ORGANISATION>University of Auckland</ORGANISATION><ADDRESS_1>PO Box 92019</ADDRESS_1><CITY>Auckland</CITY><ZIP>1003</ZIP><COUNTRY CODE="NZ">New Zealand</COUNTRY><PHONE_1>+64 9 3737599 ext: 89488</PHONE_1><FAX_1>+64 9 3035969</FAX_1></ADDRESS></PERSON><PERSON ID="E63E2A4582E26AA2003F1F39925AB3DB" ROLE="AUTHOR"><PREFIX>Miss</PREFIX><FIRST_NAME>Sabine</FIRST_NAME><LAST_NAME>van Voorst</LAST_NAME><POSITION>Student</POSITION><EMAIL_1>sabine_vv@hotmail</EMAIL_1><ADDRESS><DEPARTMENT>Faculty of Medicine</DEPARTMENT><ORGANISATION>University of Maastricht</ORGANISATION><CITY>Maastricht</CITY><COUNTRY CODE="NL">Netherlands</COUNTRY></ADDRESS></PERSON><PERSON ID="14623" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Martin</FIRST_NAME><MIDDLE_INITIALS>C</MIDDLE_INITIALS><LAST_NAME>Sowter</LAST_NAME><POSITION>Specialist Obstetrician and Gynaecologist</POSITION><EMAIL_1>martinsowter@xtra.co.nz</EMAIL_1><ADDRESS><DEPARTMENT>Fertility Plus</DEPARTMENT><ORGANISATION>Auckand Hospital</ORGANISATION><ADDRESS_1>12th Floor</ADDRESS_1><CITY>Auckland</CITY><COUNTRY CODE="NZ">New Zealand</COUNTRY></ADDRESS></PERSON><PERSON ID="B3AF992082E26AA2013849DF83802BD0" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Annika</FIRST_NAME><LAST_NAME>Strandell</LAST_NAME><POSITION>Associate Professor</POSITION><EMAIL_1>annika.strandell@medfak.gu.se</EMAIL_1><ADDRESS><DEPARTMENT>Obstetrics and Gynecology</DEPARTMENT><ORGANISATION>University of Gothenburg</ORGANISATION><ADDRESS_1>Kungälv Hospital</ADDRESS_1><CITY>Kungälv</CITY><COUNTRY CODE="SE">Sweden</COUNTRY><PHONE_1>+45 303 98002</PHONE_1></ADDRESS></PERSON><PERSON ID="422DFBB182E26AA200991D56892EC1A4" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Ben Willem</FIRST_NAME><MIDDLE_INITIALS>J</MIDDLE_INITIALS><LAST_NAME>Mol</LAST_NAME><SUFFIX>MD, PhD</SUFFIX><POSITION>Gynecologist and Epidemiologist</POSITION><EMAIL_1>b.w.mol@amc.uva.nl</EMAIL_1><ADDRESS><DEPARTMENT>Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>Máxima Medical Center</ORGANISATION><ADDRESS_1>Postbox 7777</ADDRESS_1><CITY>Veldhoven</CITY><ZIP>5500 MB</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY><PHONE_1>+31 40 8888385</PHONE_1><FAX_1>+3140 8888387</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2009-11-06 14:09:45 +1300" MODIFIED_BY="jane clarke">
<UP_TO_DATE>
<DATE DAY="28" MONTH="10" YEAR="2009"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="28" MONTH="10" YEAR="2009"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="28" MONTH="10" YEAR="2011"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2000"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2001"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2004"/>
</DATES>
<WHATS_NEW MODIFIED="2009-11-06 14:06:57 +1300" MODIFIED_BY="jane clarke">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2009-11-06 14:06:57 +1300" MODIFIED_BY="jane clarke">
<DATE DAY="25" MONTH="5" YEAR="2008"/>
<DESCRIPTION>
<P>This review was updated in August 2008. New authors have joined the team: SVV, AS and BWJM. As compared to 2004; study identification and selection was performed by a second reviewer based upon a slightly adjusted search. Three new trials were included: <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>; <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>;and <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK>. Therefore this review now includes studies reporting the effect of ultrasound guided aspiration of hydrosalpinges and the efficacy of tubal occlusion. A previously included trial was excluded: <LINK REF="STD-Goldstein-1998" TYPE="STUDY">Goldstein 1998</LINK>. One ongoing study was found: <LINK REF="STD-Darwish-2005_x002c_2006_x002c_-2007" TYPE="STUDY">Darwish 2005,2006, 2007</LINK>; this preliminary study assessed the feasibility of hysteroscopic tubal occlusion with electrocautery. Follow-up time was not long enough to assess results of pregnancy. Data extraction and data analysis of the three newly included studies was completed by the second reviewer (SVV) in consensus with the first reviewer. Outcomes were extracted according to stricter definitions of Live birth, ongoing pregnancy, viable-clinical or biochemical pregnancy. Results were imported in Revman 5 and analysis was undertaken. The Cochrane manuscript was rewritten and edited by the same panel and two newly added authors: B.W. Mol and A. Strandell.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="29" MONTH="4" YEAR="2008"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>University of Auckland, School of Medicine, Auckland</NAME>
<COUNTRY CODE="NZ">New Zealand</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2009-11-06 14:10:20 +1300" MODIFIED_BY="jane clarke">
<SUMMARY MODIFIED="2009-09-07 03:57:15 +1200" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2009-01-31 03:12:58 +1300" MODIFIED_BY="[Empty name]">Surgical treatment for tubal disease in women due to undergo in vitro fertilisation</TITLE>
<SUMMARY_BODY MODIFIED="2009-09-07 03:57:15 +1200" MODIFIED_BY="[Empty name]">
<P>Diseases of the fallopian tube, such as hydrosalpinx can severely reduce the chances of pregnancy from in vitro fertilisation (IVF). Removing (salpingectomy) or occluding blocked or diseased fallopian tubes before in IVF can increase pregnancy and live birth rates for women on the IVF program. This review of trials found both laparoscopic salpingectomy and tubal occlusion prior to IVF increase the odds of pregnancy. However, other treatment options still need to be evaluated and the place of restorative tubal surgery in clinical practice needs to be evaluated.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2009-11-06 14:10:20 +1300" MODIFIED_BY="jane clarke">
<ABS_BACKGROUND MODIFIED="2009-09-07 03:56:22 +1200" MODIFIED_BY="[Empty name]">
<P>Tubal disease, and particularly hydrosalpinx, has a detrimental effect on the outcome of in-vitro fertilisation (IVF). Performing a surgical intervention such as salpingectomy, tubal occlusion, aspiration of the hydrosalpinx fluid, or salpingostomy, prior to the IVF procedure in women with hydrosalpinges is thought improve the likelihood of successful outcome.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2009-06-08 14:02:53 +1200" MODIFIED_BY="jane clarke">
<P>To assess and compare the value of surgical treatments for tubal disease prior to IVF.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2009-11-06 14:10:20 +1300" MODIFIED_BY="jane clarke">
<P>Trials were sought in the Cochrane Menstrual Disorders and Subfertility Group trials register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, PSYCHMED and in Conference proceedings and reference lists up until Ocober 28 2009. Researchers in the field were contacted to reveal unpublished studies.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2009-06-08 14:03:13 +1200" MODIFIED_BY="jane clarke">
<P>All trials comparing a surgical treatment for tubal disease with a control group generated by randomisation were considered for inclusion in the review.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2009-06-08 14:03:21 +1200" MODIFIED_BY="jane clarke">
<P>Two reviewers independently assessed trial quality and extracted data. The studied outcomes were live birth, ongoing pregnancy, viable-, clinical- and biochemical pregnancy, ectopic pregnancy, miscarriage, multiple pregnancy, ovarian function and complications.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2009-10-27 15:40:09 +1300" MODIFIED_BY="jane clarke">
<P>Five randomised controlled trials involving 646 women were included in this review. Four studies assessed salpingectomy versus no treatment, two of which also included a tubal occlusion arm, and one trial assessed aspiration versus no treatment. No trials reported on the primary outcome: live birth. The odds of ongoing pregnancy (Peto OR 2.14, 95%CI 1.23 to 3.73) and of clinical pregnancy (Peto OR 2.31, 95%CI 1.48 to 3.62) however were increased with laparoscopic salpingectomy for hydrosalpinges prior to IVF. Laparoscopic occlusion of the fallopian tube versus no intervention did not increase the odds of ongoing pregnancy significantly (Peto OR 7.24, 95%CI 0.87 to 59.57) but the odds of clinical pregnancy (Peto OR 4.66, 95%CI 2.47 to 10.01) had sufficient power to show a significant increase. Comparison of tubal occlusion to salpingectomy did not show a significant advantage of either surgical procedure in terms of ongoing pregnancy (Peto OR: 1.65, 95%CI 0.74, 3.71) or clinical pregnancy (Peto OR 1.28, 95%CI 0,76 to 2.14). One RCT reported efficacy of ultrasound guided aspiration, however the odds of pregnancy did not show a significant increase in the odds of clinical pregnancy (Peto OR 1.97, 95%CI 0.62 to 6.29), and confidence intervals were wide. Throughout the different comparisons no significant differences were seen in adverse effects of surgical treatments.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2009-09-07 03:57:03 +1200" MODIFIED_BY="[Empty name]">
<P>Surgical treatment should be considered for all women with hydrosalpinges prior to IVF treatment. Previous evidence supported only unilateral salpingectomy for a unilateral hydrosalpinx (bilateral salpingectomy for bilateral hydrosalpinges). This review now provides evidence that laparoscopic tubal occlusion is an alternative to laparoscopic salpingectomy in improving IVF pregnancy rates in women with hydrosalpinges. Further research is required to assess the value of aspiration of hydrosalpinges prior to or during IVF procedures and also the value of tubal restorative surgery as an alternative (or as a preliminary) to IVF.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2009-11-06 14:08:45 +1300" MODIFIED_BY="jane clarke">
<BACKGROUND MODIFIED="2009-10-26 05:54:47 +1300" MODIFIED_BY="[Empty name]">
<P>Accounting for 14% of female infertility (RCOG); tubal pathology ranks among the most frequent causes of subfertility (<LINK REF="REF-Evers-2002" TYPE="REFERENCE">Evers 2002</LINK>). A spectrum of severity is recognized at laparoscopy, ranging from peritubal adhesions, through damaged fimbriae or distorted tubal anatomy, tubal blockage to the most severe manifestation of tubal disease: hydrosalpinx.</P>
<P>The couple with tubal factor subfertility has two therapeutic options to overcome the mechanical obstructions present in tubal disease: in-vitro fertilization (IVF) or reconstructive surgery. The place of reconstructive surgery is a topic of debate, as selection of patients and the method for tubal surgery is challenging (<LINK REF="REF-Dechaud-2004" TYPE="REFERENCE">Dechaud 2004</LINK>). IVF was primarily developed to treat tubal infertility (<LINK REF="REF-Steptoe-1978" TYPE="REFERENCE">Steptoe 1978</LINK>) and has been shown to be effective. However, a paradox emerged after recognition that IVF in patients with tubal disease was associated with lower implantation rates and an increased risk of early pregnancy loss (<LINK REF="REF-Andersen-1994" TYPE="REFERENCE">Andersen 1994</LINK>; <LINK REF="REF-Camus-1999" TYPE="REFERENCE">Camus 1999</LINK>; <LINK REF="REF-Englert-1987" TYPE="REFERENCE">Englert 1987</LINK>; <LINK REF="REF-Strandell-1994" TYPE="REFERENCE">Strandell 1994</LINK>; <LINK REF="REF-Vandromme-1995" TYPE="REFERENCE">Vandromme 1995</LINK>; and <LINK REF="REF-Zeyneloglu-1998" TYPE="REFERENCE">Zeyneloglu 1998</LINK>) than after IVF in other subfertile patients. This deleterious effect of tubal disease on IVF outcome may be related to the severity of tubal damage (<LINK REF="REF-Csemiczky-1996" TYPE="REFERENCE">Csemiczky 1996</LINK>; <LINK REF="REF-Vasquez-1995" TYPE="REFERENCE">Vasquez 1995</LINK>). Dissapointingly, the treatment was less effective in the patient group it was designed for than for subfertile patients with other causes for their subfertility. </P>
<P>There are several theories to explain the underlying mechanism by which hydrosalpinges exert a deleterious effect on IVF outcome. In these theories hydrosalpinx fluid seems to have a key role (<LINK REF="REF-Strandell-2002" TYPE="REFERENCE">Strandell 2002</LINK>). It has been proposed that the hydrosalpinx fluid may affect the transferred embryo; possibly by embryotoxic factors (<LINK REF="REF-Mukherjee-1996" TYPE="REFERENCE">Mukherjee 1996</LINK>) or a common factor deleterious to embryonic development and possibly by the lack of nutrients (<LINK REF="REF-Dickens-1995" TYPE="REFERENCE">Dickens 1995</LINK> and <LINK REF="REF-Tay-1997" TYPE="REFERENCE">Tay 1997</LINK>). The bathing of the endometrial cavity in hydrosalpinx fluid may interfere with the endometrial interaction with the transferred embryo necessary for implantation (<LINK REF="REF-Akman-1996" TYPE="REFERENCE">Akman 1996</LINK>; <LINK REF="REF-Fleming-1996" TYPE="REFERENCE">Fleming 1996</LINK>; <LINK REF="REF-Freeman-1996" TYPE="REFERENCE">Freeman 1996</LINK>; <LINK REF="REF-Katz-1996" TYPE="REFERENCE">Katz 1996</LINK>; <LINK REF="REF-Meyer-1997" TYPE="REFERENCE">Meyer 1997</LINK>; <LINK REF="REF-Strandell-1994" TYPE="REFERENCE">Strandell 1994</LINK> ). Furthermore mechanical effects exerted by hydrorrhoea (the leakage of hydrosalpinx fluid through the uterine cavity) (<LINK REF="REF-Andersen-1996" TYPE="REFERENCE">Andersen 1996</LINK>; <LINK REF="REF-Bloechle-1997" TYPE="REFERENCE">Bloechle 1997</LINK>; <LINK REF="REF-Mansour-1991" TYPE="REFERENCE">Mansour 1991</LINK>), the presence of a thin layer of fluid upon the endometrial surface (<LINK REF="REF-Andersen-1996" TYPE="REFERENCE">Andersen 1996</LINK>; <LINK REF="REF-Sharara-1999" TYPE="REFERENCE">Sharara 1999</LINK>) and changes in endometrial peristalsis by the fluid (<LINK REF="REF-Eytan-2001" TYPE="REFERENCE">Eytan 2001</LINK>) may wash-out or hinder implantation of the transferred embryo. Furthermore it has been postulated that hydrosalpinges, during IVF stimulation, may exert a negative influence on oocytes in early follicular recruitment (<LINK REF="REF-Freeman-1996" TYPE="REFERENCE">Freeman 1996</LINK>).</P>
<P>The lowered efficacy of IVF alone led to the concept that fallopian tube surgery prior to IVF might improve results. Suggested surgical interventions are: salpingectomy (<LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK>, <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>) salpingostomy (<LINK REF="STD-Goldstein-1998" TYPE="STUDY">Goldstein 1998</LINK>), aspiration of hydrosalpinx fluid (<LINK REF="REF-Aboulghar-1990" TYPE="REFERENCE">Aboulghar 1990</LINK>; <LINK REF="REF-Russel-1991" TYPE="REFERENCE">Russel 1991</LINK>; <LINK REF="REF-Sowter-1997" TYPE="REFERENCE">Sowter 1997</LINK>; <LINK REF="REF-Van-Voorhis-1998" TYPE="REFERENCE">Van Voorhis 1998</LINK>) tubal ligation (<LINK REF="REF-Murray-1998" TYPE="REFERENCE">Murray 1998</LINK>) and tubal occlusion by means of Filshie clips (<LINK REF="STD-Darwish-2005_x002c_2006_x002c_-2007" TYPE="STUDY">Darwish 2005,2006, 2007</LINK>), Essure micro-inserts (<LINK REF="REF-Kerin-2005" TYPE="REFERENCE">Kerin 2005</LINK>; <LINK REF="REF-Rosenfield-2005" TYPE="REFERENCE">Rosenfield 2005</LINK>) or electrocautery (<LINK REF="REF-Murray-1998" TYPE="REFERENCE">Murray 1998</LINK>; <LINK REF="REF-Stadtmauer-2000" TYPE="REFERENCE">Stadtmauer 2000</LINK>; <LINK REF="REF-Surrey-2001" TYPE="REFERENCE">Surrey 2001</LINK>).</P>
<P>Prior to the first version of this review in 2004, there was a shift in clinical practice towards surgical intervention prior to IVF. The majority of the clinicians in the field was convinced of efficacy by mostly retrospective or non-randomised published studies. Prior to this review there was a wide variation amongst surgeons in the surgical methods performed (<LINK REF="REF-Johnson2002" TYPE="REFERENCE">Johnson2002</LINK>). Despite guidelines recommending salpingectomy, based on the evidence provided by the previous version of this review, there remained a wide variation in the methods offered and employed in surgical management, according to a French (<LINK REF="REF-Ducarme-2006" TYPE="REFERENCE">Ducarme 2006</LINK>) and an English (<LINK REF="REF-Hammadieh-2004" TYPE="REFERENCE">Hammadieh 2004</LINK>) survey. Salpingectomy remains the most frequently undertaken procedure. This is still justified, as the previous version of this review analysed data on salpingectomy and the efficacy of other surgical treatments had not been proven by sufficiently powered prospective randomised controlled trials.</P>
<P>Each treatment has its own merits and drawbacks. Salpingectomy has the advantage that chronically infected tissue is removed in total; removing the risk of abscess formation or torsion and increasing the accessibility of the ovary during oocyte retrieval in IVF (<LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>). Drawbacks however are the invasiveness of the procedure itself and the difficulty of the procedure in case of dense adhesions. Furthermore it has been suggested that salpingectomy may affect ovarian function by interfering with ovarian blood flow (<LINK REF="REF-Dar-2000" TYPE="REFERENCE">Dar 2000</LINK>; <LINK REF="REF-Lass-1998" TYPE="REFERENCE">Lass 1998</LINK>). There are however reassuring data to suggest that ovarian compromise does not occur after salpingectomy (<LINK REF="REF-Strandell-2001" TYPE="REFERENCE">Strandell 2001</LINK>). Other possible adverse effects are interstitial pregnancy; which has been reported in two cases (<LINK REF="REF-Herman-1991" TYPE="REFERENCE">Herman 1991</LINK>; <LINK REF="REF-Shariff-1994" TYPE="REFERENCE">Shariff 1994</LINK>) or ovarian pregnancy (<LINK REF="REF-Hsu-2005" TYPE="REFERENCE">Hsu 2005</LINK>). Formation of cornual fistulae (<LINK REF="REF-Hsu-2005" TYPE="REFERENCE">Hsu 2005</LINK>) and cornual rupture have been described (<LINK REF="REF-Inovay-1999" TYPE="REFERENCE">Inovay 1999</LINK>) in single cases after salpingectomy by electrocautery. Salpingectomy is the treatment with the most permanent character - any possibility of conceiving spontaneously is removed. This is a psychological burden for the patient and an important drawback as many gynaecologists are aware of women who conceived spontaneously after being deemed to have hopeless tubal infertility. Compared to salpingectomy, aspiration, salpingostomy and tubal occlusion are thought to have the advantage of being less invasive, safer and easier to perform in the case of dense adhesions (<LINK REF="REF-Stadtmauer-2000" TYPE="REFERENCE">Stadtmauer 2000</LINK>), with shorter hospital stays (<LINK REF="REF-Surrey-2001" TYPE="REFERENCE">Surrey 2001</LINK>; <LINK REF="REF-Taylor-2001" TYPE="REFERENCE">Taylor 2001</LINK>). Tubal occlusion is also associated with risks of tubal surgery. A case of adnexal torsion (<LINK REF="REF-La-Combe-2003" TYPE="REFERENCE">La Combe 2003</LINK>) has been reported after occlusion by electrocautery. Theoretically aspiration may cause a flare-up of infection. The main difference of these procedures with salpingectomy is the less permanent character; this is regarded to be an advantage; however at the same time this is a disadvantage because a hydrosalpinx may recur (<LINK REF="REF-Bloechle-1997" TYPE="REFERENCE">Bloechle 1997</LINK>; <LINK REF="REF-Van-Voorhis-1998" TYPE="REFERENCE">Van Voorhis 1998</LINK> ; <LINK REF="REF-Sowter-1997" TYPE="REFERENCE">Sowter 1997</LINK>) after the intervention.</P>
<P>It is a major decision for patients who have suffered from infertility to undergo a surgical procedure to remove fallopian tubes prior to IVF and surgical procedures are not without risks. Therefore it is important to have the best available evidence that these interventions are beneficial.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2009-01-31 03:14:34 +1300" MODIFIED_BY="[Empty name]">
<P>To assess the efficacy of surgical treatment of tubal disease prior to IVF. The following surgical treatments for tubal disease were considered: salpingectomy (both unilateral and bilateral), tubal occlusion (both unilateral and bilateral), salpingostomy and hydrosalpinx fluid aspiration. The hypothesis that surgical treatment of tubal disease prior to IVF is beneficial by increasing the pregnancy and live birth rate, without substantially increasing complications related to the intervention, was tested.</P>
</OBJECTIVES>
<METHODS MODIFIED="2009-11-06 14:08:45 +1300" MODIFIED_BY="jane clarke">
<SELECTION_CRITERIA MODIFIED="2009-06-08 14:14:36 +1200" MODIFIED_BY="jane clarke">
<CRIT_STUDIES>
<P>All randomised controlled trials (RCTs) comparing women undergoing surgical treatment for tubal disease prior to IVF with a control group (which could include another type of surgery, medical treatment or no treatment) were considered eligible for inclusion.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2008-09-23 09:43:27 +1200" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: women with diagnosed tubal disease due to undergo IVF<BR/>Exclusion criteria: none</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2009-06-08 14:14:36 +1200" MODIFIED_BY="jane clarke">
<P>All studies comparing salpingectomy, tubal occlusion, salpingostomy, tubal occlusion, ultrasound guided aspiration of hydrosalpinx fluid or any other surgical procedure performed uni and/or bilaterally for tubal pathology; with no intervention or with any other mentioned intervention, were considered eligible for inclusion. <BR/>
</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2009-06-08 14:14:36 +1200" MODIFIED_BY="jane clarke">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2009-01-31 00:22:04 +1300" MODIFIED_BY="[Empty name]">
<P>(1) Live birth rate - defined as number of live birth deliveries per woman randomised.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2009-06-08 14:14:36 +1200" MODIFIED_BY="jane clarke">
<P>(1) Pregnancy<BR/>(a) Ongoing pregnancy rate- defined as number of pregnancies surpassing the first twelve weeks of pregnancy, trimester, per woman randomised<BR/>(b) Viable pregnancy rate - rate of pregnancy diagnosed by gestational sac with fetal heart activity on ultrasound.<BR/>(c) Clinical pregnancy rate - rate of pregnancy diagnosed by gestational sac on ultrasound and biochemical pregnancy test.<BR/>(d) Biochemical pregnancy rate - rate of pregnancy diagnosed by biochemical pregnancy test.<BR/>(e) Pregnancy rate according to any definition - 'pregnancy rate' undefined.</P>
<P>(2) Adverse effects<BR/>(a) Ectopic pregnancy rate. - rate of ectopic pregnancies per woman randomised.<BR/>(b) Miscarriage rate - rate of miscarried pregnancies, per woman randomised.<BR/>(c) Multiple pregnancy rate - rate of multiple pregnancies amongst clinical pregnancies<BR/>(d) Surgical complication rate. - rate of any complication of the interventions considered.<BR/>(e) Ovarian response to IVF - defined as number of oocytes retrieved.<BR/>
</P>
<P>If outcomes were not reported as above, sufficient information had to be available to convert results to the outcomes stated above.</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2009-11-06 14:08:45 +1300" MODIFIED_BY="jane clarke">
<P>Eligible studies since the previous version of this review in 2004 were identified by a predefined search strategy in electronic databases, handsearching, reference lists and contacting authors.</P>
<ELECTRONIC_SEARCHES MODIFIED="2009-11-06 14:08:45 +1300" MODIFIED_BY="jane clarke">
<P>A predefined and customised search developed by the trial search coordinator of the Menstrual Disorders and Subfertility Group was employed in the following databases:</P>
<UL>
<LI>Menstrual Disorders and Subfertility Group Specialised Register (inception to 28.10.09)</LI>
<LI>Ovid The Cochrane Central Register of Controlled Trials (CENTRAL) (from inception to 4<SUP>th</SUP> Quarter 2009)</LI>
<LI>Ovid MEDLINE (1950 to 28.10.09)</LI>
<LI>Ovid EMBASE (01.01.08 to 28.10.09).</LI>
</UL>
<P>The detailed search strategy is presented in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>
</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2009-01-31 03:21:46 +1300" MODIFIED_BY="[Empty name]">
<P>Relevant conference proceedings were retrieved by handsearching proceedings of the European Society for Human Reproduction, the British Fertility Society, the Fertility Society of Australia, the American Society of Reproductive Medicine, the World Congress on In Vitro Fertilisation and Human Reproductive Genetics, ESGE, ANZJOG and in ISI Proceedings.</P>
<P>Reference lists of included trials, eligible studies, conference abstracts and relevant review articles were searched for more potentially relevant studies. Furthermore, the authors of previously included and excluded trials, and the first or corresponding author of eligible trials were contacted to ascertain if they were aware of any ongoing or unpublished trials.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2009-10-26 05:54:47 +1300" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2009-01-31 03:22:18 +1300" MODIFIED_BY="[Empty name]">
<P>Eligibility of identified citations, according to the previously stated criteria, was assessed by two reviewers independently. This was done by reading the abstract and if necessary by retrieving the article in full. If reviewers disagreed about eligibility, a third reviewer was to be contacted (MS) to achieve consensus on eligibility.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2009-05-24 19:09:29 +1200" MODIFIED_BY="[Empty name]">
<P>Two reviewers (NJ and SVV) independently assessed study characteristics and methodological details of included studies using data extraction forms. Differences in opinion were to be resolved by consultation of a third reviewer (MS). Where additional information on trial methodology or original trial data was required corresponding authors were contacted. Reminder correspondence was sent if a reply was not received within two weeks.</P>
<P>A detailed list of the items assessed during data extraction is presented in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2009-01-31 03:23:31 +1300" MODIFIED_BY="[Empty name]">
<P>Two reviewers (NJ and SVV) independently assessed study characteristics and methodological details of included studies using data extraction forms. Differences in opinion were to be resolved by consultation of a third reviewer (MS). Where additional information on trial methodology or original trial data was required corresponding authors were contacted. Reminder correspondence was sent if a reply was not received within two weeks.</P>
<P>A detailed list of the items assessed during data extraction is presented in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2009-06-08 14:14:37 +1200" MODIFIED_BY="jane clarke">
<P>As this review considers dichotomous data (pregnant or not pregnant after IVF with or without surgical intervention), data were expressed as a Peto odds ratio (OR) with 95% confidence intervals (CI).</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2009-06-08 14:53:37 +1200" MODIFIED_BY="jane clarke">
<P>As defined by the in- and exclusion criteria, this review only incorporated randomised controlled trials. Therefore different levels of randomisation did not have to be taken into account in the analysis: the numbers of observations matched the numbers of people randomised by definition.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2009-10-26 04:17:09 +1300" MODIFIED_BY="[Empty name]">
<P>Missing data were analysed intention to treat: the total number or randomised participants were used as the denominator, irrespective of how the original study authors analysed the data. Missing data, and how this was handled by the trial, was also incorporated as a quality item. Based on the extent to which data were missing, the potential impact of the missing data on the results was to be explored by sensitivity analysis.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2009-06-08 14:14:37 +1200" MODIFIED_BY="jane clarke">
<P>Prior to meta-analysis, statistical heterogeneity between the results of different studies was examined graphically by inspecting the scatter in the data points on the graphs and the overlap in their confidence intervals and, more formally, by checking the results of chi-squared tests.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2009-10-26 05:54:47 +1300" MODIFIED_BY="[Empty name]">
<P>Regarding the source of data; a funnel plot was planned to examine the possibility of a publication bias if there were ten or more included trials. When funnel plots suggested liability of a publication bias; funnel plots were to be attached.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2009-09-07 04:00:48 +1200" MODIFIED_BY="[Empty name]">
<P>Statistical analysis was performed in accordance with the guidelines for statistical analysis of the Cochrane handbook.</P>
<P>Peto odds ratios (OR) were combined for meta-analysis with RevMan 5 software using the Peto-modified Mantel-Haenszel method, where pooling was acceptable in the absence of heterogeneity. An increase in the odds of a particular outcome (which may be beneficial, for example in the case of live birth, or detrimental, for example in the case of ectopic pregnancy) was displayed graphically in the meta-analyses to the right of the centre-line and a decrease in the odds of an outcome was displayed graphically to the left of the centre-line.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2009-09-07 04:00:52 +1200" MODIFIED_BY="[Empty name]">
<P>If heterogeneity was present clinical considerations were examined which theoretically could lead to heterogeneity. Further investigation was to be done by sensitivity analysis.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2009-09-07 04:01:00 +1200" MODIFIED_BY="[Empty name]">
<P>A sensitivity analysis was planned to examine the stability of the results in relation to potential risk of bias and the source of the data (published or unpublished).</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2009-10-27 15:50:44 +1300" MODIFIED_BY="jane clarke">
<STUDY_DESCRIPTION MODIFIED="2009-10-27 15:49:40 +1300" MODIFIED_BY="jane clarke">
<SEARCH_RESULTS MODIFIED="2009-10-27 15:48:19 +1300" MODIFIED_BY="jane clarke">
<P>The employed search strategy identified 103 potentially relevant citations. Contacting authors did not reveal any unpublished trials. Nine of the 103 citations were potentially eligible and retrieved in full for final in or exclusion:<LINK REF="STD-Darwish-2005_x002c_2006_x002c_-2007" TYPE="STUDY">Darwish 2005,2006, 2007</LINK>; <LINK REF="STD-Gelbaya-2006" TYPE="STUDY">Gelbaya 2006</LINK>; <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK>; <LINK REF="STD-Hotineanu-2007" TYPE="STUDY">Hotineanu 2007</LINK>; <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>; <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> and <LINK REF="STD-Zolghadri-2006" TYPE="STUDY">Zolghadri 2006</LINK>. Previously, four studies were found to be eligible in this review (<LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK>; <LINK REF="STD-Goldstein-1998" TYPE="STUDY">Goldstein 1998</LINK>; <LINK REF="STD-Mardesic-1999" TYPE="STUDY">Mardesic 1999</LINK>; and <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>).</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2009-10-27 15:49:40 +1300" MODIFIED_BY="jane clarke">
<P>Previously three RCTs, with a total of 295 women, met the criteria for inclusion in the review (<LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK>; <LINK REF="STD-Goldstein-1998" TYPE="STUDY">Goldstein 1998</LINK>; <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>). Of the newly identified trials <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK>; <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> and <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> were included.</P>
<P>Inclusion of <LINK REF="STD-Goldstein-1998" TYPE="STUDY">Goldstein 1998</LINK> was reconsidered as it was unsure whether randomisation was performed; it appeared that patients may have been their own historical controls. This study was presented only in abstract form and has not been published in a peer reviewed journal. Attempts to contact the author to clarify this were unsuccessful and the trial was therefore excluded. This review therefore considers five trials, analysing a total of 646 women.</P>
<P>Of the included trials, two trials assessed the effectiveness of laparoscopic salpingectomy compared to no salpingectomy for women with hydrosalpinges prior to IVF (<LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK>; <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>); two trials assessed and compared effectiveness of laparoscopic tubal occlusion with laparoscopic salpingectomy and no intervention (<LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>, <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>); <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK> was the only trial to contribute to the comparison of ultrasound guided aspiration of the hydrosalpinges during the IVF cycle with no aspiration.</P>
<P>
<B>
<I>Design: </I>
</B>
<BR/>All studies were randomised controlled trials. Time of follow-up was longest in <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK>; which had a follow-up time of 1 to 5 years in which data on outcomes of more than one IVF attempt per patient were collected. Follow-up of the four other studies (<LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK>; <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>; <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>; <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>) was up to the results of the first IVF cycle. The follow-up scheme was known for all trials.</P>
<P>
<B>
<I>Sample size</I>
</B>
<I>
<BR/>
</I>
<LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK> and <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK> were the trials with the smallest study size, each assessing around 60 women. <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> reported results of 112 women; these women were randomised into three intervention groups. <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> and <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK> were the largest trial both reporting results of 204 women; <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> also had three randomisation groups.</P>
<P>Losses to follow-up and withdrawal occurred, but were of acceptable size in <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK> (N=17); and <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> (N=3), and dealt with by intention to treat. In the trials of <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> and <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK> there were no losses to follow-up or withdrawals; in the trial of <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK> loss to follow-up and withdrawal was not reported, but the number of analysable results was the same as the number of women randomised.</P>
<P>Three of the five trials (<LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK>; <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK>; <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>) were performed in single centre studies; 2 of these settings were academic, one was non-academic. <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>; was a multicenter trial (9 Nordic centres) and <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> was a trial performed in an academic- and a non-academic centre. None of the studies reported data on the characteristics of the surgeons involved.</P>
<P>
<B>
<I>Participants:</I>
</B>
<BR/>Inherent to RCT's, participants were recruited prospectively; correspondence clarified that patient sampling was consecutive in the trials of <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> and <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>. The method of participant sampling was not reported in the remaining studies.</P>
<P>The important prognostic factor of age was stated by all trials; all participants were at least below the age of 41. The population in the trail of <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> was younger; as age &#8806;35 was applied as an inclusion criterion. The duration of subfertility was stated in two trials; the duration varied from 22 to 89 months in the trial of <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK> and after application of the inclusion criterion (subfertility &gt;2 years) the duration of subfertility varied from 19 to 73 months in the trial of <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>. Distribution was similar among intervention and control group(s) in both trials. The proportion of women with primary and secondary subfertility was specified in <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>; <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK>; <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK>; <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> and <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> (after correspondence). The majority of patients had primary subfertility; the distribution of primary subfertility throughout the intervention groups was similar. A standard fertility investigative work-up was done in two trials: <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK> and <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>. <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> and <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK> only reported baseline FSH's. <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK>; <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> and <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>; included couples with coexistent male factor infertility undergoing ICSI; the proportion of these couples were similar in groups within the studies. As <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK> was a multicentre trial; it was specified that ICSI patients were included only when the unit had an ICSI program with success rates equivalent to conventional IVF for non-male factor causes of infertility. <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>; also a multicentre trial, did not specify this. No trials stated previous fertility treatments; all trials either specified that patients did not undergo IVF treatment prior to the trial or applied this as an exclusion criterion.</P>
<P>The extent of the cause of infertility was defined in all trials. In the <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK> trial, tubal infertility was defined by both radiologic and laparoscopic criteria as being severe and unsuitable for tubal repair. The inclusion criteria for this trial were either (1) a hysterosalpingogram showing extensive inflammatory disease in the proximal part of tube with diverticula extending to involve more than two centimetres of the tubal isthmus or hydrosalpinges with poor prognosis because of disturbed mucosal folds or irregular walls; or (2) a laparoscopy revealing the presence of proximal nodes or an inflammatory and thick-walled hydrosalpinx. The inclusion criteria for the <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK> trial were uni- or bi-lateral hydrosalpinges, defined as a distally occluded or pathologically dilated fallopian tube or one which became so on diagnostic tubal patency testing. The <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK> trial included women with uni- or bi-lateral hydrosalpinx diagnosed by ultrasound during ovarian stimulation in the IVF cycle or previous ultrasound examination. Furthermore, this trial included women with hydrosalpinges from the waiting list for tubal surgery. The <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> trial included women with unilateral of bilateral hydrosalpinges; confirmed by HSG, suitability for IVF-ICSI treatment. <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> included women with bilateral distal tubal occlusion diagnosed by HSG and hydrosalpinges visible on ultrasound. The distribution of tubal pathology uni- and bilaterally was specified in trials of <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK>; <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>; and <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>. <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK>. In the trial of <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> all patients had bilateral tubal pathology. The proportion of hydrosalpinges visible on ultrasound was reported in <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK>; <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>; <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> and <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>; . Besides in the trial of <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK>, where patients were included after diagnosis of hydrosalpinges by ultrasound, it was not clear whether identified subgroups were pre-specified.</P>
<P>The IVF protocol was clearly described in all trials. In the trial of <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> higher dosages of gonadotropins were used than in other trials (225 IU). Except for <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK> and <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK>, all studies reported results over 1 IVF cycle. It was possible to extract results over the first cycle separate from further IVF cycles. Timing of IVF after the intervention was reported by all studies. Of the trials assessing efficacy of salpingectomy or laparoscopic occlusion, <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>; <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> and <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK> had a time interval from surgery to IVF of approximately 2 to 3 months. The trial of <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK> had a wider variation in time from intervention to IVF; varying from 1 to 17 months. The time interval between randomisation and IVF was similar in control groups compared to intervention groups in the trials of <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK> and <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK>, differed slightly in the trial of <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK> and was not specified in the trials of <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> and <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>.</P>
<P>
<B>
<I>Interventions</I>
</B>
</P>
<P>In the previous version of this review salpingectomy was the only surgical intervention in the included trials. Trials did differ in whether uni or bilateral salpingectomy was performed; the co-interventions which were performed; and in the control group to which they were compared.<BR/>
<LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK> assessed laparoscopic bilateral salpingectomy regardless of whether tubal disease was uni- or bi-lateral; <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK> assessed uni- or bi-lateral salpingectomy (depending on whether uni- or bi-lateral hydrosalpinges were present). In fact, of the 116 women randomised to laparoscopic surgery, there were 63 bilateral salpingectomies, 40 unilateral salpingectomies, six proximal ligations with distal fenestrations, one salpingostomy, one adhesiolysis, one no intervention as the fallopian tubes were found to be patent and five women did not undergo surgery - these were all included in the treatment group in an intention to treat analysis. The control groups differed among the previously included studies. In the trials of <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK> and <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>; no salpingectomy was performed. In the trial of <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK> patients did undergo adhesiolysis. <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>; <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> also contributed data to the comparison of salpingectomy with no salpingectomy. In the trial of <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> salpingectomy was performed uni- or bilaterally depending on the presence of either uni- or bilateral tubal pathology. In the trial <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> the intervention was performed bilaterally. Control groups were similar namely: no intervention. No co-interventions were performed in <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK> and <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>; this was unclear for the trial of <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>. It was deemed appropriate to pool the data from these four trials for meta-analysis since they all prospectively evaluated a group of women who underwent salpingectomy on the fallopian tube (salpingectomy in most cases in all three trials) versus a control group who did not have this surgical intervention.</P>
<P>There was only one trial available to compare aspiration of hydrosalpinges to no aspiration. <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK> assessed aspiration of hydrosalpinges under ultrasound guidance; immediately after oocyte retrieval during the IVF cycle. This was performed uni- or bilaterally depending on the distribution of the hydrosalpinges. To prevent infection in the intervention group, co interventions administered were: using two different aspiration needles in case of bilateral tubal pathology, and intravenous Augmentin was administered at the time of intervention followed by 3 days of oral Azithromycin.</P>
<P>There were two trials evaluating proximal tubal occlusion (<LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>; <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>). In the trial of <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> tubal occlusion was performed by bipolar diathermy at two separate sites on the isthmic segment of the tube. This was performed uni- or bilaterally depending on the presence respectively of uni or bilateral tubal pathology. In the trial of <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> tubal occlusion was accomplished laparoscopically by clipping of the tubes proximally. Both studies had similar control groups: no intervention in women with hydrosalpinges. As both studies had two comparison groups (salpingectomy besides a non-intervention group) data of the control group were also used in the assessment of salpingectomy in our review. No information on the performance of co-interventions was given in <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>. The fact that the method and approach of occlusion was different in the trial of <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> was dealt with by classifying <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> under an own subgroup within the outcome. Because the studies of <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> and <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> both assessed occlusion; the main mechanism of the treatment was similar pooling was thought to be appropriate. The trials of <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> and <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> were pooled and no statistical heterogeneity was present.</P>
<P>
<B>
<I>Outcome</I>
</B>
</P>
<P>None of the trials reported live birth rates strictly. Where live birth rates were supposedly reported they were combined with ongoing pregnancy rates (<LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>). As live births are inherently also ongoing pregnancies, <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK> was pooled with ongoing pregnancy outcomes for meta-analysis.</P>
<P>
<LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK> and <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> reported ongoing pregnancy rates as defined in our objectives. <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK> and <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> did not report the ongoing pregnancy.</P>
<P>The number of pregnancies was reported in all trials. The trials of <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK>; <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>; <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> and <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK> defined clinical pregnancy as the presence of a gestational sac on ultrasound; <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> also looked at the presence of a fetal pole. Correspondence clarified that <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> also looked at cardiac activity of pregnancies at 6 weeks (which would reflect viable pregnancy); it is unclear whether results reflect only numbers with positive cardiac activity and therefore purely viable pregnancies, or gestational sacs and viable pregnancies combined. Therefore results were classified as clinical pregnancies. <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK> presented results of biochemical pregnancy. No studies presented outcomes of IVF as viable pregnancies. <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK> was the only study not to define 'pregnancy' as a viable, clinical or biochemical pregnancy; these results were therefore only classified under 'pregnancy of any kind.</P>
<P>Except for <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK>; all data of ongoing and clinical pregnancy were reported either per IVF cycle per woman or sufficient data was available to be converted to pregnancy per cycle per woman. <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK> reported the pregnancy rate for the first cycle of IVF after recruitment and for all IVF cycles - the rates per woman could be extracted from these data. Cumulative pregnancy rates were also presented although these could not be used in this meta-analysis owing to assumptions made by the authors about the couples for whom no data were available. Data of only the first cycle could be extracted. There has been a subsequent publication of the cumulative results from the Nordic multicenter trial in 2001 (<LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>). Results have been reported on an actual treatment received basis (rather than intention-to-treat in the original publication), justified on the grounds that 24 out of 77 women who were randomised to no surgical intervention, subsequently underwent salpingectomy after one or two failed cycles before proceeding with further IVF, the results of these cycles then being included in the analysis. These results have been excluded from the meta-analysis. The intention-to-treat data, requested from the trial authors, have also been excluded from the meta-analysis owing to a potential for bias from the number of women randomised to no intervention who have now, in fact, received the surgical intervention. The original 1999 data (<LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>) have been maintained in the meta-analysis.</P>
<P>Ectopic pregnancy rates per woman (the number of women experiencing at least one ectopic pregnancy over the time period) could be extracted from all trials except for <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>; which did not report these results. All studies reporting ectopic pregnancy rates, except for <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> did not define ectopic pregnancy.</P>
<P>Data on miscarriage rates could be extracted from all trials. The trial of <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK> reported miscarriage rates per biochemical pregnancy; after correspondence it was possible to convert this data to miscarriage rate per clinical pregnancy. All other studies did not define miscarriage rate as to whether this was per clinical pregnancy per woman. Therefore we extracted data for miscarriage rates where possible; but these rates were not pooled in the meta-analysis.</P>
<P>Surgical complication rates were reported by the trials of <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK> and <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>.</P>
<P>IVF-treatment characteristics, and mean number of retrieved oocytes were stated or clarified after correspondence by all trials. They were similar between intervention and control groups.</P>
<P>The included studies and their methodological details are summarised comprehensively in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2009-01-31 03:31:49 +1300" MODIFIED_BY="[Empty name]">
<P>Previously, the <LINK REF="STD-Mardesic-1999" TYPE="STUDY">Mardesic 1999</LINK> trial, was excluded because the control group was historical (the same women prior to their salpingectomy). Furthermore no pregnancies occurred in the historical control group prior to salpingectomy.</P>
<P>According to the abstracts of the potentially relevant citations, <LINK REF="STD-Gelbaya-2006" TYPE="STUDY">Gelbaya 2006</LINK> and <LINK REF="STD-Zolghadri-2006" TYPE="STUDY">Zolghadri 2006</LINK> were excluded after reading the full report of the trial. The <LINK REF="STD-Gelbaya-2006" TYPE="STUDY">Gelbaya 2006</LINK> trial did not meet inclusion criteria as the trial appeared to be a retrospective non randomised trial. The trial of <LINK REF="STD-Zolghadri-2006" TYPE="STUDY">Zolghadri 2006</LINK> was excluded because IVF was not performed. The objective of the trial was to assess continuation of spontaneous pregnancy after tubal surgery.</P>
<P>The <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table summarises the reasons for exclusion.</P>
<P>Identified non-randomised studies (<LINK REF="REF-Aboulghar-1990" TYPE="REFERENCE">Aboulghar 1990</LINK>; <LINK REF="REF-Savic-1999" TYPE="REFERENCE">Savic 1999</LINK>;<LINK REF="REF-Sowter-1997" TYPE="REFERENCE">Sowter 1997</LINK> <LINK REF="REF-Stadtmauer-2000" TYPE="REFERENCE">Stadtmauer 2000</LINK>; <LINK REF="REF-Van-Voorhis-1998" TYPE="REFERENCE">Van Voorhis 1998</LINK>) were previously summarised in a non-randomised studies table. The current employed search has identified an additional retrospective trial (<LINK REF="STD-Gelbaya-2006" TYPE="STUDY">Gelbaya 2006</LINK>) however as the identification of non-randomised studies was not a predefined objective and a filter for RCT's was applied in our search strategy, the search results may not be representative. This and the fact that the number of randomised studies has increased was reason to no longer present a table of non-randomised studies.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2009-10-27 15:46:12 +1300" MODIFIED_BY="jane clarke">
<P>
<BR/>Blinding of physician performing IVF and the outcome assessor was not performed in most trials (<LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK>; <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK>; <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>; <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>) or not reported to be performed (<LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>).</P>
<P>Incomplete data was addressed with an intention to treat analysis in <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK> and <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> (clarified after correspondence) and seemed to be performed in <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK>; and <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>; since number of randomised patients was the same as the number of analysed patients. Length of follow-up was long enough to adequately detect stated outcomes. The source of funding was either stated or clarified after correspondence in all trials except <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK>.</P>
<P>A power calculation was performed in four studies (<LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK>; <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>; <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>; <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK>); but sufficient sample size was not achieved in three of them and the calculation was not performed correctly in one trial . <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK> powered the trial based on 300 couples, but stopped recruiting after 204 couples had been recruited and randomised, owing to inability to reach the target number within a reasonable time as a result of an apparent decrease in the incidence of hydrosalpinx in Scandinavia during the study period. In the trial of <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK> the inability to generate the large number of patients for the study led to early cessation of the trial. In the trial of <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> it may be questioned whether the power calculation was adhered to because large differences were anticipated, which were unlikely to be achieved. <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK> stated that the sample size was not attained after four years because patients preferred salpingectomy rather than aspiration. Although three trials (<LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>; <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK>; <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK>) were stopped early, there is no suggestion that this was related to their accruing outcomes.</P>
<P>It was uncertain whether a power calculation was performed in <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>, but as study sizes were small it may be presumed that they have not been adhered to if they where performed.</P>
<P>Funnelplots were inspected; no publication bias is apparent.</P>
<P>Methodological quality assessment is summarised graphically in <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK> and <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2009-10-27 15:50:44 +1300" MODIFIED_BY="jane clarke">
<P>Surgical treatment for hydrosalpinges by laparoscopic salpingectomy versus non-surgical management significantly increased the odds of ongoing pregnancy (Peto OR 2.20, 95%CI 1.26 to 3.82; 329 women, three trials, <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>), and of clinical pregnancy (Peto OR 2.31, 95%CI 1.48 to 3.62; 395 women, three trials,<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> ), and pregnancy according to any definition (Peto OR 2.49, 95%CI 1.60 to 3.86; 455 women, three trials, <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P>
<P>Surgical treatment by laparoscopic occlusion of the fallopian tube versus no intervention on the fallopian tube did not increase the odds of ongoing pregnancy (Peto OR 7.21, 95%CI 0.87 to 59.57; 65 women, one trial,<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> ) significantly, but the observation had lack of power and therefore very wide confidence intervals. However the odds of clinical pregnancy were increased significantly (Peto OR 4.66, 95%CI 2.17 to 10.01; 209 women, two trials, <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>) where meta-analysis of women had improved power.</P>
<P>The one trial reporting on aspiration does not report a significantly increased odds of clinical pregnancy (Peto OR 1.97, 95%CI 0.62 to 6.29; 64 women, one trial, <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>) and of biochemical pregnancy (Peto OR 2.78, 95%CI 0.93 to 8.27, 64 women, one trial, <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). No data were available on live birth or ongoing pregnancy rate.</P>
<P>Comparison of laparoscopic salpingectomy and laparoscopic occlusion did not show a significant difference in terms of ongoing pregnancy based on 1 study (Peto OR 1.65, 95%CI 0.74 to 3.71; 100 women, one trial,<LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK> ), clinical pregnancy (Peto OR 1.28, 95%CI 0,76 to 2.14; 238 women, two trials, <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>). No data were available on live birth or ongoing pregnancy rate.</P>
<P>Throughout the different comparisons no significant differences were seen in the odds of ectopic pregnancy, miscarriage, and the odds of surgical treatment complications (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>; <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>; <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>).The trial of <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK> did not report a significant difference in infection rate between intervention and control group. <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK> reported two surgical complications, one conversion from laparoscopic surgery to laparotomy and, one case of a postoperative infection.</P>
<P>The mean number of oocytes (SD) retrieved in patient groups treated with salpingectomy (<LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>10.6(±5.9); <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK> 10.1(±5.0); <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>12.1(±5.0); <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> 10.4(±6.0)) did not differ with the mean number of oocytes retrieved in control groups (10.6(±6.1) <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>; 10.6(±6.1) <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK>; 10.9(±5.1) <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>; 9.8(±5.5) <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>) nor with number of oocytes retrieved after other surgical interventions for hydrosalpinges: (aspiration: 14.1(±7.1) <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK> ; tubal occlusion: 11.6(±4.9) <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>; 10.2(±5.7) <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>).</P>
<P>Generally there was no heterogeneity present across trials. There was a moderate heterogeneity present in the comparison group of salpingectomy where <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK> and <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> were pooled, for the outcome of clinical pregnancy (I<SUP>2</SUP>=52%)(<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>) and a mild heterogeneity for the outcome of any pregnancy (I<SUP>2</SUP>=31%)(<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>); chi<SUP>2</SUP>results for heterogeneity however were not significant. Pooling was further justified by the fact that no heterogeneity was present where these trials where pooled elsewhere and by clinical characteristics of trials.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2009-11-06 13:29:29 +1300" MODIFIED_BY="jane clarke">
<SUMMARY_OF_RESULTS MODIFIED="2009-10-27 15:46:28 +1300" MODIFIED_BY="jane clarke">
<P>This Cochrane review summarises the current evidence on the effectiveness of tubal surgery prior to IVF.</P>
<P>The effectiveness of laparoscopic salpingectomy, that was already demonstrated in the previous version of this review, is supported more strongly by the current data, in terms of ongoing pregnancy and clinical pregnancy. Unfortunately, a complete report on live birth as an outcome was lacking in all of the included studies. The ongoing pregnancy rates in the intervention and control group were 31% and 17.6%.</P>
<P>Of other surgical interventions, laparoscopic tubal occlusion is shown to improve the odds of clinical pregnancy after meta-analysis for the first time. Results for the outcome ongoing pregnancy reported by only one trial were not significant (but this comparison was underpowered). The beneficial effect of laparoscopic tubal occlusion is further supported by the finding that comparison of laparoscopic occlusion and laparoscopic salpingectomy showed similar efficacy.</P>
<P>There is only one randomised controlled trial reporting on aspiration. This study was underpowered leaving the need for more trials assessing aspiration of hydrosalpinges.</P>
<P>Currently, no conclusions can be made regarding the adverse effects of interventions. Data on ectopic pregnancy, miscarriage, and or surgical complications of treatment remain underpowered.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2009-11-06 13:29:29 +1300" MODIFIED_BY="jane clarke">
<P>This Cochrane review was performed according to current standards of the Cochrane collaboration and of the Menstrual Disorders and Subfertility group.</P>
<P>Applicability and completeness of this review reflects the study characteristics and completeness by which these were reported. Besides the lack of reporting on the primary outcome (live birth), reported outcomes, patient and treatment characteristics were reported quite complete. Given that the interventions would not be expected to alter the occurrence of pregnancy loss from second trimester onwards, ongoing pregnancy presents an entirely suitable surrogate primary outcome for live birth.</P>
<P>Current findings apply for women that were recruited by included studies: women &lt;41 years of age with hydrosalpinges, diagnosed by diagnostic laparoscopy and/or HSG, who have not had IVF previously. Results also apply for IVF-ICSI.</P>
<P>The efficacy found in this analysis applies for a time interval of two to three months between tubal occlusion or salpingectomy and IVF. Results apply for unilateral of tubal occlusion or salpingectomy in case of a unilateral hydrosalpinx and bilateral employment in case of bilateral surgery. There is no evidence for bilateral tubal salpingectomy or occlusion regardless of the distribution of tubal pathology, because this has only been assessed for salpingectomy by one study (<LINK REF="STD-Darwish-2005_x002c_2006_x002c_-2007" TYPE="STUDY">Darwish 2005,2006, 2007</LINK>).</P>
<P>An important question in evaluating the efficacy of interventions is &#8216;who can achieve the reported results from these interventions?&#8217; A weakness of included studies is that information on the skills of the performer is not provided. Despite the fact that some methods for tubal occlusion might require less surgical skill, we recommend, in agreement with the general opinion, that tubal surgery should only be performed by gynaecologists who have appropriate training in microsurgery or laparoscopy and who operate on a steady volume of patients to maintain a high level of skill (<LINK REF="REF-Dechaud-2004" TYPE="REFERENCE">Dechaud 2004</LINK>).</P>
<P>This review reflects the opinion that definitions of fertility should be sharpened (<LINK REF="REF-Clarke-2008" TYPE="REFERENCE">Clarke 2008</LINK>). Therefore we focused primarily on live birth, and secondarily on ongoing pregnancy and viable, clinical or biochemical pregnancy. Sadly however, studies either did not report on live birth, or combined ongoing pregnancy results with live birth rates. In the last case data was classified under ongoing pregnancy. As studies do not always report pregnancy strictly the category: pregnancy according to any definition was used. This was done to prevent loss of data; this was specified and outcomes should be regarded with care.</P>
<P>As there are numerous suggested outcomes for ovarian response<B>;</B> and we were only able to assess differences in the mean number of oocytes retrieved, as reported by the trials themselves, the conclusion should be interpreted with caution. More evaluation of the difference in ovarian response prior to and after salpingectomy should be performed and compared with other interventions. Other measures of ovarian reserve could be considered as other outcome measures.</P>
<P>Study size and power has been proven to be an important issue in the previous version of this review where reviewed outcomes were not significant prior to meta-analysis but significant after meta-analysis. Generally, all studies but one (<LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>) were underpowered. In the newly added comparison of tubal occlusion, study size was sufficient to show important differences for the the outcome clinical pregnancy after meta-analysis; the fact that the odds of ongoing pregnancy were not significantly improved is probably due to the fact that only one study reported this outcome. This also applies for the results of aspiration, where outcomes also depend on only one trial. Adverse effects naturally have lower event rates and thus need a larger sample size to reach significance, thus ectopic pregnancy and miscarriage were underpowered adverse events. Studies report the difficulty to adhere to power calculations because the expected number of recruits was too large for a single department (<LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK>). Furthermore drawbacks of a multicentre trial are differences in surgical skill and possibly sample selection. This is a difficult matter to be addressed in attaining sample size.</P>
<P>Data of four studies reporting on laparoscopic salpingectomy, including two that also reported on laparoscopic tubal occlusion, were pooled for meta-analysis. Was it appropriate to pool the data from these trials? In general pooling was appropriate because trials were clinically similar regarding the extent of tubal pathology and the procedure employed in both the intervention and the control group. There were however some considerations regarding pooling; it should be explained as to why pooling was still justified in these cases.  </P>
<P>A clinical consideration in the salpingectomy group was the trial of <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK>. This trial differed from other studies by the fact that salpingectomy was employed bilaterally regardless of the distribution of hydrosalpinges. Other studies in this pool employed uni or bi-lateral salpingectomy depending on whether the hydrosalpinx was uni or bi-lateral (<LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>; <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>) or bilateral by definition as all patients included had hydrosalpinges bilaterally (<LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>) . As in essence, all four trials compared a group who underwent laparoscopic surgery to remove on a fallopian tubes to thus prevent hydrosalpinx fluid spill into the uterine cavity versus a group who did not have this surgical intervention, data were pooled. There was no statistical heterogeneity for outcomes where the trial of <LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK> was involved, supporting the decision to pool the data.<BR/>
</P>
<P>Regarding analysis of data on the efficacy of tubal occlusion a consideration was that the methods of occlusion differed: <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> used diathermy to achieve occlusion; <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> used clamping. This difference was dealt with by classifying trials in different subgroups. Pooling of data of <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> and <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> however seemed acceptable because the pathophysiologic mechanism of occlusion, regardless of the method, seems similar. Pooling was supported because there was no statistical heterogeneity for outcomes in this comparison group; supporting the decision to pool the data.</P>
<P>Pooling of <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK>; <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK>and <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK> shows a moderate statistical heterogeneity.  As clinical considerations were similar, heterogeneity was not present consistently in all outcomes and as this statistical heterogeneity was moderate: heterogeneity was accepted and studies were pooled.</P>
<P>Results of miscarriage were not pooled as definitions of this outcome was not clear.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2009-06-08 14:41:16 +1200" MODIFIED_BY="jane clarke">
<P>Risk of bias assessment revealed a predisposition to detection bias, financial bias and possibly to publication bias.A detection bias may be present throughout all studies, as blinding was either not reported to be performed or not performed. The importance of patient blinding is relative, besides the limited feasibility due to ethical and practical considerations, as the extent to which patients can influence there IVF outcome is minimal.Whether physicians and outcome assessors were blinded may be more important, as knowledge of allocation could influence the physicians in the IVF procedure and further follow-up. Blinding of participants and outcome assessors would have been possible in all trials.</P>
<P>Detection bias may lead to overinflation of treatment effects.The lack of report on the source of funding was a consideration in one trial (<LINK REF="STD-Dechaud-1998" TYPE="STUDY">Dechaud 1998</LINK>). This is often a concern due to reporting rather than bias because of financial motives of an internal or external party involved in the trial.<BR/>The most important consideration was power; as addressed before. The main reasons for not adhering to power calculations was the difficulty to recruit the calculated number of patients. This may be justified for a single centre trial and to a lesser extent for multicenter trials as hydrosalpinges do not present as often as other indications for IVF. Power issues underline the importance of meta-analysis, however they may also generate a predisposition to other bias. Particularly in unblinded studies, where unblinded participating clinicians may be aware of the results (with or without preliminary analyses) and therefore be biased to cease the trial earlier. <LINK REF="STD-Hammadieh-2008" TYPE="STUDY">Hammadieh 2008</LINK> was the only trial to state how it was decided to cease recruitment; therefore in the remaining cases it is difficult to assess whether and when other factors might have been considered in the decision to cease recruitment, leaving space for potential bias of results.</P>
<P>Summarising, theoretically detection bias, financial bias, a publication bias and unknown bias leading to early cessation may be present. It is however difficult to estimate the effect on the outcomes.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2009-06-08 14:17:11 +1200" MODIFIED_BY="jane clarke">
<P>The strength of this review lies in the application of Cochrane methodology. The review was conducted according to the predefined plan. An extensive search was applied therefore we believe that the likelihood that all relevant studies were identified is quite high. In general data was obtained quite complete, a limitations was the fact that one trial was an abstract and that some uncertainties of lesser importance remain unclear because of time restrictions in the review process. </P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2009-10-27 15:51:36 +1300" MODIFIED_BY="jane clarke">
<P>Prior to the first version of this review it was generally accepted that women with hydrosalpinges had a reduced likelihood of success from IVF. Although the efficacy of surgical treatment of hydrosalpinges had not been demonstrated in randomised trials, many clinicians were convinced of the beneficial effect by conducted non-randomised studies (<LINK REF="REF-Poe_x002d_Ziegler-1995" TYPE="REFERENCE">Poe-Ziegler 1995</LINK>; <LINK REF="REF-Vandromme-1995" TYPE="REFERENCE">Vandromme 1995</LINK>; <LINK REF="REF-Andersen-1996" TYPE="REFERENCE">Andersen 1996</LINK>; <LINK REF="REF-Puttemans-1996" TYPE="REFERENCE">Puttemans 1996</LINK>, <LINK REF="REF-Shelton-1996" TYPE="REFERENCE">Shelton 1996</LINK>). Surgical interventions were performed by a majority of the clinicians (<LINK REF="REF-Johnson-2002" TYPE="REFERENCE">Johnson 2002</LINK>). The first version of this review showed a statistically significant benefit of laparoscopic salpingectomy for hydrosalpinges prior to IVF, after meta-analysis of randomised, individually non significant studies for the first time The current update is in line with this finding and further supported the beneficial effect of salpingectomy.</P>
<P>Previous to the RCT's included in this Cochrane review the beneficial effect of tubal occlusion by electrocautery was only suggested by three retrospective studies <LINK REF="REF-Stadtmauer-2000" TYPE="REFERENCE">Stadtmauer 2000</LINK>; <LINK REF="REF-Murray-1998" TYPE="REFERENCE">Murray 1998</LINK>; <LINK REF="REF-Surrey-2001" TYPE="REFERENCE">Surrey 2001</LINK>). Results seemed beneficial, and for some clinicians convincing enough (<LINK REF="REF-Ducarme-2006" TYPE="REFERENCE">Ducarme 2006</LINK>; <LINK REF="REF-Johnson-2002" TYPE="REFERENCE">Johnson 2002</LINK>; <LINK REF="REF-Hammadieh-2004" TYPE="REFERENCE">Hammadieh 2004</LINK>). Prior to the current version of the review no randomized controlled trials were included to report the efficacy of tubal occlusion. After inclusion of <LINK REF="STD-Kontoravdis-2006" TYPE="STUDY">Kontoravdis 2006</LINK> and <LINK REF="STD-Moshin-2006" TYPE="STUDY">Moshin 2006</LINK> this current review now provides the evidence, based on randomized controlled trials, that laparoscopic tubal occlusion improves clinical pregnancy rates achieved with IVF. The effects on IVF outcome of other methods and approaches for tubal occlusion than laparoscopic occlusion by electrocautery, in women with hydrosalpinges have not been addressed by randomised controlled trials. As tubal occlusion is now shown to be beneficial by this review; further evaluation of other methods for tubal occlusion would be helpful.</P>
<P>Ultrasound guided aspiration was the first reported therapeutic option (<LINK REF="REF-Aboulghar-1990" TYPE="REFERENCE">Aboulghar 1990</LINK>; <LINK REF="REF-Russel-1991" TYPE="REFERENCE">Russel 1991</LINK>; <LINK REF="REF-Sowter-1997" TYPE="REFERENCE">Sowter 1997</LINK>) since the acknowledgement of the deleterious effect of hydrosalpinges. However, up to the previous Cochrane review efficacy of aspiration had not been shown in a randomised controlled trial. Previous trials consisted of two retrospective comparative studies (<LINK REF="REF-Sowter-1997" TYPE="REFERENCE">Sowter 1997</LINK>; <LINK REF="REF-Van-Voorhis-1998" TYPE="REFERENCE">Van Voorhis 1998</LINK>), two non-randomised studies (<LINK REF="REF-Shahara-1996" TYPE="REFERENCE">Shahara 1996</LINK>; <LINK REF="REF-Aboulghar-1990" TYPE="REFERENCE">Aboulghar 1990</LINK>) and two case reports (<LINK REF="REF-Bloechle-1997" TYPE="REFERENCE">Bloechle 1997</LINK>; <LINK REF="REF-Russel-1991" TYPE="REFERENCE">Russel 1991</LINK>). Results of these studies were conflicting and weak.</P>
<P>This meta-analysis failed to show a significant effect on the odds of miscarriage. Other literature on miscarriage is conflicting (<LINK REF="REF-Andersen-1994" TYPE="REFERENCE">Andersen 1994</LINK>; <LINK REF="REF-Zeyneloglu-1998" TYPE="REFERENCE">Zeyneloglu 1998</LINK>; <LINK REF="REF-Shahara-1996" TYPE="REFERENCE">Shahara 1996</LINK>). The same literature does not show a significant effect on the odds of ectopic pregnancy, event rates were, as in the included RCT&#8217;s low. Whilst it is rational to expect a reduction in the likelihood of ectopic pregnancy following salpingectomy for a hydrosalpinx, this meta-analysis was underpowered to demonstrate a significant difference in the odds of ectopic pregnancy.</P>
<P>Our findings on ovarian function are limited and therefore cannot provide evidence as to whether salpingectomy could adversely affect ovarian ovarian reserve. Although <LINK REF="REF-Strandell-2001" TYPE="REFERENCE">Strandell 2001</LINK> was reassuring as to the integrity of ovarian function after salpingectomy and a recent retrospective study concluded that salpingectomy may not compromise ovarian function without significant differences in pregnancy (<LINK REF="STD-Gelbaya-2006" TYPE="STUDY">Gelbaya 2006</LINK>). As there is not enough evidence to resolve this matter; dissection must therefore be performed very close to the fallopian tube to avoid disrupting the ovarian blood supply. Furthermore we cannot support nor reject the hypothesis of <LINK REF="REF-Lass-1998" TYPE="REFERENCE">Lass 1998</LINK>: who suggested that proximal clamping and distal fenestration of the fallopian tube may avoid the problem of disruption of blood supply, an approach used in the <LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK> trial if extensive adhesions were present.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2009-06-08 14:44:53 +1200" MODIFIED_BY="jane clarke">
<IMPLICATIONS_PRACTICE MODIFIED="2009-02-16 03:31:39 +1300" MODIFIED_BY="[Empty name]">
<P>Surgical treatment should be considered for all women with hydrosalpinges who are due to undergo IVF. Laparoscopic salpingectomy prior to IVF treatment increases the odds of ongoing pregnancy and clinical pregnancy versus no treatment in the short term. Furthermore, this review now shows that laparoscopic tubal occlusion presents an alternative to laparoscopic salpingectomy, as the odds of clinical pregnancy are improved and comparison of tubal occlusion with salpingectomy has failed to show a difference in effectiveness.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2009-06-08 14:44:53 +1200" MODIFIED_BY="jane clarke">
<P>Firstly, randomised controlled trials need to further assess the efficacy of individual treatments:<BR/>a) ultrasound guided aspiration<BR/>b) salpingostomy<BR/>c) tubal occlusion (approaches and methods of occlusion (laparoscopically by electrocautery or clips or hysteroscopically by placement of micro inserts or electrocautery) need to be compared.<BR/>Research should have a further scope and compare efficacy amongst different surgical treatments: preferably less invasive techniques (tubal occlusion, aspiration, salpingostomy) compared to invasive surgery (salpingectomy). Interventions should be compared in terms of:<BR/>a) live birth<BR/>b) ongoing pregnancy<BR/>b) clinical pregnancy<BR/>c) adverse effects.</P>
<P>Secondly, the place of surgical treatment of hydrosalpinges in clinical practice needs to be defined:</P>
<P>(1) The spectrum of tubal disease that surgical treatment is beneficial for:<BR/>(a) the further clarification of the benefit to women whose hydrosalpinges are not visible on ultrasound.<BR/>(b) tubal surgery in the context of tubal disease without hydrosalpinx formation.</P>
<P>(2) Adverse effects:<BR/>(a) Influence on ovarian function</P>
<P>(3) Timing of treatment:<BR/>(a) Time frame to IVF <BR/>(b) With or without IVF - does surgical treatment positively affect spontaneous pregnancy rates in women with at least one patent fallopian tube, compared to pregnancy rates after IVF treatment?<BR/>(c) Efficacy of surgical intervention before IVF or after previously failed IVF.</P>
<P>(4) Comparison to restorative surgery:</P>
<P>If restorative tubal surgery and specialised diagnostic facilities such as salpingoscopy are available, their appropriate use would be best determined by further RCTs in well-defined populations. Examples of such trials which would support the suggestions of authors mentioned in the discussion section would be:<BR/>(1) restorative tubal surgery versus surgical intervention and IVF in salpingo scopically selected women with hydrosalpinges;<BR/>(2) laparoscopic salpingostomy versus laparoscopic salpingectomy prior to IVF for women with thin-walled hydrosalpinges which are free from ampullary adhesions.<BR/>
</P>
<P>In general, outcomes of subfertility should be strictly be expressed primarily in live birth rates and secondarily ongoing pregnancy rates, or viable- or clinical pregnancy rates (as defined in the methods section of this review). All trials should have adequate power, with pregnancy outcomes ideally expressed as a continuous time survival analysis. As an example, a sample size of about 600 would give 80% power at the 95% confidence interval to detect differences in pregnancy outcomes of 30% versus 20% in the two groups.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2009-10-27 15:52:03 +1300" MODIFIED_BY="jane clarke">
<P>The authors acknowledge the helpful comments of those who have refereed this review and the authors of included trials who supplied additional information or data in the previous and current review, particularly Annika Strandell, Evangelos Makrakis, Herve Déchaud, Nahed Hammadieh and Vaeceslav Moshin . We wish to thank Jane Clarke, MDSG Managing Editor, and Marian Showell, MDSG Trials Search Coordinator. Stephan Bontekoe assisted with copy editing in RevMan 5.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2009-09-07 05:20:50 +1200" MODIFIED_BY="[Empty name]">
<P>Two of the authors (MS and AS) have performed clinical studies assessing the interventions studied in this review (<LINK REF="REF-Sowter-1997" TYPE="REFERENCE">Sowter 1997</LINK>;<LINK REF="STD-Strandell-1999" TYPE="STUDY">Strandell 1999</LINK>), the latter being one of the included RCTs in this review.</P>
<P>Neil Johnson works as a gynaecologist at Auckland City Hospital (a public hospital) in the National Women's Minimal Access Surgery and Endometriosis Service. NJ is also a private gynaecologist with groups called Endometriosis Auckland and Repromed Auckland. Within the last 3 years NJ has received financial support to attend conferences or to arrange research meetings from the following companies: Organon, Serono, Schering and Device Technologies.</P>
<P>Sabine van Voorst at the time was a medical student of the faculty of Health, Medicine and Life Sciences of the University of Maastricht, the Netherlands. She is now a resident in Obstetrics and Gynaecology at the Reinier de Graaf Gasthuis in Delft, the Netherlands. She has no financial conflict of interest.</P>
<P>Annika Strandell is a gynaecologist at Kungälv Hospital, associate professor at the University of Gothenburg and employed at the regional center for Health Technology Assessment in Göteborg, Sweden. She was the principle investigator and co-ordinator of the Scandinavian trial on salpingectomy for hydrosalpinges prior to IVF. She has no financial conflict of interest.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2009-06-08 14:45:58 +1200" MODIFIED_BY="jane clarke">
<P>Neil Johnson conceptualised the protocol and the review primarily, and carried out the search, selection of trials and risk of bias assessment as a first reviewer and first author in the first version of the review and as a second reviewer in the current update.<BR/>
</P>
<P>Sabine van Voorst conducted the current update by performing the search and selection of trials, risk of bias assessment as a first reviewer and author. Martin Sowter proofread the primary protocol, was available to resolve discrepancies for differences of opinion between the other authors and added content expertise to the discussion and conclusions during the first and updated version of this review.<BR/>Ben Willem Mol and Annika Strandell proofread the updated review and added content expertise to the discussion and conclusion.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2009-02-14 06:41:23 +1300" MODIFIED_BY="[Empty name]">
<P>The current updated review differs from the original protocol in primary outcomes and risk of bias assessment. Definitions of fertility outcomes are applied stricter as of the 2008 update, reflecting current thoughts on fertility outcome (<LINK REF="REF-Dias-2006" TYPE="REFERENCE">Dias 2006</LINK>; <LINK REF="REF-Clarke-2008" TYPE="REFERENCE">Clarke 2008</LINK>). Current risk of bias assessment reflects the current opinion in assessing quality of studies (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>).</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2008-09-26 17:40:30 +1200" MODIFIED_BY="[Empty name]"/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2009-11-06 13:41:06 +1300" MODIFIED_BY="jane clarke">
<STUDIES MODIFIED="2009-11-06 13:41:06 +1300" MODIFIED_BY="jane clarke">
<INCLUDED_STUDIES MODIFIED="2009-06-08 15:00:10 +1200" MODIFIED_BY="jane clarke">
<STUDY DATA_SOURCE="PUB" ID="STD-Dechaud-1998" NAME="Dechaud 1998" YEAR="1998">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Dechaud H, Daures JP, Amal F, Humeau C, Hedon B</AU>
<TI>Does previous salpingectomy improve implantation and pregnancy rates in patients with severe tubal factor infertility who are undergoing in vitro fertilization? A pilot prospective randomized study</TI>
<SO>Fertility &amp; Sterility</SO>
<YR>1998</YR>
<VL>69</VL>
<PG>1020-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Dechaud H, Daures JP, Arnal F, Humeau C, Hedon B</AU>
<TI>Salpingectomy before undergoing IVF can increase implantation rates in severe tubal infertility patients: a prospective randomised study</TI>
<SO>Human Reproduction Abstracts of 13th Annual Meeting of the ESHRE</SO>
<YR>1997</YR>
<VL>12</VL>
<PG>23-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hammadieh-2008" MODIFIED="2009-06-08 14:59:55 +1200" MODIFIED_BY="jane clarke" NAME="Hammadieh 2008" YEAR="2008">
<REFERENCE MODIFIED="2008-10-06 16:46:09 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Hammadieh N, Afnan M, Sharif K, Evans J, Amso N</AU>
<TI>The effect of hydrosalpinx on IVF outcome: a prospective randomised controlled trial of vaginal ultrasound-guided hydrosalpinx aspiration during egg collection</TI>
<SO>Fertility &amp; Sterility</SO>
<YR>2003</YR>
<VL>80 (Suppl. 3)</VL>
<PG>S131-132</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-06-08 14:59:55 +1200" MODIFIED_BY="jane clarke" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hammadieh N, Coomarasamy A, Bolarinde O, Papaioannou S, Afnan M, Sharif K</AU>
<TI>Ultrasound-guided hydrosalpinx aspiration during oocyte collection improves pregnancy outcome in IVF: a randomized controlled trial</TI>
<SO>Human Reproduction</SO>
<YR>2008</YR>
<VL>23</VL>
<PG>1113-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kontoravdis-2006" MODIFIED="2009-06-08 15:00:10 +1200" MODIFIED_BY="jane clarke" NAME="Kontoravdis 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-06-08 15:00:10 +1200" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kontoravdis A, Makrakis E, Pantos K, Botsis D, Deligeoroglu E, Creatsas G</AU>
<TI>Proximal tubal occlusion and salpingectomy result in similar improvement in in vitro fertilization outcome in patients with hydrosalpinx</TI>
<SO>Fertility and Sterility</SO>
<YR>December 2006</YR>
<VL>Vol 86</VL>
<PG>1642-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moshin-2006" MODIFIED="2008-10-08 00:36:52 +1300" MODIFIED_BY="[Empty name]" NAME="Moshin 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-10-08 00:36:52 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Moshin V, Hotineanu A</AU>
<TI>Reproductive outcome of the proximal tubal occlusion prior to IVF in patients with hydrosalpinx</TI>
<SO>Human reproduction</SO>
<YR>June 2006</YR>
<VL>21</VL>
<PG>i193-i194</PG>
<EN>Supplement 1: Abstracts of the 22nd Annual Meeting of ESHRE, Prague. Czech republic, 18-21 June, 2006</EN>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Strandell-1999" NAME="Strandell 1999" YEAR="1999">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Strandell A, Lindhard A, Waldenstrom U, Thorburn J, Janson PO, Hamberger L</AU>
<TI>Hydrosalpinx and IVF outcome: a prospective randomized multicentre trial in Scandinavia on salpingectomy prior to IVF</TI>
<SO>Human Reproduction</SO>
<YR>1999</YR>
<VL>14</VL>
<NO>11</NO>
<PG>2762-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Strandell A, Lindhard A, Waldenstrom U, Thorburn J, Janson PO, Hamberger L</AU>
<TI>Hydrosalpinx and IVF outcome: cumulative results after salpingectomy in a randomised controlled trial</TI>
<SO>Human Reproduction</SO>
<YR>2001</YR>
<VL>16</VL>
<PG>2403-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2009-06-08 15:04:19 +1200" MODIFIED_BY="jane clarke">
<STUDY DATA_SOURCE="PUB" ID="STD-Gelbaya-2006" MODIFIED="2009-06-08 15:03:14 +1200" MODIFIED_BY="jane clarke" NAME="Gelbaya 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-06-08 15:03:14 +1200" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gelbaya TA, Nardo LG, Fitzgerald CT, Horne G, Brison DR, Lieberman BA</AU>
<TI>Ovarian response to gonadotrophins after laparoscopic salpingectomy or the division of fallopian tubes for hydrosalpinges</TI>
<SO>Fertility and Sterility</SO>
<YR>2006</YR>
<VL>85</VL>
<NO>5</NO>
<PG>1464-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goldstein-1998" MODIFIED="2009-06-08 15:03:30 +1200" MODIFIED_BY="jane clarke" NAME="Goldstein 1998" YEAR="1998">
<REFERENCE MODIFIED="2009-06-08 15:03:30 +1200" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goldstein DB, Sasaran LH, Stadtmauer L, Popa R</AU>
<TI>Selective salpingostomy-salpingectomy (SSS) and medical treatment prior to IVF in patients with hydrosalpinx</TI>
<SO>Fertility &amp; Sterility</SO>
<YR>1998</YR>
<VL>70</VL>
<NO>1</NO>
<PG>S320</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hotineanu-2007" MODIFIED="2009-02-14 10:54:57 +1300" MODIFIED_BY="[Empty name]" NAME="Hotineanu 2007" YEAR="">
<REFERENCE MODIFIED="2009-02-14 10:54:57 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hotineanu 2007  Hotineanu AL, Moshin VN, Hotineanu AV, Croitor ME</AU>
<TI>The effect of proximal tubal ''clamping'' prior to the IVF in patients with distal tubal occlusion</TI>
<SO>Human Reproduction</SO>
<YR>July 2007</YR>
<VL>22</VL>
<NO>Supplement 1; Abstracts of the 23rd Annual Meeting of the European Society of Human Reproduction and Embryology</NO>
<PG>i126</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mardesic-1999" MODIFIED="2009-06-08 15:04:07 +1200" MODIFIED_BY="jane clarke" NAME="Mardesic 1999" YEAR="1999">
<REFERENCE MODIFIED="2009-06-08 15:04:07 +1200" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mardesic T, Muller P, Huttelová R, Zvárová J, Hulvert J, Voboril J, et al</AU>
<TI>Effect of salpingectomy on the results of IVF in women with tubal sterility--prospective study</TI>
<SO>Ceska Gynekol.</SO>
<YR>2001</YR>
<VL>66</VL>
<NO>1</NO>
<PG>259-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Although this study was described as a randomised trial in the abstract title, this was not the case. The control group was a historical group of women who had previously undergone IVF acting as their own controls.&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Mardesic T, Muller P, Voboril J, Hulvert J, Huttelova R, Becvarova V, et al</AU>
<TI>The influence of salpingectomy of hydrosalpinges visible on ultrasound on IVF results. A pilot prospective randomized study</TI>
<SO>Abstracts of 11th World Congress on In Vitro Fertilization and Human Reproductive Genetics</SO>
<YR>9-14 May, 1999</YR>
<PG>156</PG>
<CY>Sydney, Australia</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zolghadri-2006" MODIFIED="2009-06-08 15:04:19 +1200" MODIFIED_BY="jane clarke" NAME="Zolghadri 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-06-08 15:04:19 +1200" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zolghadri J, Momtahan M, Alborzi S, Mohammadinejad A, Khosravi D</AU>
<TI>Pregnancy outcome in patients with early recurrent abortion following laparoscopic tubal corneal interruption of a fallopian tube with hydrosalpinx.</TI>
<SO>Fertility and Sterility</SO>
<YR>July 2006</YR>
<VL>86</VL>
<NO>6</NO>
<PG>149-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2009-11-06 13:41:06 +1300" MODIFIED_BY="jane clarke">
<STUDY DATA_SOURCE="PUB" ID="STD-Hammadieh2008" MODIFIED="2009-11-06 13:37:47 +1300" MODIFIED_BY="jane clarke" NAME="Hammadieh2008" YEAR="2008">
<REFERENCE MODIFIED="2009-11-06 13:37:45 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hammadieh N, Coomarasamy A, Ola B, Papaioannou S, Afnan M, Sharif K</AU>
<TI>Ultrasound-guided hydrosalpinx aspiration during oocyte collection improves pregnancy outcome in IVF: a randomized controlled trial</TI>
<SO>Human reproduction</SO>
<YR>2008</YR>
<VL>23</VL>
<NO>5</NO>
<PG>1113-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mol-2008" MODIFIED="2009-11-06 13:41:06 +1300" MODIFIED_BY="jane clarke" NAME="Mol 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-11-06 13:41:06 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mol F, Strandell A, Jurkovic D, Yalcinkaya T, Verhoeve HR, et al</AU>
<TI>The ESEP study: salpingostomy versus salpingectomy for tubal ectopic pregnancy; the impact on future fertility: a randomised controlled trial</TI>
<SO>BMC women's health</SO>
<YR>2008</YR>
<VL>8</VL>
<PG>11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2009-06-08 15:00:38 +1200" MODIFIED_BY="jane clarke">
<STUDY DATA_SOURCE="PUB" ID="STD-Darwish-2005_x002c_2006_x002c_-2007" MODIFIED="2009-06-08 15:00:38 +1200" MODIFIED_BY="jane clarke" NAME="Darwish 2005,2006, 2007" YEAR="">
<REFERENCE MODIFIED="2009-02-14 10:55:39 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Darwish A, El Saman E</AU>
<TI>Hysteroscopic vs laparoscopic tubal occlusion of hydrosalpinges prior to IVF/ICSI</TI>
<SO>Human Reproduction</SO>
<YR>2006</YR>
<VL>21</VL>
<PG>i134</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-02-14 10:55:52 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Darwish A, ElSaman E.</AU>
<TI>Hysteroscopic versus laparoscopic tubal occlusion of hydrosalpinges prior to IVF/ICSI</TI>
<SO>Middle-East Fertility Society Journal</SO>
<YR>2005</YR>
<VL>10</VL>
<NO>Supplement 12th Annual Meeting of the Middle East Fertility Society 23-26November</NO>
<PG>i126</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-06-08 15:00:38 +1200" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Darwish AM, El Saman AM</AU>
<TI>Is there a role for hysteroscopic tubal occlusion of functionless hydrosalpinges prior to IVF/IVCSI in modern practice?</TI>
<SO>Acta Obstetrica et Gynaecologica</SO>
<YR>2007</YR>
<VL>86</VL>
<PG>1484-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2009-10-26 06:06:44 +1300" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2009-10-26 06:06:44 +1300" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Aboulghar-1990" NAME="Aboulghar 1990" TYPE="JOURNAL_ARTICLE">
<AU>Aboulghar MA, Mansour RT, Serour GI, Sattar MA, Awad MM, Amin Y</AU>
<TI>Transvaginal ultrasonic needle guided aspiration of pelvic inflammatory masses before ovulation induction for in vitro fertilization</TI>
<SO>Fertility &amp; Sterility</SO>
<YR>1990</YR>
<VL>53</VL>
<PG>311</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Akman-1996" MODIFIED="2009-02-14 07:00:52 +1300" MODIFIED_BY="[Empty name]" NAME="Akman 1996" TYPE="JOURNAL_ARTICLE">
<AU>Akman MA, Garcia JE, Damewood MD, Watts LD, Katz E</AU>
<TI>Hydrosalpinx affects the implantation of previously cryopreserved embryos</TI>
<SO>Human Reproduction</SO>
<YR>1996</YR>
<VL>11</VL>
<PG>1013-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Andersen-1994" MODIFIED="2009-02-14 07:00:57 +1300" MODIFIED_BY="[Empty name]" NAME="Andersen 1994" TYPE="JOURNAL_ARTICLE">
<AU>Andersen A, Yue Z, Meng F, Petersen K</AU>
<TI>Low implantation rate after in-vitro fertilisation in patients with hydrosalpinges diagnosed by ultrasonography</TI>
<SO>Human Reproduction</SO>
<YR>1994</YR>
<VL>9</VL>
<PG>1935-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Andersen-1996" MODIFIED="2009-02-14 07:01:05 +1300" MODIFIED_BY="[Empty name]" NAME="Andersen 1996" TYPE="JOURNAL_ARTICLE">
<AU>Andersen AN, Lindhard A, Loft A, Ziebe S, Andersen CY</AU>
<TI>The infertile patient with hydrosalpinges: IVF with or without salpingectomy?</TI>
<SO>Human Reproduction</SO>
<YR>1996</YR>
<VL>11</VL>
<PG>2081-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bloechle-1997" MODIFIED="2008-10-07 12:21:19 +1300" MODIFIED_BY="[Empty name]" NAME="Bloechle 1997" TYPE="JOURNAL_ARTICLE">
<AU>Bloechle M, Schreiner Th, Lisse K</AU>
<TI>Recurrence of hydrosalpinges after transvaginal aspiration of tubal fluid in an IVF cycle with development of a serometra</TI>
<SO>Human Reproduction</SO>
<YR>1997</YR>
<VL>12</VL>
<PG>703-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Camus-1999" MODIFIED="2009-06-08 15:05:13 +1200" MODIFIED_BY="jane clarke" NAME="Camus 1999" TYPE="JOURNAL_ARTICLE">
<AU>Camus E, Poncelet C, Goffinet F, Wainer B, Merlet F, Nisand I, et al</AU>
<TI>Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies</TI>
<SO>Human Reproduction</SO>
<YR>May 1999</YR>
<VL>14</VL>
<NO>5</NO>
<PG>1243-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Clarke-2008" MODIFIED="2009-06-08 15:30:33 +1200" MODIFIED_BY="jane clarke" NAME="Clarke 2008" TYPE="UNPUBLISHED">
<AU>JF Clarke, M van Rummste, C Farquhar, N Johnson, BW Mol, P Herbison</AU>
<TI>Measuring outcomes in fertility trials - can we rely on clinical pregnancy rates?</TI>
<YR>Submitted for publication</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Csemiczky-1996" MODIFIED="2009-02-14 07:01:16 +1300" MODIFIED_BY="[Empty name]" NAME="Csemiczky 1996" TYPE="JOURNAL_ARTICLE">
<AU>Csemiczky G, Landgren BM, Fried G, Wramsby H</AU>
<TI>High tubal damage grade is associated with low pregnancy rate in women undergoing in vitro fertilisation treatment</TI>
<SO>Human Reproduction</SO>
<YR>1996</YR>
<VL>11</VL>
<PG>2438-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dar-2000" NAME="Dar 2000" TYPE="JOURNAL_ARTICLE">
<AU>Dar P, Sachs GS, Strassburger D, et al</AU>
<TI>Ovarian function before and after salpingectomy in artificial reproductive technology patients</TI>
<SO>Human Reproduction</SO>
<YR>2000</YR>
<VL>15</VL>
<PG>142-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dechaud-2004" MODIFIED="2009-02-14 11:29:39 +1300" MODIFIED_BY="[Empty name]" NAME="Dechaud 2004" TYPE="JOURNAL_ARTICLE">
<AU>Dechaud H, Reyftmann L, Faidherbe, Hamamah S, Hedon B</AU>
<TI>Evidence based reproductive surgery: tubal infertility</TI>
<SO>International congress series</SO>
<YR>2004</YR>
<VL>1266</VL>
<PG>96-106</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dias-2006" MODIFIED="2009-06-08 15:05:40 +1200" MODIFIED_BY="jane clarke" NAME="Dias 2006" TYPE="JOURNAL_ARTICLE">
<AU>Dias S, McNamee R, Vail A</AU>
<TI>Evidence of improving quality of reporting of randomized controlled trial in subfertility</TI>
<SO>Human Reproduction</SO>
<YR>2006</YR>
<VL>21</VL>
<PG>2617-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dickens-1995" MODIFIED="2009-06-08 15:05:47 +1200" MODIFIED_BY="jane clarke" NAME="Dickens 1995" TYPE="JOURNAL_ARTICLE">
<AU>Dickens CJ, Maguiness SD, Comer MT, Palmer S, Rutherford AJ, Leese HJ</AU>
<TI>Human tubal fluid: formation and composition during vascular perfusion of the Fallopian tube</TI>
<SO>Human Reproduction</SO>
<YR>1995</YR>
<VL>10</VL>
<PG>505-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ducarme-2006" MODIFIED="2009-06-08 15:05:52 +1200" MODIFIED_BY="jane clarke" NAME="Ducarme 2006" TYPE="JOURNAL_ARTICLE">
<AU>Ducarme G, Uzan M, Hugues JN, Cedrin-Durnerin I, Ponselet C</AU>
<TI>Management of hydrosalpinx before or during in vitro fertilization -embryo transfer: a national postal survey in France</TI>
<SO>Fertility and Sterility</SO>
<YR>2006</YR>
<VL>86</VL>
<NO>4</NO>
<PG>1013-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Englert-1987" MODIFIED="2009-06-08 15:06:00 +1200" MODIFIED_BY="jane clarke" NAME="Englert 1987" TYPE="JOURNAL_ARTICLE">
<AU>Englert Y, Vekemans M, Lejeune B, Van Rysselberge M, Puissant F, Degueldre M et al</AU>
<TI>Higher pregnancy rates after in vitro fertilization and embryo transfer in cases with sperm defects</TI>
<SO>Fertility &amp; Sterility</SO>
<YR>1987</YR>
<VL>48</VL>
<PG>254-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Evers-2002" MODIFIED="2009-02-14 11:24:07 +1300" MODIFIED_BY="[Empty name]" NAME="Evers 2002" TYPE="JOURNAL_ARTICLE">
<AU>Evers JL</AU>
<TI>Female subfertility</TI>
<SO>The Lancet</SO>
<YR>2002</YR>
<VL>360</VL>
<NO>9327</NO>
<PG>151-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Eytan-2001" MODIFIED="2009-06-08 15:06:10 +1200" MODIFIED_BY="jane clarke" NAME="Eytan 2001" TYPE="JOURNAL_ARTICLE">
<AU>Eytan O, Azem F, Gull I, Wolman I, Elad D, Jaffa AJ</AU>
<TI>The mechanism of hydrosalpinx in embryo implantation</TI>
<SO>Human Reproduction</SO>
<YR>2001</YR>
<VL>12</VL>
<PG>2662-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fleming-1996" MODIFIED="2008-10-07 23:56:44 +1300" MODIFIED_BY="[Empty name]" NAME="Fleming 1996" TYPE="JOURNAL_ARTICLE">
<AU>Fleming C, Hull MGR</AU>
<TI>Impaired implantation after in vitro fertilisation treatment associated with hydrosalpinx</TI>
<SO>British Journal of Obstetrics &amp; Gynaecology</SO>
<YR>1996</YR>
<VL>103</VL>
<PG>268-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Freeman-1996" MODIFIED="2008-10-07 23:56:55 +1300" MODIFIED_BY="[Empty name]" NAME="Freeman 1996" TYPE="CONFERENCE_PROC">
<AU>Freeman MR, Whitworth CM, Hill GA</AU>
<TI>Hydrosalpinx reduces in vitro fertilisation / embryo transfer rates and in vitro blastocyst development</TI>
<SO>52nd Annual Meeting of the American Fertility Society</SO>
<YR>1996</YR>
<PG>S211</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hammadieh-2004" MODIFIED="2009-06-08 15:06:32 +1200" MODIFIED_BY="jane clarke" NAME="Hammadieh 2004" TYPE="JOURNAL_ARTICLE">
<AU>Hammadieh N, Afnan M, Evans J, Sharif K, Amso N, Olufowobi O</AU>
<TI>A postal survey of hydrosalpinx management prior to IVF in the United Kingdom</TI>
<SO>Human Reproduction</SO>
<YR>2004</YR>
<VL>19</VL>
<NO>4</NO>
<PG>1009-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Herman-1991" MODIFIED="2009-06-08 15:06:41 +1200" MODIFIED_BY="jane clarke" NAME="Herman 1991" TYPE="JOURNAL_ARTICLE">
<AU>Herman A, Ron-el R, Golan A, Soffer Y, Bukovsky Y, Caspi E</AU>
<TI>The dilemma of the optimal surgical procedure occurring in ectopic pregnancies in in-vitro fertilisation</TI>
<SO>Human Reproduction</SO>
<YR>1991</YR>
<VL>6</VL>
<PG>1167-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2008-10-07 22:40:19 +1300" MODIFIED_BY="[Empty name]" NAME="Higgins 2008" TYPE="BOOK">
<AU>Higgins JPT, Green S (editors)</AU>
<SO>Cochrane Handbook for Systematic Reviews of Interventions Version</SO>
<YR>February 2008. Available from www.cochrane-handbook.org</YR>
<EN>5.0.0</EN>
<PB>The Cochrane Collaboration</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hsu-2005" MODIFIED="2009-06-08 15:07:03 +1200" MODIFIED_BY="jane clarke" NAME="Hsu 2005" TYPE="JOURNAL_ARTICLE">
<AU>Hsu CC, Yang TT, Hsu CT</AU>
<TI>Ovarian pregnancy resulting from cornual fistulae in a woman who had undergone bilateral salpingectomy</TI>
<SO>Fertility &amp; Sterility</SO>
<YR>2005</YR>
<VL>83</VL>
<NO>1</NO>
<PG>205-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Inovay-1999" NAME="Inovay 1999" TYPE="JOURNAL_ARTICLE">
<AU>Inovay J, Marton T, Urbancsek J, et al</AU>
<TI>Spontaneous bilateral cornual dehiscence early in the second trimester after bilateral laparoscopic salpingectomy and in vitro fertilization</TI>
<SO>Human Reproduction</SO>
<YR>1999</YR>
<VL>14</VL>
<PG>2471-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johnson-2002" MODIFIED="2009-02-14 10:57:35 +1300" MODIFIED_BY="[Empty name]" NAME="Johnson 2002" TYPE="JOURNAL_ARTICLE">
<AU>Johnson NP, Merrilees M, Sadler L</AU>
<TI>IVF and tubal pathology - not all bad news</TI>
<SO>Australian and New Zealand Journal of Obstetrics &amp; Gynaecology</SO>
<YR>2002</YR>
<VL>42</VL>
<PG>285-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johnson2002" MODIFIED="2009-06-08 15:07:21 +1200" MODIFIED_BY="jane clarke" NAME="Johnson2002" TYPE="JOURNAL_ARTICLE">
<AU>Johnson NP, Norris J</AU>
<TI>An Australasian survey of the management of hydrosalpinges in women due to undergo in vitro fertilisation</TI>
<SO>The Australian and New Zealand Journal of Obstetrics and Gynaecology</SO>
<YR>2002</YR>
<VL>42</VL>
<NO>3</NO>
<PG>271-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Katz-1996" MODIFIED="2009-06-08 15:07:28 +1200" MODIFIED_BY="jane clarke" NAME="Katz 1996" TYPE="JOURNAL_ARTICLE">
<AU>Katz E, Akman MA, Damewood MD, Garcia JE</AU>
<TI>Deleterious effect of the presence of hydrosalpinx on implantation and pregnancy rates with in vitro fertilisation</TI>
<SO>Fertility &amp; Sterility</SO>
<YR>1996</YR>
<VL>66</VL>
<PG>122-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kerin-2005" MODIFIED="2009-06-08 15:07:35 +1200" MODIFIED_BY="jane clarke" NAME="Kerin 2005" TYPE="JOURNAL_ARTICLE">
<AU>Kerin J, Swann N, Scroggs S, Rosenfield R</AU>
<TI>Hysteroscopic placement of Essure micro-inserts to obstruct hydrosalpinges followed by IVF and successful pregnancy outcomes</TI>
<SO>Australian and New Zealand Journal of Obstetrics and Gynaecology</SO>
<YR>2005</YR>
<VL>45</VL>
<NO>s(1)</NO>
<PG>A11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-La-Combe-2003" MODIFIED="2009-06-08 15:07:43 +1200" MODIFIED_BY="jane clarke" NAME="La Combe 2003" TYPE="JOURNAL_ARTICLE">
<AU>LaCombe</AU>
<TI>Adnexal torsion in a patient with hydrosalpinx who underwent tubal occlusion before in vitro fertilization</TI>
<SO>Fertility &amp; Sterility</SO>
<YR>2003</YR>
<VL>79</VL>
<NO>2</NO>
<PG>437-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lass-1998" MODIFIED="2009-06-08 15:07:51 +1200" MODIFIED_BY="jane clarke" NAME="Lass 1998" TYPE="JOURNAL_ARTICLE">
<AU>Lass A, Ellenbogen A, Croucher C, et al</AU>
<TI>Effect of salpingectomy on ovarian response to superovulation in an in vitro fertilization-embryo transfer program</TI>
<SO>Fertility &amp; Sterility</SO>
<YR>1998</YR>
<VL>70</VL>
<PG>1035-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mansour-1991" MODIFIED="2009-06-08 15:07:58 +1200" MODIFIED_BY="jane clarke" NAME="Mansour 1991" TYPE="JOURNAL_ARTICLE">
<AU>Mansour RT, Aboulghar MA, Serrour GI, Riad R</AU>
<TI>Fluid accumulation of the uterine cavity before embryo transfer: a possible hindrance for implantation</TI>
<SO>Journal of In vitro fertilisation and Embryo Transfer</SO>
<YR>1991</YR>
<VL>8</VL>
<PG>157-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Meyer-1997" NAME="Meyer 1997" TYPE="JOURNAL_ARTICLE">
<AU>Meyer WR, Castelbaum AJ, Somkuti S, Sagoskin AW, Doyle M, Harris JE, et al</AU>
<TI>Hydrosalpinges adversely affect markers of endometrial receptivity</TI>
<SO>Human Reproduction</SO>
<YR>1997</YR>
<VL>12</VL>
<PG>1393-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mukherjee-1996" MODIFIED="2009-06-08 15:08:17 +1200" MODIFIED_BY="jane clarke" NAME="Mukherjee 1996" TYPE="JOURNAL_ARTICLE">
<AU>Mukhurjee T, Copperman AB, McCaffrey C</AU>
<TI>Hydrosalpinx fluid has embryotoxic effects on murine embryogenesis: a case for prophylactic salpingectomy</TI>
<SO>Fertility &amp; Sterility</SO>
<YR>1996</YR>
<VL>66</VL>
<PG>851-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Murray-1998" MODIFIED="2009-06-08 15:08:25 +1200" MODIFIED_BY="jane clarke" NAME="Murray 1998" TYPE="JOURNAL_ARTICLE">
<AU>Murray DL, Sagoskin AW, Widra EA, Levy MJ</AU>
<TI>The adverse effect of hydrosalpinges on in vitro fertilisation pregnancy rates and the benefit of surgical correction</TI>
<SO>Fertility &amp; Sterility</SO>
<YR>1998</YR>
<VL>69</VL>
<NO>1</NO>
<PG>619-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Poe_x002d_Ziegler-1995" MODIFIED="2008-10-07 23:57:20 +1300" MODIFIED_BY="[Empty name]" NAME="Poe-Ziegler 1995" TYPE="JOURNAL_ARTICLE">
<AU>Poe-Ziegler R, Shelton KE, Toner JP</AU>
<TI>Salpingectomy(ies) improves the pregnancy rate after IVF in patients with unilateral or bilateral hydrosalpinx</TI>
<SO>Journal of Assisted Reproduction &amp; Genetics</SO>
<YR>1995</YR>
<VL>12</VL>
<PG>S65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Puttemans-1996" MODIFIED="2008-10-07 23:57:42 +1300" MODIFIED_BY="[Empty name]" NAME="Puttemans 1996" TYPE="JOURNAL_ARTICLE">
<AU>Puttemans PJ, Brosens IA</AU>
<TI>Salpingectomy improves in vitro fertilisation outcome in patients with a hydrosalpinx: blind victimisation of the fallopian tube?</TI>
<SO>Human Reproduction</SO>
<YR>1996</YR>
<VL>11</VL>
<PG>2079-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rosenfield-2005" MODIFIED="2009-06-08 15:08:49 +1200" MODIFIED_BY="jane clarke" NAME="Rosenfield 2005" TYPE="JOURNAL_ARTICLE">
<AU>Rosenfield RB, Stones RE, Coates A, Matteri RK, Hesla JS</AU>
<TI>Proximal occlusion of hydrosalpinx by hysteroscopic placement of microinsert before in vitro fertilization embryo transfer</TI>
<SO>Fertility &amp; Sterility</SO>
<YR>2005</YR>
<VL>83</VL>
<NO>5</NO>
<PG>1547</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Russel-1991" MODIFIED="2009-06-08 15:08:55 +1200" MODIFIED_BY="jane clarke" NAME="Russel 1991" TYPE="JOURNAL_ARTICLE">
<AU>Russel JB, Rodriguez Z, Komins JI</AU>
<TI>The use of transvaginal ultrasound to aspirate bilateral hydrosalpinges prior to in vitro fertilisation: a case report</TI>
<SO>Journal of In vitro fertilisation and Embryo Transfer</SO>
<YR>1991</YR>
<VL>8</VL>
<NO>4</NO>
<PG>213-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Savic-1999" MODIFIED="2009-02-14 10:34:49 +1300" MODIFIED_BY="[Empty name]" NAME="Savic 1999" TYPE="CONFERENCE_PROC">
<AU>Savic B, Milacic D, Peako N</AU>
<TI>Hydrosalpingeal fluid aspiration during oocyte retrieval has beneficial effect on outcome of in-vitro fertilization-embryo transfer</TI>
<SO>Abstracts of the 15th Annual Meeting of the European Society of Human Reproduction and Embryology</SO>
<YR>1999</YR>
<PG>310</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shahara-1996" MODIFIED="2008-10-07 23:57:48 +1300" MODIFIED_BY="[Empty name]" NAME="Shahara 1996" TYPE="JOURNAL_ARTICLE">
<AU>Shahara FI, Scott RT Jr, Marut EL, Queenan JT Jr</AU>
<TI>In-vitro fertilisation outcome in women with hydrosalpinx</TI>
<SO>Human Reproduction</SO>
<YR>1996</YR>
<VL>11</VL>
<PG>526-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sharara-1999" MODIFIED="2009-06-08 15:09:24 +1200" MODIFIED_BY="jane clarke" NAME="Sharara 1999" TYPE="JOURNAL_ARTICLE">
<AU>Sharara FI</AU>
<TI>The role of hydrosalpinx in IVF: simply mechanical?</TI>
<SO>Human Reproduction</SO>
<YR>1999</YR>
<VL>14</VL>
<PG>577-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shariff-1994" MODIFIED="2009-06-08 15:09:29 +1200" MODIFIED_BY="jane clarke" NAME="Shariff 1994" TYPE="JOURNAL_ARTICLE">
<AU>Shariff K, Kaufmann S, Sharma V</AU>
<TI>Heterotopic pregnancy obtained after In-vitro fertilization and embryo transfer following bilateral total salpingectomy: case report</TI>
<SO>Human Reproduction</SO>
<YR>1994</YR>
<VL>9</VL>
<PG>1966-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shelton-1996" MODIFIED="2008-10-07 23:57:54 +1300" MODIFIED_BY="[Empty name]" NAME="Shelton 1996" TYPE="JOURNAL_ARTICLE">
<AU>Shelton KE, Butier L, Toner JP</AU>
<TI>Salpingectomy improves the pregnancy rate in in vitro fertilisation patients with hydrosalpinx</TI>
<SO>Human Reproduction</SO>
<YR>1996</YR>
<VL>11</VL>
<PG>523-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sowter-1997" MODIFIED="2008-10-07 23:57:57 +1300" MODIFIED_BY="[Empty name]" NAME="Sowter 1997" TYPE="JOURNAL_ARTICLE">
<AU>Sowter MC, Akande VA, Williams JA, Hull MG</AU>
<TI>Is the outcome of in-vitro fertilisation and embryo transfer treatment improved by spontaneous or surgical drainage of a hydrosalpinx?</TI>
<SO>Human Reproduction</SO>
<YR>1997</YR>
<VL>12</VL>
<PG>2147-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stadtmauer-2000" NAME="Stadtmauer 2000" TYPE="JOURNAL_ARTICLE">
<AU>Stadtmauer LA, Riehl RM, Toma SK, Talbert LM</AU>
<TI>Cauterization of hydrosalpinges before in vitro fertilization is an effective surgical treatment associated with improved pregnancy rates</TI>
<SO>American Journal of Obstetrics &amp; Gynecology</SO>
<YR>2000</YR>
<VL>183</VL>
<PG>367-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Steptoe-1978" NAME="Steptoe 1978" TYPE="JOURNAL_ARTICLE">
<AU>Steptoe PC, Edwards RG</AU>
<TI>Birth after the reimplantation of a human embryo</TI>
<SO>Lancet</SO>
<YR>1978</YR>
<VL>2</VL>
<PG>366</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Strandell-1994" MODIFIED="2008-10-07 23:58:02 +1300" MODIFIED_BY="[Empty name]" NAME="Strandell 1994" TYPE="JOURNAL_ARTICLE">
<AU>Strandell A, Waldenstrom U, Nilsson L, Hamberger L</AU>
<TI>Hydrosalpinx reduces in-vitro fertilisation / embryo transfer pregnancy rates</TI>
<SO>Human Reproduction</SO>
<YR>1994</YR>
<VL>9</VL>
<PG>861-3</PG>
<IDENTIFIERS MODIFIED="2008-10-06 16:46:09 +1300" MODIFIED_BY="[Empty name]" NOTES="&lt;h1 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s46&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Data and analyses&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s213&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types)&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s214&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.1 Live birth rate&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s215&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.1.1 Laparoscopic bilateral salpingectomy and adhesiolysis versus laparoscopic adhesiolysis&lt;/h4&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-03 11:31:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Kontoravdis: compares 3 groups: salpingectomy/ no salpingectomy/ proximalt ubal occlusion.&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-03 11:33:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;question regarding if splitting of data in subgroups is correct: &lt;/span&gt;&lt;br&gt;&lt;span modified=&quot;2008-09-03 11:34:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;what i dif: &lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:32:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Salpingectomy vs no salpingectomy was already a subgroup --&amp;gt; added comparison of these 2 groups by kontoravdis there&lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:34:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;;&lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:32:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt; and adde&lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:33:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;d &lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:31:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;salpingectomy &lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:32:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;versus &lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:33:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;tubal occlusion as a separate group (no previous studies compared this)..... &lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:34:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;is this &lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:33:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;OK?&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-03 11:34:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;converted clinical pregnancy rate per 100 ET to clinical pregnancy rate per woman; have to ch&lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:35:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;eck this.&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-03 11:32:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;deleted&quot;&gt;&lt;br&gt;&lt;/span&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s217&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.1.2 Laparoscopic salpingectomy versus no intervention&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s219&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.1.3 Laparoscopic selective salpingostomy-salpingectomy versus progesterone medical treatment&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s221&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.1.4 &lt;span modified=&quot;2008-09-02 17:55:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Aspiration versus no aspiration&lt;/span&gt;&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s326&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.1.5 &lt;span modified=&quot;2008-09-03 13:41:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Proximal tubal occlusion versus laparoscopic salpingectomy&lt;/span&gt;&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s223&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.2 Total pregnancy rate&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s224&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.2.1 Laparoscopic bilateral salpingectomy and adhesiolysis vesus laparoscopic adhesiolysis&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s226&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.2.2 Laparoscopic salpingectomy versus no intervention&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s228&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.2.3 Laparoscopic selective salpingostomy-salpingectomy versus progesterone medical treatment&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s313&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.2.4 &lt;span modified=&quot;2008-09-03 10:30:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;As&lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:31:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;piration versus no aspiration&lt;/span&gt;&lt;/h4&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-03 10:32:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Clinical pregnancy is defined as the prescence of gestational sac on ultrasound; resu&lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:33:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;lts per woman, I think&lt;/span&gt;&lt;/p&gt;&lt;h3 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s230&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.3 Ectopic pregnancy rate&lt;/h3&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-03 10:39:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;0 events; talked to vanessa: that you cant add something to the zero.. correct?&lt;/span&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s231&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.3.1 Laparoscopic bilateral salpingectomy and adhesiolysis vesus laparoscopic adhesiolysis&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s233&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.3.2 Laparoscopic salpingectomy versus no intervention&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s235&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.3.3 Laparoscopic selective salpingostomy-salpingectomy versus progesterone medical treatment&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s315&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.3.4 &lt;span modified=&quot;2008-09-03 10:33:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Aspiration versus no aspiration&lt;/span&gt;&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s237&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.4 Miscarriage rate&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s238&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.4.1 Laparoscopic bilateral salpingectomy and adhesiolysis vesus laparoscopic adhesiolysis&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s240&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.4.2 Laparoscopic salpingectomy versus no intervention&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s242&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.4.3 Laparoscopic selective salpingostomy-salpingectomy versus progesterone medical treatment&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s317&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.4.4 &lt;span modified=&quot;2008-09-03 10:40:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Aspiration versus no aspiration&lt;/span&gt;&lt;/h4&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-03 10:52:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Hammadieh: results per Biochemical pregnancy&lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:53:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt; &lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:53:16 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;I &lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:53:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Abortion: &lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:53:16 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;4/14 C: 3/7&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-03 10:52:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;We want per clinical pregnancy&lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:53:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt; --&amp;gt; kant convert this because we don't know which &lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:54:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;aborted &lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:53:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;biochemical pregnancy was a&lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:54:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;n aborted&lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:53:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt; clinical pre&lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:54:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;gnancy... &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s244&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.5 Multiple pregnancy rate&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s245&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.5.1 Laparoscopic bilateral salpingectomy and adhesiolysis vesus laparoscopic adhesiolysis&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s246&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.5.2 Laparoscopic salpingectomy versus no intervention&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s247&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.5.3 Laparoscopic selective salpingostomy-salpingectomy versus progesterone medical treatment&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s248&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.6 Complication rate&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s249&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.6.1 Laparoscopic bilateral salpingectomy and adhesiolysis vesus laparoscopic adhesiolysis&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s250&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.6.2 Laparoscopic salpingectomy versus no intervention&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s252&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.6.3 Laparoscopic selective salpingostomy-salpingectomy versus progesterone medical treatment&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s319&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.6.4 &lt;span modified=&quot;2008-09-03 10:56:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Aspiration versus no aspiration&lt;/span&gt;&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s343&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;2 &lt;span modified=&quot;2008-09-03 13:54:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Laparoscopic surgery on the fallopian tube (all types) VERSUS other&lt;/span&gt;&lt;span modified=&quot;2008-09-03 13:55:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt; laparoscopic surgical technique on the fallopian tube&lt;/span&gt;&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s331&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;3 &lt;span modified=&quot;2008-09-03 13:47:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Comparison of surgical techniques&lt;/span&gt;&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s332&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;3.1 &lt;span modified=&quot;2008-09-03 13:48:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Live birth rate&lt;/span&gt;&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s335&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;3.2 &lt;span modified=&quot;2008-09-03 13:48:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Total pregnancy rate&lt;/span&gt;&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s339&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;3.3 &lt;span modified=&quot;2008-09-03 13:52:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Ectopic pregnancy rate&lt;/span&gt;&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s340&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;3.4 &lt;span modified=&quot;2008-09-03 13:52:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Miscarriage rate&lt;/span&gt;&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s341&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;3.5 &lt;span modified=&quot;2008-09-03 13:52:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Multiple pregnancy rate&lt;/span&gt;&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 readonly=&quot;true&quot; class=&quot;fixedtext&quot;&gt;&lt;span coll_flag=&quot;s342&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;3.6 &lt;span modified=&quot;2008-09-03 13:53:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Complications rate&lt;/span&gt;&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-10-06 16:46:09 +1300" NOTES_MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Strandell-2001" NAME="Strandell 2001" TYPE="JOURNAL_ARTICLE">
<AU>Strandell A, Lindhard A, Waldenstrom U, et al</AU>
<TI>Salpingectomy prior to IVF does not impair the ovarian response</TI>
<SO>Human Reproduction</SO>
<YR>2001</YR>
<VL>16</VL>
<PG>1135-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Strandell-2002" MODIFIED="2009-06-08 15:09:57 +1200" MODIFIED_BY="jane clarke" NAME="Strandell 2002" TYPE="JOURNAL_ARTICLE">
<AU>Strandell A, Lindhard A</AU>
<TI>Why does hydrosalpinx reduce fertility; the importance of hydro salpingeal fluid</TI>
<SO>Human Reproduction</SO>
<YR>2002</YR>
<VL>17</VL>
<NO>5</NO>
<PG>1141-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Surrey-2001" MODIFIED="2009-06-08 15:10:19 +1200" MODIFIED_BY="jane clarke" NAME="Surrey 2001" TYPE="JOURNAL_ARTICLE">
<AU>Surrey AS, Schoolcraft WB</AU>
<TI>Laparoscopic management of hydrosalpinges before in vitro fertilization embryo transfer: salpingectomy versus proximal tubal occlusion</TI>
<SO>Fertility &amp; Sterility</SO>
<YR>March 2001</YR>
<VL>75</VL>
<NO>3</NO>
<PG>612-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tay-1997" MODIFIED="2009-06-08 15:10:26 +1200" MODIFIED_BY="jane clarke" NAME="Tay 1997" TYPE="JOURNAL_ARTICLE">
<AU>Tay JI, Rutherford AJ, Killick SR, Maguiness SD, Partridge RJ, Leese HJ</AU>
<TI>Human tubal fluid: production, nutrient composition and response to adrenergic agents</TI>
<SO>Human Reproduction</SO>
<YR>1998</YR>
<VL>70</VL>
<PG>492-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Taylor-2001" MODIFIED="2009-02-14 11:19:26 +1300" MODIFIED_BY="[Empty name]" NAME="Taylor 2001" TYPE="JOURNAL_ARTICLE">
<AU>Taylor RC, Berkowitz J, McComb PF</AU>
<TI>Role of laparoscopic salpingostomy in the treatment of hydrosalpinx</TI>
<SO>Fertility and Sterilty</SO>
<YR>2001</YR>
<VL>75</VL>
<PG>594-600</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Van-Voorhis-1998" NAME="Van Voorhis 1998" TYPE="JOURNAL_ARTICLE">
<AU>Van Voorhis BJ, Sparks AET, Syrop CH, Stovall DW</AU>
<TI>Ultrasound-guided aspiration of hydrosalpinges is associated with improved pregnancy and implantation rates after in-vitro fertilization cycles</TI>
<SO>Human Reproduction</SO>
<YR>1998</YR>
<VL>13</VL>
<PG>736-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vandromme-1995" MODIFIED="2008-10-07 23:58:07 +1300" MODIFIED_BY="[Empty name]" NAME="Vandromme 1995" TYPE="JOURNAL_ARTICLE">
<AU>Vandromme J, Chasse E, Lejeune B, Van Rysselberge M, Delvigne A, Leroy F</AU>
<TI>Hydrosalpinges in in vitro fertilisation: an unfavourable prognostic feature</TI>
<SO>Human Reproduction</SO>
<YR>1995</YR>
<VL>10</VL>
<PG>576-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vasquez-1995" MODIFIED="2009-06-08 15:10:50 +1200" MODIFIED_BY="jane clarke" NAME="Vasquez 1995" TYPE="JOURNAL_ARTICLE">
<AU>Vasquez G, Boeckx K, Brosens IA</AU>
<TI>Prospective study of tubal mucosal lesions and fertility in hydrosalpinges</TI>
<SO>Human Reproduction</SO>
<YR>1995</YR>
<VL>10</VL>
<PG>1075-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zeyneloglu-1998" NAME="Zeyneloglu 1998" TYPE="JOURNAL_ARTICLE">
<AU>Zeyneloglu HB, Arici A, Olive DL</AU>
<TI>Adverse effects of hydrosalpinx on pregnancy rates after in vitro fertilization - embryo transfer</TI>
<SO>Fertility &amp; Sterility</SO>
<YR>1998</YR>
<VL>70</VL>
<PG>492-9</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2008-10-06 18:50:54 +1300" MODIFIED_BY="[Empty name]"/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2009-11-06 13:42:56 +1300" MODIFIED_BY="jane clarke">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2009-11-06 13:42:56 +1300" MODIFIED_BY="jane clarke" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2009-09-07 04:06:15 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dechaud-1998">
<CHAR_METHODS MODIFIED="2009-09-07 04:06:15 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial.</P>
<P>Single-centre, Department of Obstetrics and Gynaecology at a university hospital (Montpelier, France).<BR/>Patient sampling: not explained.</P>
<P>Inclusion criteria: women with severe tubal infertility, not suitable for tubal repair.<BR/>Exclusion criteria: age &gt;40 years; additional causes of infertility; tubal pathology suitable for repair by tubal catheterization, laparoscopic surgery, or microsurgical techniques; tubal pathology so severe as to require bilateral salpingectomy; lack of patient consent for salpingectomy or randomisation.</P>
<P>60 women recruited, 60 randomised (30 to laparoscopic bilateral salpingectomy and adhesiolysis; 30 to laparoscopic adhesiolysis).<BR/>Number excluded not known.<BR/>No loss to follow up.<BR/>60 women analysed.</P>
<P>Follow-up duration 1-5 years. Follow-up scheme: not specified.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-06-08 14:14:38 +1200" MODIFIED_BY="jane clarke" NOTES="&lt;h1 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s46&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Data and analyses&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s213&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types)&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s214&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.1 Live birth rate&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s215&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.1.1 Laparoscopic bilateral salpingectomy and adhesiolysis versus laparoscopic adhesiolysis&lt;/h4&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-03 11:31:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Kontoravdis: compares 3 groups: salpingectomy/ no salpingectomy/ proximalt ubal occlusion.&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-03 11:33:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;question regarding if splitting of data in subgroups is correct: &lt;/span&gt;&lt;br&gt;&lt;span modified=&quot;2008-09-03 11:34:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;what i dif: &lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:32:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Salpingectomy vs no salpingectomy was already a subgroup --&amp;gt; added comparison of these 2 groups by kontoravdis there&lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:34:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;;&lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:32:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt; and adde&lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:33:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;d &lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:31:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;salpingectomy &lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:32:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;versus &lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:33:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;tubal occlusion as a separate group (no previous studies compared this)..... &lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:34:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;is this &lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:33:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;OK?&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-03 11:34:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;converted clinical pregnancy rate per 100 ET to clinical pregnancy rate per woman; have to ch&lt;/span&gt;&lt;span modified=&quot;2008-09-03 11:35:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;eck this.&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-03 11:32:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;deleted&quot;&gt;&lt;br&gt;&lt;/span&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s217&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.1.2 Laparoscopic salpingectomy versus no intervention&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s219&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.1.3 Laparoscopic selective salpingostomy-salpingectomy versus progesterone medical treatment&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s221&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.1.4 &lt;span modified=&quot;2008-09-02 17:55:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Aspiration versus no aspiration&lt;/span&gt;&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s326&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.1.5 &lt;span modified=&quot;2008-09-03 13:41:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Proximal tubal occlusion versus laparoscopic salpingectomy&lt;/span&gt;&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s223&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.2 Total pregnancy rate&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s224&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.2.1 Laparoscopic bilateral salpingectomy and adhesiolysis vesus laparoscopic adhesiolysis&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s226&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.2.2 Laparoscopic salpingectomy versus no intervention&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s228&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.2.3 Laparoscopic selective salpingostomy-salpingectomy versus progesterone medical treatment&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s313&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.2.4 &lt;span modified=&quot;2008-09-03 10:30:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;As&lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:31:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;piration versus no aspiration&lt;/span&gt;&lt;/h4&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-03 10:32:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Clinical pregnancy is defined as the prescence of gestational sac on ultrasound; resu&lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:33:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;lts per woman, I think&lt;/span&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s230&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.3 Ectopic pregnancy rate&lt;/h3&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-03 10:39:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;0 events; talked to vanessa: that you cant add something to the zero.. correct?&lt;/span&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s231&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.3.1 Laparoscopic bilateral salpingectomy and adhesiolysis vesus laparoscopic adhesiolysis&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s233&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.3.2 Laparoscopic salpingectomy versus no intervention&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s235&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.3.3 Laparoscopic selective salpingostomy-salpingectomy versus progesterone medical treatment&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s315&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.3.4 &lt;span modified=&quot;2008-09-03 10:33:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Aspiration versus no aspiration&lt;/span&gt;&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s237&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.4 Miscarriage rate&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s238&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.4.1 Laparoscopic bilateral salpingectomy and adhesiolysis vesus laparoscopic adhesiolysis&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s240&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.4.2 Laparoscopic salpingectomy versus no intervention&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s242&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.4.3 Laparoscopic selective salpingostomy-salpingectomy versus progesterone medical treatment&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s317&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.4.4 &lt;span modified=&quot;2008-09-03 10:40:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Aspiration versus no aspiration&lt;/span&gt;&lt;/h4&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-03 10:52:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Hammadieh: results per Biochemical pregnancy&lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:53:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt; &lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:53:16 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;I &lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:53:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Abortion: &lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:53:16 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;4/14 C: 3/7&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-03 10:52:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;We want per clinical pregnancy&lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:53:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt; --&amp;gt; kant convert this because we don't know which &lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:54:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;aborted &lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:53:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;biochemical pregnancy was a&lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:54:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;n aborted&lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:53:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt; clinical pre&lt;/span&gt;&lt;span modified=&quot;2008-09-03 10:54:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;gnancy... &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s244&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.5 Multiple pregnancy rate&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s245&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.5.1 Laparoscopic bilateral salpingectomy and adhesiolysis vesus laparoscopic adhesiolysis&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s246&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.5.2 Laparoscopic salpingectomy versus no intervention&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s247&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.5.3 Laparoscopic selective salpingostomy-salpingectomy versus progesterone medical treatment&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s248&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.6 Complication rate&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s249&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.6.1 Laparoscopic bilateral salpingectomy and adhesiolysis vesus laparoscopic adhesiolysis&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s250&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.6.2 Laparoscopic salpingectomy versus no intervention&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s252&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.6.3 Laparoscopic selective salpingostomy-salpingectomy versus progesterone medical treatment&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s319&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.6.4 &lt;span modified=&quot;2008-09-03 10:56:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Aspiration versus no aspiration&lt;/span&gt;&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s343&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;2 &lt;span modified=&quot;2008-09-03 13:54:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Laparoscopic surgery on the fallopian tube (all types) VERSUS other&lt;/span&gt;&lt;span modified=&quot;2008-09-03 13:55:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt; laparoscopic surgical technique on the fallopian tube&lt;/span&gt;&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s331&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;3 &lt;span modified=&quot;2008-09-03 13:47:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Comparison of surgical techniques&lt;/span&gt;&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s332&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;3.1 &lt;span modified=&quot;2008-09-03 13:48:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Live birth rate&lt;/span&gt;&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s335&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;3.2 &lt;span modified=&quot;2008-09-03 13:48:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Total pregnancy rate&lt;/span&gt;&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s339&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;3.3 &lt;span modified=&quot;2008-09-03 13:52:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Ectopic pregnancy rate&lt;/span&gt;&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s340&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;3.4 &lt;span modified=&quot;2008-09-03 13:52:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Miscarriage rate&lt;/span&gt;&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s341&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;3.5 &lt;span modified=&quot;2008-09-03 13:52:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Multiple pregnancy rate&lt;/span&gt;&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s342&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;3.6 &lt;span modified=&quot;2008-09-03 13:53:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Complications rate&lt;/span&gt;&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2009-06-08 14:14:38 +1200" NOTES_MODIFIED_BY="jane clarke">
<P>Age &lt;/=40 years (range 27-36).<BR/>Type (primary or secondary) of infertility: not stated.<BR/>Duration of infertility, mean months (SD): laparoscopic salpingectomy group 55.2 (33.3); laparoscopic adhesiolysis group 48.0 (25.4).<BR/>Investigative work-up: baseline FSH, endocrine laboratory screening, semen analysis, post coital test, laparoscopy and confirmatory test of ovulation.<BR/>Other contributory causes: none<BR/>Previous treatment: no previous IVF.<BR/>
<BR/>Diagnosis of tubal pathology: by laparoscopy and(or) HSG; diagnostic criteria are specified.<BR/>Extent of tubal pathology: salpingitis isthmica nodosa or hydrosalpinx with a poor prognosis (disturbed with mucosal folds or irregular walls on HSG; proximal nodes or a thick walled hydrosalpinx). Distribution: unclear.</P>
<P>Characteristics of IVF treatment:<BR/>IVF protocol: a GnRH agonist protocol with hMG and hCG. <BR/>Number of IVF ovarian stimulation cycles per woman: not stated.<BR/>Mean oocytes retrieved per cycle (SD): 10.1 (5.0) in the salpingectomy group; 10.5 (6.0) in the laparoscopic adhesiolysis group. No ICSI. Fertilization rate: not stated. Mean number of embryos transferred (SD): 3.3 (1.2) in the salpingectomy group; 3.4 (1.2) in the laparoscopic adhesiolysis; up to 5 embryos were replaced in some cases.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-08 00:17:31 +1300" MODIFIED_BY="[Empty name]">
<P>Laparoscopic bilateral salpingectomy and adhesiolysis VERSUS laparoscopic adhesiolysis.</P>
<P>Criteria for surgical treatment prior to IVF: a communicating non-draining hydrosalpinx with salpingitis isthmica nodosa.<BR/>Mean interval from surgical intervention to IVF in months (SD): treatment group 10.1 (7.5); control group 9.5 (7.2).<BR/>Cointerventions: none stated.<BR/>Data on performer: not stated.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-06-08 14:14:38 +1200" MODIFIED_BY="jane clarke">
<P>PRIMARY OUTCOMES<BR/>Ongoing pregnancy rate - not defined; reported per transfer.<BR/>Pregnancy rate - not defined; reported per transfer, per oocyte retrieval, per IVF cycle.<BR/>Cumulative pregnancy rates were presented also and obtained with the use of cumulative proportion test (the cumulative probability of becoming pregnant after each IVF attempt according to the number of patients, the number of pregnancies for each IVF attempt and the number of patients who discontinued IVF after each IVF attempt). The investigators hypothesized that the likelihood of becoming pregnant would have been equal for the patients who became pregnant after IVF and for those who discontinued IVF treatment.</P>
<P>SECONDARY OUTCOMES<BR/>Implantation rate - not defined.<BR/>Proportion of IVF cycles resulting in embryo transfer.<BR/>Ectopic pregnancy and miscarriage rate - not defined.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-02-14 06:44:03 +1300" MODIFIED_BY="[Empty name]">
<P>Subsequent publication of the cumulative results from this trial (<LINK REF="REF-Strandell-2001" TYPE="REFERENCE">Strandell 2001</LINK>) were excluded from meta-analysis (not intention to treat and too many protocol breached when intention to treat data was provided).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-06-08 14:14:38 +1200" MODIFIED_BY="jane clarke" STUDY_ID="STD-Hammadieh-2008">
<CHAR_METHODS MODIFIED="2008-10-08 14:33:55 +1300" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial.</P>
<P>Single centre, non academic, trial in the Assisted Conception Unit of Birmingham Women's Hospital, UK.<BR/>Patient sampling unclear.</P>
<P>Inclusion criteria: a uni- or bilateral hydrosalpinx diagnosed by ultrasound during ovarian stimulation in the IVF cycle or previous to the IVF cycle, or women with severe tubal pathology on the waiting list for salpingectomy for hydrosalpinges.<BR/>Exclusion criteria: other major fertility factors.</P>
<P>66 women recruited and randomised (32 to aspiration; 34 to no intervention). 1,154 exclusions prior to randomisation. No women withdrew or lost to follow up. 66 women were analysed.</P>
<P>Follow-up duration up to 1 IVF cycle. Type of follow-up: biochemical pregnancy 14 days post ET; if positive ultrasound examination is performed 6 weeks post transfer. After diagnosis of viable pregnancy patients are referred to their GP.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-06-08 14:14:38 +1200" MODIFIED_BY="jane clarke">
<P>Age (years (SD)): aspiration group: 33.4±4.5 / no intervention group 33.9±4.7.<BR/>Type (primary/secondary) of subfertility: primary infertility 32/66 (aspiration group 41%, control group 56%).<BR/>Duration of infertility: not stated.<BR/>Previous investigative work-up: not stated other than baseline FSH levels.<BR/>Contributary causes to infertility: exclusion criterion.<BR/>Previous treatments: no previous IVF treatment; not otherwise specified.</P>
<P>Diagnosis of tubal pathology: by ultrasound and by DLS or HSG in 7 patients.<BR/>Characteristics of tubal pathology: hydrosalpinges. 14 bilateral (8 in the aspiration group; 6 in the non intervention group).</P>
<P>Characteristics of IVF treatment:<BR/>Ovarian stimulation protocol: long antagonist protocol.<BR/>Single IVF ovarian stimulation cycle per woman.<BR/>Mean oocytes retrieved at IVF (SD) - aspiration group 14.1 (7.1); non intervention group 12.4 (7.1).Proportion undergoing ICSI, 5% aspiration group; 7% non-intervention group. Mean no. of fertilized oocytes in the aspiration group 9.2 (5.2); 7.0 (4.6) in the non-aspiration group. Mean embryos transferred per cycles (SD) - 2.3 (0.58) in the aspiration group; 2.1 (0.64) in the control group.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-06-08 14:14:38 +1200" MODIFIED_BY="jane clarke">
<P>Aspiration of hydrosalpinx or hydrosalpinges after collection of all eggs (covered with intravenous Augmentin followed by 3 days of oral Azithromycin antibiotic) VERSUS no aspiration.</P>
<P>Criteria for surgical treatment prior to IVF - Ultrasound visible hydrosalpinges (uni- or bilateral) during ovarian stimulation phase of IVF treatment or severe tubal pathology.<BR/>Timing of intervention: All interventions administered just after oocyte aspiration of the IVF cycle studied.<BR/>Cointerventions: antibiotics were administered in the aspiration group.<BR/>Data on performer: not stated.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-10-08 00:11:31 +1300" MODIFIED_BY="[Empty name]">
<P>PRIMARY OUTCOMES<BR/>Biochemical (urinary HCG test 14 days after ET) and clinical (transvaginal ultrasound verified gestation sac) pregnancy per woman.</P>
<P>SECONDARY OUTCOMES<BR/>Ectopic pregnancy rate - not defined; presumably per woman.<BR/>Miscarriage - any pregnancy loss before 12 weeks.<BR/>Implantation rate - number of gestational sacs on ultrasound divided by the number of embryos transferred.<BR/>Pelvic infection - pelvic abdominal pain and pyrexia or positive culture of genital swabs<BR/>Recurrence rate of hydrosalpinges after aspiration.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-07 23:27:36 +1300" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-11-06 13:42:56 +1300" MODIFIED_BY="jane clarke" STUDY_ID="STD-Kontoravdis-2006">
<CHAR_METHODS MODIFIED="2009-06-08 14:14:39 +1200" MODIFIED_BY="jane clarke">
<P>Randomised Controlled Trial</P>
<P>Study in two centres: a academic centre: Aretaieon University Hospital; a non-academic centre: the Centre for Human Reproduction, Genesis Clinic; both in Athens, Greece. Patients recruited prospectively; patient sampling consecutively.</P>
<P>Inclusion criteria: Women aged &#8804;41 with unilateral of bilateral hydrosalpinges; confirmed by HSG, suitability for IVF-ICSI treatment, FSH on day 2/3 &lt;12mIU/ml, no contraindications for laparoscopic surgery, no history of IVF attempts before recruitment, absence of other obvious pelvic pathology in females.<BR/>Exclusion criteria: Not specified.</P>
<P>115 patients were recruited and randomised (50 to proximal tubal occlusion; 50 to salpingectomy; 15 to non-intervention). 112 patients underwent IVF and were analysed. 3 women withdrew from IVF; 3 women didn't respond to ovarian stimulation and in 4 women IVF did not result in embryo's. </P>
<P>Follow-up scheme: up to the first IVF cycle after tubal surgery. Type: ultrasound 4 weeks after ET.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-06-08 14:14:39 +1200" MODIFIED_BY="jane clarke">
<P>Age (years (SD)): 31±4.5 vs 29.8±3.4 vs 3.4±5.3.<BR/>Type (primary or secondary) of subfertility: primary subfertility in 92% vs 84% vs 87% of the patients; duration not stated.<BR/>Previous investigation: included baseline FSH.<BR/>Contributary causes for infertility: other obvious pathology was reason for exclusion.<BR/>Previous treatments: no previous fertility treatment.</P>
<P>Diagnosis of tubal pathology was confirmed with HSG. </P>
<P>Characteristics and distribution of tubal pathology: all patients had hydrosalpinges; bilateral in 70/115 patients (70% vs 54% vs 54%). 70/115 women (58% vs 64% vs 60%) had ultrasound visible hydrosalpinges. </P>
<P>Characteristics of IVF treatment:<BR/>IVF protocol: a standard long antagonist protocol; ovarian stimulation; rec FSH; HCG; luteal phase support; ET on day 3. Doxycycline and prednisolon 6 days after oocyte retrieval.<BR/>Number of ovarian stimulation cycles per woman: one<BR/>Collected oocytes (mean±SD): 11.6±4.9 in the laparoscopic occlusion group; 12.1±5.0 in the salpingectomy group, 10.9±5.1 in the non-intervention group. ICSI procedures: n=7(14.9%)in the laparoscopic occlusion group; n=6(12.5%) in the salpingectomy group, n=3(20%) in the non-intervention group. Fertilized oocytes (mean±SD): 8.7±3.9 in the laparoscopic occlusion group; 8.53±4.0 in the salpingectomy group, 7.9±5.1 in the non-intervention group. No of transferred embryo's: 118 in the laparoscopic occlusion group; 121 in the salpingectomy group, 36 in the non-intervention group.<BR/>Embryo's per ET (mean±SD) 2.6±0.6 in the laparoscopic occlusion group; 2.6±0.6 in the salpingectomy group, 2.6±0.8in the non-intervention group. Number of transfers with all embryo's grade 2.7 in the laparoscopic occlusion group; 5 in the salpingectomy group, 1 in the non-intervention group.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-11-06 13:42:56 +1300" MODIFIED_BY="jane clarke">
<P>Uni- or bilateral laparoscopic tubal occlusion by bipolar diathermy at two separate sites on the isthmic segment of the tube VERSUS uni- or bilateral salpingectomy; with transection 1 to 1.5 cm from the cornual section VERSUS no intervention.</P>
<P>Criteria for surgery: unilateral of bilateral hydrosalpinges.<BR/>Timing of surgery: 2 to 3 months after tubal surgery prior to IVF; time interval between randomisation to IVF in the control group:unclear.<BR/>co-interventions: none stated.<BR/>Data on performer: not stated.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-06-08 14:14:39 +1200" MODIFIED_BY="jane clarke">
<P>PRIMARY OBJECTIVES<BR/>Ongoing pregnancy rate - (pregnancy's beyond first trimester) per 100 ET.<BR/>Clinical pregnancy rate - (gestational sacs on ultrasound with fetal pole, 4 weeks after ET) per 100 ET.<BR/>Ectopic pregnancy rate - defined per 100 ET.<BR/>Miscarriage rate - abortion of clinical pregnancies (ultrasonographically identified pregnancies) per 100 ET.</P>
<P>SECONDARY OBJECTIVES:<BR/>Subgroup analysis for bilateral hydrosalpinges and ultrasound visible hydrosalpinges.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-07 23:44:40 +1300" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-09-07 04:06:41 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Moshin-2006">
<CHAR_METHODS MODIFIED="2009-09-07 04:06:41 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised Controlled Trial.</P>
<P>Single academic centre, Center for Reproductive Health and Genetics, Chisinau, Moldova.<BR/>Patients were recruited prospectively and consecutively.</P>
<P>Inclusion criteria: women with hydrosalpinges.<BR/>Exclusion criteria: not specified.</P>
<P>204 patients recruited and randomised (66 women randomised to no surgical treatment; 60 women randomised to salpingectomy; 78 randomised to proximal tubal occlusion) 204 women analysed. loss to follow-up/withdrawal: none.</P>
<P>Follow-up duration: up to one IVF cycle.<BR/>Type of follow-up: diagnosis of pregnancy by ultrasound examination 21 days and 35 days after ET.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-06-08 14:14:39 +1200" MODIFIED_BY="jane clarke">
<P>Age: similar in all groups; range: 22-35 years<BR/>Type (primary or secondary): about 65% of the patients in each group were primary infertile.</P>
<P>Duration of infertility: &gt;2 years (mean months (SD): salpingectomy group: 46.2 (27.2); tubal occlusion group: 47.4 (28.5); non-intervention group: 46.9 (27.8)).</P>
<P>Previous investigative work-up: ovulatory cycles, hormonal tests, transvaginal ultrasound examination of the genitalia interna, male semen parameters.<BR/>Contributary causes to infertility: none.<BR/>Previous fertility treatment: no previous IVF treatment.<BR/>
</P>
<P>Diagnosis of tubal pathology: bilateral distal tubal occlusion diagnosed by HSG or ultrasound visible hydrosalpinges.<BR/>Characteristics and distribution of tubal pathology: bilateral hydrosalpinges.</P>
<P>IVF:<BR/>Ovarian stimulation in a long course GnRH analogue protocol (Decapeptyl or Dipherelin) with a fixed doses (225 IU daily) of recombinant FSH for stimulation, starting on day 3 of the cycle. Ovarian response was monitored by ultrasonography and serum E2 concentration. Ovulation was triggered with 10000 IU of HCG (Pregnyl) when the leading follicles reached 18-20 mm. Oocyte retrieval was carried out 36 hours after HCG administration. Retrieved oocytes were evaluated and fertilized by conventional insemination. Embryos were transferred on day 3 after insemination. : Utrogestan 400 mg/day vaginal from the day of ovum pick-up until 12 week of pregnancy. Results reported over one cycle.<BR/>Number of oocytes retrieved: 9.8±5.5 in the non-intervention group / 10.4±6.0 in the salpingectomy group, 10.2±5.7 in the proximal occlusion group.<BR/>Proportion undergoing ICSI: not stated. Fertilized oocytes: 6.8±4.6 in the non-intervention group, 7.0±4.7 in the salpingectomy group, 6.9±4.6 in the proximal occlusion group.<BR/>Mean number of preembryo's transferred: 3.5±1.3 in the non-intervention group, 3.4±1.2 in the salpingectomy group, 3.4±1.3 in the proximal occlusion group.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-06-08 14:14:39 +1200" MODIFIED_BY="jane clarke">
<P>Salpingectomy VERSUS proximal tubal clamping of hydrosalpinges VERSUS No intervention .</P>
<P>Criterium for intervention: ultrasound visible hydrosalpinges.</P>
<P>Timing of intervention: minimally 2 months before IVF treatment. Timing to the IVF treatment cycle after randomisation in the control group: unclear.<BR/>Cointerventions: not reported.<BR/>Data on performer: not reported.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-02-14 08:37:58 +1300" MODIFIED_BY="[Empty name]">
<P>PRIMARY OUTCOMES:</P>
<P>Clinical pregnancy - gestational sac on ultrasound.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-06-08 14:48:57 +1200" MODIFIED_BY="jane clarke">
<P>As data extraction on the abstract was limited; queries were resolved by contacting the author.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-07-01 15:41:20 +1200" MODIFIED_BY="Julie A Brown" STUDY_ID="STD-Strandell-1999">
<CHAR_METHODS MODIFIED="2009-06-08 14:14:39 +1200" MODIFIED_BY="jane clarke">
<P>Randomised controlled trial.<BR/>
<BR/>Multicentre trial involving 9 Scandinavian IVF centres.<BR/>Patients recruited prospectively; patient sampling not explained explicitly.<BR/>
</P>
<P>Inclusion criteria: hydrosalpinges, laparoscopic acces ability, age&lt;39 at time of randomisation.<BR/>Exclusion criteria - previous IVF; uterine fibroids.Concomitant male factor requiring ICSI accepted if centre had established successful ICSI programme with results equivalent to conventional IVF.</P>
<P>204 women were recruited and randomised. Number of exclusions not known. 5 patients of the intervention group did not undergo surgery; 6 patients in the intervention group and 6 patients in the non-intervention group did not undergo IVF. 204 women were analysed.<BR/>Follow-up duration up to 1 IVF cycle (further follow-up data anticipated).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-06-08 14:14:39 +1200" MODIFIED_BY="jane clarke">
<P>Age &lt;39 years (range 22-38)<BR/>Type of infertility: majority primary infertility (treatment group 73%, control group 63%)<BR/>Duration of infertility not stated.<BR/>Investigative work-up not stated.<BR/>Contributary causes to infertility: not stated.<BR/>Previous fertility treatment: not stated; no previous IVF. <BR/>
</P>
<P>Diagnosis of tubal pathology: by HSG or laparoscopy. 37(51%) had ultrasound visible hydrosalpinges compared to 42(57%). </P>
<P>Characteristics and distribution of tubal pathology: Hydrosalpinges. Bilateral in 69(59%) and 36(41%); unilateral in 47(41%) and 52(59%). </P>
<P>Characteristics of IVF treatment :<BR/>IVF protocol: Long GnRh antagonist protocol, with either HMG of FSH. <BR/>1-2 IVF ovarian stimulation cycles per woman.<BR/>Mean oocytes retrieved at IVF (SD) - 10.6 (5.9) in the salpingectomy group; 10.6 (6.1) in the non intervention group. Proportion undergoing ICSI, 13.1% in the salpingectomy group; in the non intervention group12.6%. Mean no. of fertilized and cleaved oocytes in treatment group 6.8 (4.8); 7.0 (4.9) in the non intervention group. Mean embryos transferred per cycles (SD) - treatment group 2.0 (0.3); 2.0 (0.4)in the non intervention group.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-07-01 15:41:20 +1200" MODIFIED_BY="Julie A Brown">
<P>Laparoscopic bilateral or unilateral salpingectomy (or, if technical difficulties e.g. extensive adhesions, proximal ligation and distal fenestration recommended) VERSUS no surgery.</P>
<P>Criteria for surgical treatment prior to IVF - Uni- or bilateral hydrosalpinges (a distally occluded pathologically dilated tube or one which became pathologically dilated on patency testing by HSG/laparoscopy.<BR/>Interval from surgical intervention to IVF - minimum 2 months, IVF was performed in the control group directly after randomisation.<BR/>Co-interventions: none (deviations from protocol though)<BR/>Data on surgeons: not stated.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-06-08 14:14:39 +1200" MODIFIED_BY="jane clarke">
<P>PRIMARY OUTCOMES<BR/>Ongoing pregnancy (pregnancy&gt;20 weeks) or delivery rate in first cycle per woman, per started cycle, and per transfer cycle.<BR/>Pregnancy rate - per woman, per started cycle and per transfer cycle.<BR/>Clinical pregnancy verified by gestational sac on ultrasound.</P>
<P>SECONDARY OUTCOMES<BR/>Ectopic pregnancy rate - per implanted embryo's/ clinical pregnancy<BR/>Miscarriage rate - not defined, presumably as outcome of clinical pregnancy<BR/>Implantation rate - number of gestational sacs on ultrasound divided by the number of embryos transferred.<BR/>Multiple pregnancy rate not stated</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-02-14 10:28:26 +1300" MODIFIED_BY="[Empty name]">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2008-10-10 17:50:57 +1300" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2008-09-26 17:39:13 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gelbaya-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-09-26 17:39:13 +1200" MODIFIED_BY="[Empty name]">
<P>Retrospective non-randomised controlled study. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-08 00:08:56 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Goldstein-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-08 00:08:56 +1300" MODIFIED_BY="[Empty name]">
<P>Study design and whether randomisation has been performed is unclear. It appears that patients serve as there own control after surgical intervention. Correspondance was sought to resolve this issue, but not with success.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-10 17:50:57 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hotineanu-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-10 17:50:57 +1300" MODIFIED_BY="[Empty name]">
<P>This trial was excluded because this article compared proximal/distal tubal occlusion with clamping; however comparisons were between outcomes in different degrees of tubal pathology rather than different interventions. Comparative data was not obtained as correspondence was unsuccessful. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-08 01:01:23 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mardesic-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-08 01:01:23 +1300" MODIFIED_BY="[Empty name]">
<P>This trial is not a randomised trial - the 'control' group was historical (the same women prior to their salpingectomy) and biased by the fact that no pregnancies occurred.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-07 23:01:49 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zolghadri-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-07 23:01:49 +1300" MODIFIED_BY="[Empty name]" NOTES="&lt;h1 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;/h1&gt;&lt;p&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.3.1&lt;br&gt;Exported from Review Manager 4.2.3&lt;br&gt;Exported from Review Manager 4.2.2&lt;br&gt;Exported from Review Manager 4.2.3&lt;br&gt;Exported from Review Manager 4.2.2&lt;br&gt;Short title (no longer in use): Surgery for tubal disease before IVF&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; id=&quot;f4&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f4&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Title&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s0&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Review information&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s3&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Authors&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s51&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Johnson, Neil&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s53&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;van Voorst, Sabine&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s55&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Sowter, Martin&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s57&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Strandell, Annika&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s1&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Contact person&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s6&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Dates&lt;/h2&gt;&lt;p&gt;Minor update: 3/17/04&lt;/p&gt;&lt;p&gt;New studies found and included or excluded: 5/1/08&lt;/p&gt;&lt;p&gt;Conclusions changed: 5/1/08&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s10&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;What's new&lt;/h2&gt;&lt;p&gt;The review was updated in May 2008, based upon a search undertaken in January 2008. Three further trials were included in this update (Hammadieh 2008, Kontovardis 2006, Moshin 2006). Hammadieh 2008 assessed the benefit of aspiration of hysdrosalpinx fluid at IVF egg collection. Kontovardis 2006 and Moshin 2006 compared salpingectomy versus tubal occlusion versus no intervention for women with hydrosalpinges prior to IVF in somilar three-arm trials. Another trial was excluded (Darwish 2005) as it did not inlcude data for the outcome from subsequent IVF cycles and was simply a randomised trial to assess the feasibility of hysteroscopic versus laparoscopic tubal occlusion for women with hydrosalpinges due to undergo IVF.&lt;br&gt;&lt;br&gt;The review was previously updated in March 2004, based upon a repeat search in February and March 2004. A further publication of cumulative results of one of the included trials (Strandell 1999) was the only trial considered for inclusion, but these data were excluded from the meta-analysis as they were analysed on a per-protocol basis. Intention-to-treat data (provided in correspondence by the authors) were also excluded from the meta-analysis owing to the high proportion of women randomised to no intervention who did, in fact, receive the surgical intervention.&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s59&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Amended, 26 May 2008&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s11&quot;&gt;&lt;img src=&quot;expand.png&quot;&gt;&lt;/span&gt;History&lt;/h2&gt;&lt;h1 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s49&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Abstract&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; id=&quot;f211&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f211&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Background&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; id=&quot;f213&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f213&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Objectives&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; id=&quot;f215&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f215&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Search methods&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; id=&quot;f217&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f217&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Selection criteria&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; id=&quot;f219&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f219&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Data collection and analysis&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; id=&quot;f221&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f221&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Results&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; id=&quot;f223&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f223&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Authors' conclusions&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s48&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Plain language summary&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; id=&quot;f206&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f206&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Plain language title&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; id=&quot;f208&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f208&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Summary text&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; id=&quot;f236&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f236&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Background&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; id=&quot;f246&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f246&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Objectives&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; id=&quot;f248&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f248&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Methods&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; id=&quot;f250&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f250&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Criteria for considering studies for this review&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; id=&quot;f252&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f252&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Types of studies&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; id=&quot;f254&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f254&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Types of participants&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; id=&quot;f256&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f256&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Types of interventions&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; id=&quot;f258&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f258&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Types of outcome measures&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; id=&quot;f264&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f264&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Search methods for identification of studies&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; id=&quot;f270&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f270&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Data collection and analysis&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; id=&quot;f294&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f294&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Results&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; id=&quot;f296&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f296&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Description of studies&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; id=&quot;f304&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f304&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Risk of bias in included studies&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; id=&quot;f316&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f316&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Effects of interventions&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; id=&quot;f318&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f318&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Discussion&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; id=&quot;f330&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f330&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Authors' conclusions&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; id=&quot;f332&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f332&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Implications for practice&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; id=&quot;f334&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f334&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Implications for research&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; id=&quot;f225&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f225&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Acknowledgements&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; id=&quot;f229&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f229&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Contributions of authors&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; id=&quot;f227&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f227&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Declarations of interest&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; id=&quot;f231&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f231&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Differences between protocol and review&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; id=&quot;f233&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;f233&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Published notes&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s19&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Characteristics of studies&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s20&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Characteristics of included studies&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s170&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Dechaud 1998&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Methods&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Participants&lt;/th&gt;&lt;h1 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s46&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Data and analyses&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s177&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types)&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s178&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.1 Live birth rate&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s179&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.1.1 Laparoscopic bilateral salpingectomy and adhesiolysis versus laparoscopic adhesiolysis&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s181&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.1.2 Laparoscopic salpingectomy versus no intervention&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s183&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.1.3 Laparoscopic selective salpingostomy-salpingectomy versus progesterone medical treatment&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s185&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.2 Total pregnancy rate&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s186&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.2.1 Laparoscopic bilateral salpingectomy and adhesiolysis vesus laparoscopic adhesiolysis&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s188&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.2.2 Laparoscopic salpingectomy versus no intervention&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s190&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.2.3 Laparoscopic selective salpingostomy-salpingectomy versus progesterone medical treatment&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s192&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.3 Ectopic pregnancy rate&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s193&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.3.1 Laparoscopic bilateral salpingectomy and adhesiolysis vesus laparoscopic adhesiolysis&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s195&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.3.2 Laparoscopic salpingectomy versus no intervention&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s197&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.3.3 Laparoscopic selective salpingostomy-salpingectomy versus progesterone medical treatment&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s199&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.4 Miscarriage rate&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s200&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.4.1 Laparoscopic bilateral salpingectomy and adhesiolysis vesus laparoscopic adhesiolysis&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s202&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.4.2 Laparoscopic salpingectomy versus no intervention&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s204&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.4.3 Laparoscopic selective salpingostomy-salpingectomy versus progesterone medical treatment&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s206&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.5 Multiple pregnancy rate&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s207&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.5.1 Laparoscopic bilateral salpingectomy and adhesiolysis vesus laparoscopic adhesiolysis&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s208&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.5.2 Laparoscopic salpingectomy versus no intervention&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s209&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.5.3 Laparoscopic selective salpingostomy-salpingectomy versus progesterone medical treatment&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s210&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.6 Complication rate&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s211&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.6.1 Laparoscopic bilateral salpingectomy and adhesiolysis vesus laparoscopic adhesiolysis&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s212&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.6.2 Laparoscopic salpingectomy versus no intervention&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s214&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1.6.3 Laparoscopic selective salpingostomy-salpingectomy versus progesterone medical treatment&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Interventions&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Outcomes&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Notes&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s69&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Risk of bias table&lt;/h4&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Item&lt;/th&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot;&gt;Notes&lt;/th&gt;Allocation concealment?&lt;p&gt;&lt;/p&gt;Blinding? (All outcomes. Participants, outcome assessors, clinicians, statisticians)&lt;p&gt;&lt;/p&gt;Incomplete outcome data addressed? (Intention to treat for primary outcome?)&lt;p&gt;&lt;/p&gt;Free of selective reporting?&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 12:29:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;D&lt;/span&gt;&lt;span modified=&quot;2008-09-01 12:31:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;etection &lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 14:54:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Source of funding &lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 12:27:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;S&lt;/span&gt;&lt;span modified=&quot;2008-09-01 12:26:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;tudy size &lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 15:02:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Attrition bias&lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s171&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Goldstein 1998&lt;/h3&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-01 15:15:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;contact author for:&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-01 15:15:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;study design and whet&lt;/span&gt;&lt;span modified=&quot;2008-09-01 15:16:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;er randomisation has been performed and how between group 2 and 3. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-01 15:17:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;other information which is lacking:&lt;/span&gt;&lt;br&gt;&lt;span modified=&quot;2008-09-01 15:17:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;p&lt;/span&gt;&lt;span modified=&quot;2008-09-01 15:18:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;atients included? withdrawal and loss to follow up &lt;/span&gt;&lt;br&gt;&lt;span modified=&quot;2008-09-01 15:18:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;intention to treat?&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-02 17:02:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;I suggest we exclude if author doesnt respond; &lt;/span&gt;&lt;span modified=&quot;2008-09-02 17:05:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;or if the items are not explained &lt;/span&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Methods&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Participants&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Interventions&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Outcomes&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Notes&lt;/th&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-01 15:14:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;grfdsg&lt;/span&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s75&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Risk of bias table&lt;/h4&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Item&lt;/th&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot;&gt;Notes&lt;/th&gt;Allocation concealment?&lt;p&gt;&lt;/p&gt;Blinding? (All outcomes. Participants, outcome assessors, clinicians, statisticians)&lt;p&gt;&lt;/p&gt;Incomplete outcome data addressed? (Intention to treat for primary outcome?)&lt;p&gt;&lt;/p&gt;Free of selective reporting?&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 12:29:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;D&lt;/span&gt;&lt;span modified=&quot;2008-09-01 12:31:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;etection &lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 14:54:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Source of funding &lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 12:27:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;S&lt;/span&gt;&lt;span modified=&quot;2008-09-01 12:26:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;tudy size &lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 15:02:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Attrition bias&lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s172&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Hammadieh 2008&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Methods&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Participants&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Interventions&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Outcomes&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Notes&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s83&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Risk of bias table&lt;/h4&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Item&lt;/th&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot;&gt;Notes&lt;/th&gt;Allocation concealment?&lt;p&gt;&lt;/p&gt;Blinding? (All outcomes. Participants, outcome assessors, clinicians, statisticians)&lt;p&gt;&lt;/p&gt;Incomplete outcome data addressed? (Intention to treat for primary outcome?)&lt;p&gt;&lt;/p&gt;Free of selective reporting?&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 12:29:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;D&lt;/span&gt;&lt;span modified=&quot;2008-09-01 12:31:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;etection &lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 14:54:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Source of funding &lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 12:27:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;S&lt;/span&gt;&lt;span modified=&quot;2008-09-01 12:26:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;tudy size &lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 15:02:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Attrition bias&lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s1624&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Kontoravdis 2006&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Methods&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Participants&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Interventions&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Outcomes&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Notes&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s1633&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Risk of bias table&lt;/h4&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Item&lt;/th&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot;&gt;Notes&lt;/th&gt;Allocation concealment?&lt;p&gt;&lt;/p&gt;Blinding? (All outcomes. Participants, outcome assessors, clinicians, statisticians)&lt;p&gt;&lt;/p&gt;Incomplete outcome data addressed? (Intention to treat for primary outcome?)&lt;p&gt;&lt;/p&gt;Free of selective reporting?&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 12:29:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;D&lt;/span&gt;&lt;span modified=&quot;2008-09-01 12:31:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;etection &lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 14:54:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Source of funding &lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 12:27:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;S&lt;/span&gt;&lt;span modified=&quot;2008-09-01 12:26:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;tudy size &lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 15:02:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Attrition bias&lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s402&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Moshin 2006&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Methods&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Participants&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Interventions&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Outcomes&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Notes&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s411&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Risk of bias table&lt;/h4&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Item&lt;/th&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot;&gt;Notes&lt;/th&gt;Allocation concealment?&lt;p&gt;&lt;/p&gt;Blinding? (All outcomes. Participants, outcome assessors, clinicians, statisticians)&lt;p&gt;&lt;/p&gt;Incomplete outcome data addressed? (Intention to treat for primary outcome?)&lt;p&gt;&lt;/p&gt;Free of selective reporting?&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 12:29:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;D&lt;/span&gt;&lt;span modified=&quot;2008-09-01 12:31:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;etection &lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 14:54:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Source of funding &lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 12:27:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;S&lt;/span&gt;&lt;span modified=&quot;2008-09-01 12:26:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;tudy size &lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 15:02:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Attrition bias&lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s173&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Strandell 1999&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Methods&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Participants&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Interventions&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Outcomes&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Notes&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s91&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Risk of bias table&lt;/h4&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Item&lt;/th&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot;&gt;Notes&lt;/th&gt;Allocation concealment?&lt;p&gt;&lt;/p&gt;Blinding? (All outcomes. Participants, outcome assessors, clinicians, statisticians)&lt;p&gt;&lt;/p&gt;Incomplete outcome data addressed? (Intention to treat for primary outcome?)&lt;p&gt;&lt;/p&gt;Free of selective reporting?&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 12:29:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;D&lt;/span&gt;&lt;span modified=&quot;2008-09-01 12:31:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;etection &lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 14:54:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Source of funding &lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 12:27:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;S&lt;/span&gt;&lt;span modified=&quot;2008-09-01 12:26:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;tudy size &lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;span modified=&quot;2008-09-01 15:02:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Attrition bias&lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s21&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Characteristics of excluded studies&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s174&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Mardesic 1999&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Reason for exclusion&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s1775&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Zolghadri 2006&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Reason for exclusion&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s22&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Characteristics of studies awaiting classification&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s740&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Darwish 2007,2006, 2005&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Methods&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Participants&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Interventions&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Outcomes&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Notes&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s1262&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Hotineanu 2007&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Methods&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Participants&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Interventions&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Outcomes&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Notes&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s23&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Characteristics of ongoing studies&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s1500&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Darwish 2005,2006,2007&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Study name&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Methods&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Participants&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Interventions&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Outcomes&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Starting date&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Contact information&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;th class=&quot;fixedcell&quot; readonly=&quot;true&quot; width=&quot;25%&quot;&gt;Notes&lt;/th&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s31&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Summary of findings tables&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s32&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Additional tables&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s176&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;1 Non-randomised Comparative Studies&lt;/h2&gt;&lt;p&gt;&lt;span modified=&quot;2008-09-02 16:50:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;We have to decide whether to keep this table, yes or no.. I dont think we should.. because our search was limited to RCT;s so adding in the ones we&lt;/span&gt;&lt;span modified=&quot;2008-09-02 16:51:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt; found by coincidence wouldnt be good. And.. as more studies are now include&lt;/span&gt;&lt;span modified=&quot;2008-09-02 16:52:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;d than before. &lt;/span&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s34&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;References to studies&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s35&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Included studies&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s62&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Dechaud 1998&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s65&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Dechaud H, Daures JP, Amal F, Humeau C, Hedon B. Does previous salpingectomy improve implantation and pregnancy rates in patients with severe tubal factor infertility who are undergoing in vitro fertilization? A pilot prospective randomized study. Fertility &amp;amp; Sterility 1998;69:1020-5.&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s67&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Dechaud H, Daures JP, Arnal F, Humeau C, Hedon B. Salpingectomy before undergoing IVF can increase implantation rates in severe tubal infertility patients: a prospective randomised study. In: Human Reproduction Abstracts of 13th Annual Meeting of the ESHRE. Vol. 12. 1997:23-4.&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s70&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Goldstein 1998&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s73&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Goldstein DB, Sasaran LH, Stadtmauer L, Popa R. Selective salpingostomy-salpingectomy (SSS) and medical treatment prior to IVF in patients with hydrosalpinx. In: Fertility &amp;amp; Sterility (Abstracts of 1998 Meetings). Vol. 70 Suppl 1. 1998:S320.&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s76&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Hammadieh 2008&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s79&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Hammadieh N, Afnan M, Sharif K, Evans J, Amso N. The effect of hydrosalpinx on IVF outcome: a prospective randomised controlled trial of vaginal ultrasound-guided hydrosalpinx aspiration during egg collection. Fertility &amp;amp; Sterility 2003;80 (Suppl. 3):S131-132.&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s81&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Hammadieh N, Coomarasamy A, Bolarinde O, Papaioannou S, Afnan M, Sharif K. Ultrasound-guided hydrosalpinx aspiration during oocyte collection improves pregnancy outcome in IVF: a randomized controlled trial. Human Reproduction 2008;23:1113-1117.&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s1525&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Kontoravdis 2006&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s1636&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;&lt;span modified=&quot;2008-09-02 15:01:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Kontoravdis A., Makrakis E, Pantos K,&lt;/span&gt;&lt;span modified=&quot;2008-09-02 15:02:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt; Botsis D, Deligeoroglu E, Creatsas G&lt;/span&gt;. &lt;span modified=&quot;2008-09-02 15:04:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Proximal tubal occlusion and salpingectomy result in similar improvement in &lt;/span&gt;&lt;span modified=&quot;2008-09-02 15:05:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;in vitro fertilization outcome in patients with hydrosalpinx&lt;/span&gt;. &lt;span modified=&quot;2008-09-02 15:05:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Fertility and Sterility&lt;/span&gt; &lt;span modified=&quot;2008-09-02 15:05:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;December 2006&lt;/span&gt;;&lt;span modified=&quot;2008-09-02 15:05:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Vol 86&lt;/span&gt;:&lt;span modified=&quot;2008-09-02 15:05:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;1642-164&lt;/span&gt;&lt;span modified=&quot;2008-09-02 15:06:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;8&lt;/span&gt;.&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s267&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Moshin 2006&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s414&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;&lt;span modified=&quot;2008-09-02 15:10:46 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;V. Moshin, A. Hotineanu&lt;/span&gt;. &lt;span modified=&quot;2008-09-02 15:10:53 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Reproductive outcome of the proximal tubal occlusion prior to IVF in patients with hydrosalpinx&lt;/span&gt;. In: &lt;span modified=&quot;2008-09-02 15:11:06 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Human reproduction&lt;/span&gt;. &lt;span modified=&quot;2008-09-02 15:11:30 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Supplement 1: Abstracts of the 22nd Annual Meeting of ESHRE, Prague. Czech republic, 18-21 June, 2006&lt;/span&gt; edition. Vol. &lt;span modified=&quot;2008-09-02 15:11:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;21&lt;/span&gt;. &lt;span modified=&quot;2008-09-02 15:11:12 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;June 2006&lt;/span&gt;:&lt;span modified=&quot;2008-09-02 15:11:24 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;i193-i194&lt;/span&gt;.&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s84&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Strandell 1999&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s87&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Strandell A, Lindhard A, Waldenstrom U, Thorburn J, Janson PO, Hamberger L. Hydrosalpinx and IVF outcome: a prospective randomized multicentre trial in Scandinavia on salpingectomy prior to IVF. Human Reproduction 1999;14(11):2762-9.&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s89&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Strandell A, Lindhard A, Waldenstrom U, Thorburn J, Janson PO, Hamberger L. Hydrosalpinx and IVF outcome: cumulative results after salpingectomy in a randomised controlled trial. Human Reproduction 2001;16:2403-10.&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s36&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Excluded studies&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s92&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Mardesic 1999&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s95&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Mardesic T, Muller P, Voboril J, Hulvert J, Huttelova R, Becvarova V, et al. The influence of salpingectomy of hydrosalpinges visible on ultrasound on IVF results. A pilot prospective randomized study. In: Abstracts of 11th World Congress on In Vitro Fertilization and Human Reproductive Genetics. Sydney, Australia, 9-14 May, 1999:156.&lt;/h4&gt;&lt;p&gt;Although this study was described as a randomised trial in the abstract title, this was not the case. The control group was a historical group of women who had previously undergone IVF acting as their own controls.&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s1652&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Zolghadri 2006&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s1778&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;&lt;span modified=&quot;2008-09-02 16:53:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Zolghadri J, Momtahan &lt;/span&gt;&lt;span modified=&quot;2008-09-02 16:54:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;M, Alborzi S, Mohammadinejad A, Khosravi D&lt;/span&gt;. &lt;span modified=&quot;2008-09-02 16:54:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Pregnancy outcome in patients with early recurrent abortion following laparoscopic tubal corneal interruption of a fallopian tube with hydrosalpinx. &lt;/span&gt;. &lt;span modified=&quot;2008-09-02 16:55:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Fertility and Sterility&lt;/span&gt; &lt;span modified=&quot;2008-09-02 16:55:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;July 2006&lt;/span&gt;;&lt;span modified=&quot;2008-09-02 16:56:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;86&lt;/span&gt;(&lt;span modified=&quot;2008-09-02 16:56:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;6&lt;/span&gt;):&lt;span modified=&quot;2008-09-02 16:56:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;149-151&lt;/span&gt;.&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s37&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Studies awaiting classification&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s599&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Darwish 2007,2006, 2005&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s741&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;&lt;span modified=&quot;2008-09-02 13:56:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Darwish AM, El Saman AM&lt;/span&gt;. &lt;span modified=&quot;2008-09-02 13:56:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Is there a role for hysteroscopic tubal occlusio&lt;/span&gt;&lt;span modified=&quot;2008-09-02 13:57:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;n of functionless hydrosalpinges prior to IVF/ICSI in modern practice?&lt;/span&gt;. &lt;span modified=&quot;2008-09-02 13:57:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Acta Obstetrica et Gynecologica&lt;/span&gt; &lt;span modified=&quot;2008-09-02 13:57:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;2007&lt;/span&gt;;&lt;span modified=&quot;2008-09-02 13:57:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;86&lt;/span&gt;:&lt;span modified=&quot;2008-09-02 13:57:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;1484-1489&lt;/span&gt;.&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s1249&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Hotineanu 2007&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h4 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s1252&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;&lt;span modified=&quot;2008-09-02 12:10:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Hotineanu AL, Moshin VN, Hotineanu AV, Croi&lt;/span&gt;&lt;span modified=&quot;2008-09-02 12:11:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;tor ME&lt;/span&gt;. &lt;span modified=&quot;2008-09-02 12:11:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;The effect of proximal tubal ''clamping'' prior to the IVF in patients with distal tubal occlusion.&lt;/span&gt;. In: &lt;span modified=&quot;2008-09-02 12:11:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Human Reproduction&lt;/span&gt;. &lt;span modified=&quot;2008-09-02 12:24:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Supplement 1;&lt;/span&gt;&lt;span modified=&quot;2008-09-02 12:24:28 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt; Abstracts of the 23rd Annual Meeting of the European Society of Human Reproduction and Embryology&lt;/span&gt; edition. Vol. &lt;span modified=&quot;2008-09-02 12:24:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;22&lt;/span&gt;. &lt;span modified=&quot;2008-09-02 12:25:00 +1200&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;i126&lt;/span&gt;.&lt;/h4&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s38&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Ongoing studies&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s1263&quot;&gt;&lt;img src=&quot;expand.png&quot;&gt;&lt;/span&gt;Darwish 2005,2006,2007&lt;/h3&gt;&lt;h1 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s39&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Other references&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s40&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Additional references&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s100&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Aboulghar 1990&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s102&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Akman 1996&lt;/h3&gt;&lt;p&gt;Akman MA, Garcia JE, Damewood MD, Watts LD, Katz E. Hydrosalpinx affects the implantation of previously cryopreserved embryos. Hum Reprod 1996;11:1013-4.&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s104&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Andersen 1994&lt;/h3&gt;&lt;p&gt;Andersen A, Yue Z, Meng F, Petersen K. Low implantation rate after in-vitro fertilisation in patients with hydrosalpinges diagnosed by ultrasonography. Hum Reprod 1994;9:1935-8.&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s106&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Andersen 1996&lt;/h3&gt;&lt;p&gt;Andersen AN, Lindhard A, Loft A, Ziebe S, Andersen CY. The infertile patient with hydrosalpinges: IVF with or without salpingectomy? Hum Reprod 1996;11:2081-4.&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s108&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Bloeche 1997&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s110&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Choe 1999&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s112&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Csemiczky 1996&lt;/h3&gt;&lt;p&gt;Csemiczy G, Landgren BM, Fried G, Wramsby H. High tubal damage grade is associated with low pregnancy rate in women undergoing in vitro fertilisation treatment. Hum Reprod 1996;11:2438-40.&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s114&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Dar 2000&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s116&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Dechaud 2000&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s118&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Englert 1987&lt;/h3&gt;&lt;p&gt;Englert Y, Vekemans M, Lejeune B Van Rysselberge M, Puissant F, Degueldre M, et al. Higher pregnancy rates after in vitro fertilization and embryo transfer in cases with sperm defects. Fertil Steril 1987;48:254-7.&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s120&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Fleming 1996&lt;/h3&gt;&lt;p&gt;Fleming C, Hull MGR. Impaired implantation after in vitro fertilisation treatment associated with hydrosalpinx. Br J Obstet Gynaecol 1996;103:268-72.&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s122&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Freeman 1996&lt;/h3&gt;&lt;p&gt;Freeman MR, Whitworth CM, Hill GA. Hydrosalpinx reduces in vitro fertilisation / embryo transfer rates and in vitro blastocyst development. 52nd Annual Meeting of the American Fertility Society 1996, program supplement S211.&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s124&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Gillett 1998&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s126&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Inovay 1999&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s128&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Johnson 1998&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s130&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Johnson 2002&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s132&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Katz 1996&lt;/h3&gt;&lt;p&gt;Katz E, Akman MA, Damewood MD, Garcia JE. Deleterious effect of the presence of hydrosalpinx on implantation and pregnancy rates with in vitro fertilisation. Fertil Steril 1996;66:122-5.&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s134&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Lass 1998&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s136&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Meyer 1997&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s138&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Mukherjee 1996&lt;/h3&gt;&lt;p&gt;Mukherjee T, Copperman AB, McCaffrey C, Cook CA, Bustillo M, Obasaju MF. Hydrosalpinx fluid has direct embryotoxic effects on murine embryogenesis: a case for prophylactic salpingectomy. Fertil Steril 1996;66:851-3.&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s140&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Poe-Ziegler 1995&lt;/h3&gt;&lt;p&gt;Poe-Ziegler R, Shelton KE, Toner JP. Salpingectomy(ies) improves the pregnancy rate after IVF in patients with unilateral or bilateral hydrosalpinx. J Assist Reprod Genet 1995;12:S65.&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s142&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Puttemans 1996&lt;/h3&gt;&lt;p&gt;Puttemans PJ, Brosens IA. Salpingectomy improves in vitro fertilisation outcome in patients with a hydrosalpinx: blind victimisation of the fallopian tube? Hum Reprod 1996;11:2079-81.&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s144&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Puttemans 2000&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s146&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Savic 1999&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s148&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Shahara 1996&lt;/h3&gt;&lt;p&gt;Shahara FI, Scott RT Jr, Marut EL, Queenan JT Jr. In-vitro fertilisation outcome in women with hydrosalpinx. Hum Reprod 1996;11:526-30.&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s150&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Shelton 1996&lt;/h3&gt;&lt;p&gt;Shelton KE, Butier L, Toner JP. Salpingectomy improves the pregnancy rate in in vitro fertilisation patients with hydrosalpinx. Hum Reprod 1996;11:523-5.&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s152&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Sowter 1997&lt;/h3&gt;&lt;p&gt;Sowter MC, Akande VA, Williams JA, Hull MG. Is the outcome of in-vitro fertilisation and embryo transfer treatment improved by spontaneous or surgical drainage of a hydrosalpinx? Hum Reprod 1997;12:2147-50.&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s154&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Stadtmauer 2000&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s156&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Steptoe 1978&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s158&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Strandell 1994&lt;/h3&gt;&lt;p&gt;Strandell A, Waldenstrom U, Nilsson L, Hamberger L. Hydrosalpinx reduces in-vitro fertilisation / embryo transfer pregnancy rates. Hum Reprod 1994;9:861-3.&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s160&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Strandell 2001&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s162&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Van Voorhis 1998&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s164&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Vandromme 1995&lt;/h3&gt;&lt;p&gt;Vandromme J, Chasse E, Lejeune B, Van Rysselberge M, Delvigne ?, Leroy F. Hydrosalpinges in in vitro fertilisation: an unfavourable prognostic feature. Hum Reprod 1995;10:576-9.&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s166&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Vasquez 1995&lt;/h3&gt;&lt;p&gt;Vasquez G, Boeckx K, Brosens IA. Prospective study of tubal mucosal lesions and fertility in hydrosalpinges. Hum Reprod 1995;10:1075-8.&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s168&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Zeyneloglu 1998&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s41&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Other published versions of this review&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s42&quot;&gt;&lt;img src=&quot;expand.png&quot;&gt;&lt;/span&gt;Classification pending references&lt;/h2&gt;&lt;h1 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s43&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Figures&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s12&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Sources of support&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s13&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Internal sources&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h3 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s61&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;University of Auckland, School of Medicine, Auckland, New Zealand&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;h2 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s14&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;External sources&lt;/h2&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s44&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Feedback&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;&lt;h1 class=&quot;fixedtext&quot; readonly=&quot;true&quot;&gt;&lt;span coll_flag=&quot;s17&quot;&gt;&lt;img src=&quot;collapse.png&quot;&gt;&lt;/span&gt;Appendices&lt;/h1&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-10-07 23:01:49 +1300" NOTES_MODIFIED_BY="[Empty name]">
<P>The primary outcome of this study is the continuation of spontaneous pregnancy; IVF is not performed after tubal surgery. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2009-11-06 13:36:50 +1300" MODIFIED_BY="jane clarke" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR STUDY_ID="STD-Hammadieh2008">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Mol-2008">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2009-06-08 15:35:56 +1200" MODIFIED_BY="jane clarke" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2009-06-08 15:35:56 +1200" MODIFIED_BY="jane clarke" STUDY_ID="STD-Darwish-2005_x002c_2006_x002c_-2007">
<CHAR_STUDY_NAME MODIFIED="2008-10-08 00:39:22 +1300" MODIFIED_BY="[Empty name]">
<P>Is there a role for hysteroscopic tubal occlusion of functionless hydrosalpinges prior to IVF/ICSI in modern practice?</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2009-06-08 15:35:56 +1200" MODIFIED_BY="jane clarke">
<P>Randomised controlled trial.</P>
<P>Single academic centre in Egypt (women's Health University  Center, Assiut University, Assiut Egypt)<BR/>Patient recruitment from April 2004 to October 2006.</P>
<P>Inclusion criteria: women with uni- or bilaterally laparoscopically-proven functionless hydrosalpinges (a large blocked tube with lost major and minor folds) scheduled for IVF.<BR/>Exclusion criteria: women with a frozen pelvis at laparoscopy or inaccessible tubes at lap or hysteroscopy.</P>
<P>Follow-up: HSG in the following cycle after the procedure; follow-up procedure for pregnancy unclear.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-08 00:45:32 +1300" MODIFIED_BY="[Empty name]">
<P>Women with uni- or bilaterally laparoscopically-proven functionless hydrosalpinges scheduled for IVF. Women with a frozen pelvis at laparoscopy or inaccessible tubes at lap or hysteroscopy were excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-06-08 14:14:39 +1200" MODIFIED_BY="jane clarke">
<P>Laparoscopic occlusion by coagulation and incision of the isthmic part of the fallopian tube VERSUS Hysteroscopic tubal occlusion by electrocautery with a rollerball electrode (3mm) introduced by a resectoscope; after cervical priming with misoprostol 200mg. <BR/>Procedures are performed under broad-spectrum antibiotic coverage. </P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-10-08 00:41:06 +1300" MODIFIED_BY="[Empty name]">
<P>PRIMARY OUTCOMES:<BR/>Feasible acces<BR/>Confirmed tubal occlusion</P>
<P>SECONDARY OUTCOMES<BR/>Operative time<BR/>Hospital stay<BR/>Complications<BR/>Pregnancy: not defined.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2008-10-08 00:44:18 +1300" MODIFIED_BY="[Empty name]">
<P>April 2004</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2009-06-08 14:14:40 +1200" MODIFIED_BY="jane clarke">
<P>Atef M.M. Darwish, dept of obstetrics and gynaecology, women's Health University, P.O. Box(1), 71111 Assiut Egypt. a_darwish@mailcity.com</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2009-02-14 06:57:38 +1300" MODIFIED_BY="[Empty name]">
<P>The objective of Darwish 2007 is mainly to conduct a safety study and a study to address the value of hysteroscopic tubal occlusion compared to laparoscopic tubal occlusion. This current study is stated to be only a preliminary study of which the follow-up time was to short to detect pregnancy. Subsequent studies might report outcomes in terms of pregnancy. </P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2009-09-07 04:06:31 +1200" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2008-09-01 14:54:51 +1200" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2009-02-14 07:28:04 +1300" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-10-07 23:09:24 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dechaud-1998">
<DESCRIPTION>
<P>With sealed opaque envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-10-07 23:29:14 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hammadieh-2008">
<DESCRIPTION>
<P>Randomisation by computer algorithm using a third party administrator just prior to oocyte retrieval procedure.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-10-08 00:10:03 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kontoravdis-2006">
<DESCRIPTION>
<P>Randomisation by computer generated randomisation in blocks.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-14 07:28:04 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moshin-2006">
<DESCRIPTION>
<P>By opaque numbered envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-09-26 17:38:55 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Strandell-1999">
<DESCRIPTION>
<P>True randomisation - sealed opaque envelopes in blocks of 10-30.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2009-06-08 14:14:39 +1200" MODIFIED_BY="jane clarke" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes. Participants, outcome assessors, clinicians, statisticians</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-10-07 23:09:37 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Dechaud-1998">
<DESCRIPTION>
<P>No blinding. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-09-23 12:29:17 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hammadieh-2008">
<DESCRIPTION>
<P>Investigator nor the outcome assessor were blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-06-08 14:14:39 +1200" MODIFIED_BY="jane clarke" RESULT="NO" STUDY_ID="STD-Kontoravdis-2006">
<DESCRIPTION>
<P>The operator and the IVF performer were the same person in some cases.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-02-14 07:53:02 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moshin-2006">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-09-26 17:38:57 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Strandell-1999">
<DESCRIPTION>
<P>No blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2009-06-08 14:14:39 +1200" MODIFIED_BY="jane clarke" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>Intention to treat for primary outcome?</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-06-08 14:14:38 +1200" MODIFIED_BY="jane clarke" RESULT="YES" STUDY_ID="STD-Dechaud-1998">
<DESCRIPTION>
<P>Intention to treat analysis is unclear; but number randomised is same as number analysed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-09-23 12:29:18 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hammadieh-2008">
<DESCRIPTION>
<P>'Intention to treat' analysis performed (as there were no drop-outs or losses).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-10-08 00:08:00 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kontoravdis-2006">
<DESCRIPTION>
<P>112 women analysed of 115 randomised. Intention to treat analysis not explicitly stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-02-16 04:39:10 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moshin-2006">
<DESCRIPTION>
<P>Not stated in abstract; but number of patients randomised is the same as numbers of patients analysed, correspondence clarified there was no loss to follow-up or withdrawal.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-06-08 14:14:39 +1200" MODIFIED_BY="jane clarke" RESULT="YES" STUDY_ID="STD-Strandell-1999">
<DESCRIPTION>
<P>'Intention to treat' analysis performed. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2009-02-14 07:57:32 +1300" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-09-23 12:20:49 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dechaud-1998">
<DESCRIPTION>
<P>No suggestion of selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-10-07 23:29:26 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hammadieh-2008">
<DESCRIPTION>
<P>No suggestion of selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-09-26 17:45:39 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kontoravdis-2006">
<DESCRIPTION>
<P>No suggestions of selective outcome reporting. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-14 07:57:32 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moshin-2006">
<DESCRIPTION>
<P>no suggestions of selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-09-26 17:38:59 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Strandell-1999">
<DESCRIPTION>
<P>No suggestions of selective reporting. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2008-09-01 16:22:13 +1200" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="STUDY" MODIFIED="2009-02-14 10:29:11 +1300" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Detection adequate?</NAME>
<DESCRIPTION>
<P>Was the period of follow-up long enough to detect outcome of IVF (live birth?)</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-10-08 00:13:08 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dechaud-1998">
<DESCRIPTION>
<P>Sufficient length of follow-up: 1-5 years.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-10-07 23:29:29 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hammadieh-2008">
<DESCRIPTION>
<P>Follow-up duration up to 1 IVF cycle.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-14 10:29:11 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kontoravdis-2006">
<DESCRIPTION>
<P>adequate detection of stated outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-14 07:57:51 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moshin-2006">
<DESCRIPTION>
<P>yes, adequate follow-up after IVF.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-09-02 09:43:19 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Strandell-1999">
<DESCRIPTION>
<P>Follow-up duration up to 1 IVF cycle (further follow-up data anticipated).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="STUDY" MODIFIED="2009-09-07 04:06:31 +1200" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Source of funding stated?</NAME>
<DESCRIPTION>
<P>Source of funding is stated</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-09-23 12:20:55 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dechaud-1998">
<DESCRIPTION>
<P>Presence or absence of funding is not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-09-07 04:06:31 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hammadieh-2008">
<DESCRIPTION>
<P>No source of funding reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-23 10:38:47 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kontoravdis-2006">
<DESCRIPTION>
<P>correspondence stated that there was no source of funding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-14 07:55:19 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moshin-2006">
<DESCRIPTION>
<P>Source of funding: the Academy of Science of the Republic of Moldova (clarified by correspondence)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-29 13:28:49 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Strandell-1999">
<DESCRIPTION>
<P>Study was funded by grants from the Goteborg Medical Society, the Hjalmar Svensson Foundation and the society 'ordensallskapet W:6'</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2009-06-08 14:16:23 +1200" MODIFIED_BY="jane clarke" NO="9">
<NAME>Powercalculation performed?</NAME>
<DESCRIPTION>
<P>A powercalculation was performed and adhered to?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-08 14:14:38 +1200" MODIFIED_BY="jane clarke" RESULT="NO" STUDY_ID="STD-Dechaud-1998">
<DESCRIPTION>
<P>A power calculation was performed but not adhered to as the number calculated (322 patients in each group) would not be achieved in the setting of the trial. When the trial was ceased and the exact reasons for cessation are unknown.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-08 14:14:38 +1200" MODIFIED_BY="jane clarke" RESULT="NO" STUDY_ID="STD-Hammadieh-2008">
<DESCRIPTION>
<P>Power calculation performed - sample size 158 not attained owing to decrease in recruitment rate by virtue of patient preference for salpingectomy, recruitment was stopped on advice of the Data Monitoring Committee after 4 years.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-08 14:16:23 +1200" MODIFIED_BY="jane clarke" RESULT="UNKNOWN" STUDY_ID="STD-Kontoravdis-2006">
<DESCRIPTION>
<P>Power calculation is performed and calculated sample sizes were achieved. However, power calculations in this trial were made with very large anticipated differences (46% vs73% comparing salpingectomy to tubal occlusion and 46% vs 14% comparing surgery to no surgery) and not performed correctly. It is quite unlikely that these anticipated differences would be achieved; and therefore it may be questioned whether the made power calculation was adhered to.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-08 14:14:39 +1200" MODIFIED_BY="jane clarke" RESULT="UNKNOWN" STUDY_ID="STD-Moshin-2006">
<DESCRIPTION>
<P>Not clear. As study sizes were small it may be presumed that they have not been adhered to if they where performed. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-09-26 17:39:02 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Strandell-1999">
<DESCRIPTION>
<P>Power calculation performed - sample size 300 not adhered to due to decrease in recruitment rate.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="STUDY" MODIFIED="2009-05-29 13:35:48 +1200" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Loss to Follow-up explained?</NAME>
<DESCRIPTION>
<P>Is loss to follow up explained?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-29 13:35:48 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dechaud-1998">
<DESCRIPTION>
<P>No withdrawals or losses to follow-up.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-10-08 00:11:18 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hammadieh-2008">
<DESCRIPTION>
<P>Yes, no loss to follow-up occurred.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-09-26 17:45:49 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kontoravdis-2006">
<DESCRIPTION>
<P>Withdrawal and losses to follow-up were explained. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-14 07:56:18 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moshin-2006">
<DESCRIPTION>
<P>No loss to Follow-up/ withdrawal, clarified by correspondence.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-10-08 00:25:02 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Strandell-1999">
<DESCRIPTION>
<P>Withdrawal and loss to follow up explained.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2008-09-26 17:40:08 +1200" MODIFIED_BY="[Empty name]"/>
<ADDITIONAL_TABLES MODIFIED="2008-09-26 17:40:00 +1200" MODIFIED_BY="[Empty name]"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2009-09-07 04:49:26 +1200" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2009-05-28 11:02:44 +1200" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types)</NAME>
<DICH_OUTCOME CHI2="0.9508128427104297" CI_END="3.817368820899812" CI_START="1.263944028784024" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="OR" EFFECT_SIZE="2.196574725986491" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="23" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.5817641219987406" LOG_CI_START="0.10172784251562962" LOG_EFFECT_SIZE="0.3417459822571851" METHOD="MH" MODIFIED="2009-05-28 10:40:51 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6216324029106073" P_Q="0.0" P_Z="0.005260015656111904" Q="0.0" RANDOM="NO" SCALE="10.37" SORT_BY="WEIGHT" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="196" TOTAL_2="133" WEIGHT="100.0" Z="2.7906633132253207">
<NAME>Ongoing pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control
</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment 
</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="9.657284194330876" CI_START="0.9688439519648329" DF="0" EFFECT_SIZE="3.0588235294117645" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="6" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="0.9848550120010728" LOG_CI_START="-0.013746167488022439" LOG_EFFECT_SIZE="0.48555442225652523" MODIFIED="2008-10-08 18:07:27 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.056649619416949" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="18.961818961818963" Z="1.9060045185282808">
<NAME>Laparoscopic bilateral salpingectomy and adhesiolysis versus no surgery on the fallopian tube</NAME>
<DICH_DATA CI_END="9.657284194330876" CI_START="0.9688439519648329" EFFECT_SIZE="3.0588235294117645" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="6" LOG_CI_END="0.9848550120010728" LOG_CI_START="-0.013746167488022439" LOG_EFFECT_SIZE="0.48555442225652523" MODIFIED="2008-10-06 10:27:14 +1300" MODIFIED_BY="[Empty name]" ORDER="29" O_E="0.0" SE="0.5865832759874552" STUDY_ID="STD-Dechaud-1998" TOTAL_1="30" TOTAL_2="30" VAR="0.344079939668175" WEIGHT="18.961818961818963"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5124786350293103" CI_END="3.7448746368529897" CI_START="1.0626012109774767" DF="1" EFFECT_SIZE="1.9948203738880412" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="17" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="0.5734372838687934" LOG_CI_START="0.02637030651117008" LOG_EFFECT_SIZE="0.2999037951899817" MODIFIED="2009-05-28 10:40:51 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4740678994231746" P_Z="0.0316410166313372" STUDIES="2" TAU2="0.0" TOTAL_1="166" TOTAL_2="103" WEIGHT="81.03818103818104" Z="2.1489165375631494">
<NAME>Laparoscopic salpingectomy versus no intervention</NAME>
<DICH_DATA CI_END="16.57791028564947" CI_START="0.6763428313542315" EFFECT_SIZE="3.3484848484848486" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="2" LOG_CI_END="1.2195297850436218" LOG_CI_START="-0.16983310875713767" LOG_EFFECT_SIZE="0.524848338143242" MODIFIED="2009-05-28 10:40:51 +1200" MODIFIED_BY="[Empty name]" ORDER="30" O_E="0.0" SE="0.8161186412758086" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="15" VAR="0.6660496366378719" WEIGHT="11.325611325611325"/>
<DICH_DATA CI_END="3.5430886942842443" CI_START="0.8891329690611663" EFFECT_SIZE="1.7749019607843137" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="15" LOG_CI_END="0.5493820241807895" LOG_CI_START="-0.05103328581128034" LOG_EFFECT_SIZE="0.24917436918475458" MODIFIED="2008-09-16 16:10:00 +1200" MODIFIED_BY="[Empty name]" ORDER="45" O_E="0.0" SE="0.3526869251930598" STUDY_ID="STD-Strandell-1999" TOTAL_1="116" TOTAL_2="88" VAR="0.12438806720213494" WEIGHT="69.71256971256972"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.796392459157283" CI_END="3.622488145417315" CI_START="1.4786524130974676" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="2.314389949346973" ESTIMABLE="YES" EVENTS_1="83" EVENTS_2="32" I2="47.31840763259874" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.559006972918017" LOG_CI_START="0.1698660963668247" LOG_EFFECT_SIZE="0.3644365346424209" METHOD="PETO" MODIFIED="2009-02-14 11:40:27 +1300" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.14983876558185383" P_Q="1.0" P_Z="2.4153336444076147E-4" Q="0.0" RANDOM="NO" SCALE="11.09" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="226" TOTAL_2="169" WEIGHT="100.00000000000001" Z="3.671074027895208">
<NAME>Clinical pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.796392459157283" CI_END="3.622488145417315" CI_START="1.4786524130974676" DF="2" EFFECT_SIZE="2.314389949346973" ESTIMABLE="YES" EVENTS_1="83" EVENTS_2="32" I2="47.31840763259874" ID="CMP-001.02.01" LOG_CI_END="0.559006972918017" LOG_CI_START="0.1698660963668247" LOG_EFFECT_SIZE="0.3644365346424209" MODIFIED="2009-02-14 11:05:16 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.14983876558185383" P_Z="2.4153336444076147E-4" STUDIES="3" TAU2="0.0" TOTAL_1="226" TOTAL_2="169" WEIGHT="100.00000000000001" Z="3.671074027895208">
<NAME>Laparoscopic salpingectomy versus no intervention</NAME>
<DICH_DATA CI_END="10.833341580356919" CI_START="0.9633726629326612" EFFECT_SIZE="3.2305642118254774" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="2" LOG_CI_END="1.034762436871717" LOG_CI_START="-0.01620568156937621" LOG_EFFECT_SIZE="0.5092783776511703" MODIFIED="2008-09-16 16:13:54 +1200" MODIFIED_BY="[Empty name]" ORDER="22" O_E="3.0769230769230766" SE="0.6173438751483873" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="15" VAR="2.623890532544379" WEIGHT="13.709910579956162"/>
<DICH_DATA CI_END="9.118843509562902" CI_START="1.810006467555497" EFFECT_SIZE="4.062655009834741" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="8" LOG_CI_END="0.9599397627513254" LOG_CI_START="0.2576801267026903" LOG_EFFECT_SIZE="0.6088099447270079" MODIFIED="2008-10-09 13:03:13 +1300" MODIFIED_BY="[Empty name]" ORDER="40" O_E="8.238095238095237" SE="0.41251078645623085" STUDY_ID="STD-Moshin-2006" TOTAL_1="60" TOTAL_2="66" VAR="5.876643990929706" WEIGHT="30.705649731414734"/>
<DICH_DATA CI_END="2.848994835669476" CI_START="0.8565250280532644" EFFECT_SIZE="1.562125277161023" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="22" LOG_CI_END="0.4546916620010486" LOG_CI_START="-0.0672599422295654" LOG_EFFECT_SIZE="0.19371585988574158" ORDER="11265" O_E="4.745098039215684" SE="0.30659695602717296" STUDY_ID="STD-Strandell-1999" TOTAL_1="116" TOTAL_2="88" VAR="10.63810622288131" WEIGHT="55.58443968862911"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.342136562529732" CI_END="3.858634025330341" CI_START="1.6008643622187966" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="OR" EFFECT_SIZE="2.4853872330074047" ESTIMABLE="YES" EVENTS_1="96" EVENTS_2="38" I2="30.909588936277082" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.5864335895802766" LOG_CI_START="0.20435453664424402" LOG_EFFECT_SIZE="0.39539406311226033" METHOD="MH" MODIFIED="2009-02-14 11:44:02 +1300" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.22681121963601725" P_Q="0.0" P_Z="4.9806550463604525E-5" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="256" TOTAL_2="199" WEIGHT="100.00000000000001" Z="4.056532895200252">
<NAME>Pregnancy rate - any definition</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="9.657284194330876" CI_START="0.9688439519648329" DF="0" EFFECT_SIZE="3.0588235294117645" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="6" I2="0.0" ID="CMP-001.03.01" LOG_CI_END="0.9848550120010728" LOG_CI_START="-0.013746167488022439" LOG_EFFECT_SIZE="0.48555442225652523" MODIFIED="2009-02-14 11:44:02 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.056649619416949" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="12.909730445269007" Z="1.9060045185282808">
<NAME>Laparoscopic bilateral salpingectomy and adhesiolysis versus no surgery on the fallopian tube</NAME>
<DICH_DATA CI_END="9.657284194330876" CI_START="0.9688439519648329" EFFECT_SIZE="3.0588235294117645" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="6" LOG_CI_END="0.9848550120010728" LOG_CI_START="-0.013746167488022439" LOG_EFFECT_SIZE="0.48555442225652523" MODIFIED="2008-10-09 12:47:35 +1300" MODIFIED_BY="[Empty name]" ORDER="33" O_E="0.0" SE="0.5865832759874552" STUDY_ID="STD-Dechaud-1998" TOTAL_1="30" TOTAL_2="30" VAR="0.344079939668175" WEIGHT="12.909730445269007"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.1702652507665245" CI_END="3.863755059495374" CI_START="1.491255480712597" DF="2" EFFECT_SIZE="2.4003845334869793" ESTIMABLE="YES" EVENTS_1="83" EVENTS_2="32" I2="52.04141991609801" ID="CMP-001.03.02" LOG_CI_END="0.5870095867700307" LOG_CI_START="0.17355205281510494" LOG_EFFECT_SIZE="0.3802808197925678" MODIFIED="2008-10-09 12:49:45 +1300" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.12429068353331452" P_Z="3.116909877092233E-4" STUDIES="3" TAU2="0.0" TOTAL_1="226" TOTAL_2="169" WEIGHT="87.09026955473101" Z="3.6053845901671475">
<NAME>Laparoscopic salpingectomy versus no intervention</NAME>
<DICH_DATA CI_END="21.30471922660121" CI_START="0.8813905303352564" EFFECT_SIZE="4.333333333333333" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="2" LOG_CI_END="1.3284758150377034" LOG_CI_START="-0.05483161986335489" LOG_EFFECT_SIZE="0.6368220975871743" MODIFIED="2008-10-09 12:49:29 +1300" MODIFIED_BY="[Empty name]" ORDER="34" O_E="0.0" SE="0.8125616347431193" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="15" VAR="0.6602564102564104" WEIGHT="7.009808386571407"/>
<DICH_DATA CI_END="11.129516901982804" CI_START="1.824954006849494" EFFECT_SIZE="4.506756756756757" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="8" LOG_CI_END="1.0464763133592767" LOG_CI_START="0.2612519236839066" LOG_EFFECT_SIZE="0.6538641185215917" MODIFIED="2008-10-09 12:49:36 +1300" MODIFIED_BY="[Empty name]" ORDER="35" O_E="0.0" SE="0.46124469341872876" STUDY_ID="STD-Moshin-2006" TOTAL_1="60" TOTAL_2="66" VAR="0.21274666720693708" WEIGHT="17.83977689915792"/>
<DICH_DATA CI_END="2.9232939711647976" CI_START="0.8528306823861413" EFFECT_SIZE="1.5789473684210527" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="22" LOG_CI_END="0.46587249090828886" LOG_CI_START="-0.06913718337462188" LOG_EFFECT_SIZE="0.19836765376683346" MODIFIED="2008-10-09 12:49:45 +1300" MODIFIED_BY="[Empty name]" ORDER="36" O_E="0.0" SE="0.3142673310143813" STUDY_ID="STD-Strandell-1999" TOTAL_1="116" TOTAL_2="88" VAR="0.0987639553429027" WEIGHT="62.24068426900167"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.1658910629003825" CI_END="3.5605662831574434" CI_START="0.12874304794286479" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.6770510731815487" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.5515190749651286" LOG_CI_START="-0.8902762133280834" LOG_EFFECT_SIZE="-0.1693785691814773" METHOD="PETO" MODIFIED="2009-02-14 11:40:27 +1300" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.5582517921562432" P_Q="0.37421852835177083" P_Z="0.6451548542639118" Q="0.789608670851071" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="196" TOTAL_2="133" WEIGHT="99.99999999999999" Z="0.4605035098174201">
<NAME>Ectopic pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.820467167072353" CI_START="0.0026853936013588454" DF="0" EFFECT_SIZE="0.1353352832366127" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-001.04.01" LOG_CI_END="0.8338141226232083" LOG_CI_START="-2.570992050236215" LOG_EFFECT_SIZE="-0.8685889638065036" MODIFIED="2008-10-08 18:06:50 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.31731052126128756" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="17.9317393131459" Z="1.0">
<NAME>Laparoscopic bilateral salpingectomy and adhesiolysis versus laparoscopic adhesiolysis</NAME>
<DICH_DATA CI_END="6.820467167072353" CI_START="0.0026853936013588454" EFFECT_SIZE="0.1353352832366127" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8338141226232083" LOG_CI_START="-2.570992050236215" LOG_EFFECT_SIZE="-0.8685889638065036" MODIFIED="2008-09-03 12:14:33 +1200" MODIFIED_BY="[Empty name]" ORDER="11267" O_E="-0.5" SE="2.0" STUDY_ID="STD-Dechaud-1998" TOTAL_1="30" TOTAL_2="30" VAR="0.25" WEIGHT="17.9317393131459"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.3762823920493115" CI_END="6.014015279982626" CI_START="0.15403885576342435" DF="1" EFFECT_SIZE="0.9624926141390768" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="0.7791645271904561" LOG_CI_START="-0.8123697160781073" LOG_EFFECT_SIZE="-0.01660259444382556" MODIFIED="2008-09-16 17:59:34 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5395998864078989" P_Z="0.9673820172055959" STUDIES="2" TAU2="0.0" TOTAL_1="166" TOTAL_2="103" WEIGHT="82.06826068685409" Z="0.04089197238130912">
<NAME>Laparoscopic salpingectomy versus no intervention</NAME>
<DICH_DATA CI_END="384.48499891705853" CI_START="0.03501758995259551" EFFECT_SIZE="3.6692966676192427" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.5848794000161623" LOG_CI_START="-1.455713747067708" LOG_EFFECT_SIZE="0.5645828264742272" MODIFIED="2008-09-16 17:59:34 +1200" MODIFIED_BY="[Empty name]" ORDER="24" O_E="0.23076923076923073" SE="2.37346441585572" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="15" VAR="0.1775147928994083" WEIGHT="12.73259596199709"/>
<DICH_DATA CI_END="5.526189177683152" CI_START="0.10254505607964245" EFFECT_SIZE="0.7527837532334449" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7424257480103889" LOG_CI_START="-0.9890852730731675" LOG_EFFECT_SIZE="-0.12332976253138929" ORDER="11268" O_E="-0.27450980392156854" SE="1.0170981449022687" STUDY_ID="STD-Strandell-1999" TOTAL_1="116" TOTAL_2="88" VAR="0.9666611742736311" WEIGHT="69.335664724857"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.6649307925922727" CI_END="1.281501509544461" CI_START="0.11135249690762529" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.37775440815252803" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.10771912209766703" LOG_CI_START="-0.9533000401382908" LOG_EFFECT_SIZE="-0.42279045902031187" METHOD="PETO" MODIFIED="2009-05-28 11:02:44 +1200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.4349758269893269" P_Q="0.6194645279793494" P_Z="0.11828882947042028" Q="0.24662093343734393" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="86" TOTAL_2="29" WEIGHT="100.00000000000003" Z="1.5619964316962758">
<NAME>Miscarriage rate</NAME>
<GROUP_LABEL_1>Favours treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.239960801632149" CI_START="0.005319336984903432" DF="0" EFFECT_SIZE="0.16695244020848013" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-001.05.01" LOG_CI_END="0.7193280381862971" LOG_CI_START="-2.274142495851967" LOG_EFFECT_SIZE="-0.7774072288328349" MODIFIED="2009-05-28 11:02:44 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.3086736304048481" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="8" WEIGHT="12.563090252265646" Z="1.0180091318807472">
<NAME>Laparoscopic bilateral salpingectomy and adhesiolysis versus laparoscopic adhesiolysis</NAME>
<DICH_DATA CI_END="5.239960801632146" CI_START="0.0053193369849034375" EFFECT_SIZE="0.16695244020848013" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.7193280381862969" LOG_CI_START="-2.2741424958519665" LOG_EFFECT_SIZE="-0.7774072288328349" MODIFIED="2009-05-28 11:02:44 +1200" MODIFIED_BY="[Empty name]" ORDER="11270" O_E="-0.5789473684210527" SE="1.7583794096121996" STUDY_ID="STD-Dechaud-1998" TOTAL_1="30" TOTAL_2="8" VAR="0.32342591899378603" WEIGHT="12.563090252265646"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.4183098591549288" CI_END="1.5685727946977126" CI_START="0.11503191143621834" DF="1" EFFECT_SIZE="0.42477750270103615" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" I2="29.493545183713966" ID="CMP-001.05.02" LOG_CI_END="0.19550467834261578" LOG_CI_START="-0.939181663662491" LOG_EFFECT_SIZE="-0.3718384926599376" MODIFIED="2009-05-28 11:02:44 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.23368203232766072" P_Z="0.19894379773725715" STUDIES="2" TAU2="0.0" TOTAL_1="56" TOTAL_2="21" WEIGHT="87.43690974773438" Z="1.2845665391394285">
<NAME>Laparoscopic salpingectomy versus no intervention</NAME>
<DICH_DATA CI_END="2.4500519145704684" CI_START="6.234015275578608E-4" EFFECT_SIZE="0.0390815315224377" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="0.38917528680233465" LOG_CI_START="-3.205232137880262" LOG_EFFECT_SIZE="-1.4080284255389635" MODIFIED="2009-05-28 11:02:44 +1200" MODIFIED_BY="[Empty name]" ORDER="23" O_E="-0.7272727272727271" SE="2.1113727138622647" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="20" TOTAL_2="2" VAR="0.2243211334120425" WEIGHT="8.713484229444695"/>
<DICH_DATA CI_END="2.1916410063340184" CI_START="0.13961577305919878" EFFECT_SIZE="0.5531615074890555" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.34076941763326063" LOG_CI_START="-0.8550655146239536" LOG_EFFECT_SIZE="-0.2571480484953465" MODIFIED="2009-05-28 11:02:43 +1200" MODIFIED_BY="[Empty name]" ORDER="11271" O_E="-1.2000000000000002" SE="0.7024393586862705" STUDY_ID="STD-Strandell-1999" TOTAL_1="36" TOTAL_2="19" VAR="2.0266666666666664" WEIGHT="78.72342551828967"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="96.78925584245458" CI_START="0.35420390480049513" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="5.855179959841674" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="1.9858271508279342" LOG_CI_START="-0.45074665538772735" LOG_EFFECT_SIZE="0.7675402477201034" METHOD="PETO" MODIFIED="2009-05-24 07:24:59 +1200" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.2169017398234614" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="116" TOTAL_2="88" WEIGHT="100.0" Z="1.2348086796129694">
<NAME>Surgical complication rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="96.78925584245458" CI_START="0.35420390480049513" DF="0" EFFECT_SIZE="5.855179959841674" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-001.06.01" LOG_CI_END="1.9858271508279342" LOG_CI_START="-0.45074665538772735" LOG_EFFECT_SIZE="0.7675402477201034" MODIFIED="2009-02-14 11:45:25 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.2169017398234614" STUDIES="1" TAU2="0.0" TOTAL_1="116" TOTAL_2="88" WEIGHT="100.0" Z="1.2348086796129694">
<NAME>Laparoscopic salpingectomy versus no intervention</NAME>
<DICH_DATA CI_END="96.78925584245458" CI_START="0.35420390480049513" EFFECT_SIZE="5.855179959841674" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9858271508279342" LOG_CI_START="-0.45074665538772735" LOG_EFFECT_SIZE="0.7675402477201034" ORDER="11273" O_E="0.8627450980392157" SE="1.4312555150059416" STUDY_ID="STD-Strandell-1999" TOTAL_1="116" TOTAL_2="88" VAR="0.4881638930081837" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2009-05-28 11:02:40 +1200" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="59.573686497810925" CI_START="0.8731152197579721" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="7.212121212121212" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="1.7750544756422226" LOG_CI_START="-0.05892844128497393" LOG_EFFECT_SIZE="0.8580630171786244" METHOD="MH" MODIFIED="2009-02-14 11:40:32 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.06665233082207438" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="50" TOTAL_2="15" WEIGHT="100.0" Z="1.8340112054627595">
<NAME>Ongoing pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="59.573686497810925" CI_START="0.8731152197579721" DF="0" EFFECT_SIZE="7.212121212121212" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="1" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="1.7750544756422226" LOG_CI_START="-0.05892844128497393" LOG_EFFECT_SIZE="0.8580630171786244" MODIFIED="2008-10-08 18:27:46 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.06665233082207438" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="15" WEIGHT="100.0" Z="1.8340112054627595">
<NAME>Laparoscopic proximal tubal occlusion by diathermy VERSUS no intervention</NAME>
<DICH_DATA CI_END="59.573686497810876" CI_START="0.8731152197579726" EFFECT_SIZE="7.212121212121212" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="1" LOG_CI_END="1.7750544756422224" LOG_CI_START="-0.0589284412849737" LOG_EFFECT_SIZE="0.8580630171786244" MODIFIED="2008-09-12 13:57:45 +1200" MODIFIED_BY="[Empty name]" ORDER="42" O_E="0.0" SE="1.0772906437648877" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="15" VAR="1.1605551311433664" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.011369271946217396" CI_END="10.009329762172282" CI_START="2.173962974696834" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="OR" EFFECT_SIZE="4.664752116082226" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="1.000404997525723" LOG_CI_START="0.3372521432361151" LOG_EFFECT_SIZE="0.668828570380919" METHOD="MH" MODIFIED="2009-02-14 11:40:32 +1300" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9150850670660647" P_Q="0.0" P_Z="7.702354336478663E-5" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="128" TOTAL_2="81" WEIGHT="100.00000000000001" Z="3.953477396044004">
<NAME>Clinical pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="21.30471922660121" CI_START="0.8813905303352564" DF="0" EFFECT_SIZE="4.333333333333333" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="2" I2="0.0" ID="CMP-002.02.01" LOG_CI_END="1.3284758150377034" LOG_CI_START="-0.05483161986335489" LOG_EFFECT_SIZE="0.6368220975871743" MODIFIED="2008-10-08 18:40:19 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.07113954470134382" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="15" WEIGHT="26.118500604594924" Z="1.8045856536864313">
<NAME>Laparoscopic proximal tubal occlusion by diathermy VERSUS no intervention</NAME>
<DICH_DATA CI_END="21.30471922660121" CI_START="0.8813905303352564" EFFECT_SIZE="4.333333333333333" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="2" LOG_CI_END="1.3284758150377034" LOG_CI_START="-0.05483161986335489" LOG_EFFECT_SIZE="0.6368220975871743" MODIFIED="2008-10-08 18:40:19 +1300" MODIFIED_BY="[Empty name]" ORDER="40" O_E="0.0" SE="0.8125616347431193" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="15" VAR="0.6602564102564104" WEIGHT="26.118500604594924"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="11.382285311114009" CI_START="2.008973543078256" DF="0" EFFECT_SIZE="4.781914893617022" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="8" I2="0.0" ID="CMP-002.02.02" LOG_CI_END="1.0562294675391715" LOG_CI_START="0.30297421739992664" LOG_EFFECT_SIZE="0.6796018424695489" MODIFIED="2009-02-14 08:44:28 +1300" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="4.0525649373448016E-4" STUDIES="1" TAU2="0.0" TOTAL_1="78" TOTAL_2="66" WEIGHT="73.88149939540509" Z="3.5366368434103856">
<NAME>Proximal tubal clamping VERSUS no intervention</NAME>
<DICH_DATA CI_END="11.382285311114009" CI_START="2.008973543078256" EFFECT_SIZE="4.781914893617022" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="8" LOG_CI_END="1.0562294675391715" LOG_CI_START="0.30297421739992664" LOG_EFFECT_SIZE="0.6796018424695489" MODIFIED="2008-10-08 18:40:38 +1300" MODIFIED_BY="[Empty name]" ORDER="41" O_E="0.0" SE="0.4424658626054158" STUDY_ID="STD-Moshin-2006" TOTAL_1="78" TOTAL_2="66" VAR="0.19577603957115472" WEIGHT="73.88149939540509"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.011369271946217396" CI_END="10.009329762172282" CI_START="2.173962974696834" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="OR" EFFECT_SIZE="4.664752116082226" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="1.000404997525723" LOG_CI_START="0.3372521432361151" LOG_EFFECT_SIZE="0.668828570380919" METHOD="MH" MODIFIED="2009-02-14 11:40:32 +1300" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9150850670660647" P_Q="0.0" P_Z="7.702354336478663E-5" Q="0.0" RANDOM="NO" SCALE="50.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="128" TOTAL_2="81" WEIGHT="100.00000000000001" Z="3.953477396044004">
<NAME>Pregnancy rate - any definition</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="21.30471922660121" CI_START="0.8813905303352564" DF="0" EFFECT_SIZE="4.333333333333333" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="2" I2="0.0" ID="CMP-002.03.01" LOG_CI_END="1.3284758150377034" LOG_CI_START="-0.05483161986335489" LOG_EFFECT_SIZE="0.6368220975871743" MODIFIED="2008-10-09 12:54:13 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.07113954470134382" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="15" WEIGHT="26.118500604594924" Z="1.8045856536864313">
<NAME>Laparoscopic proximal tubal occlusion by diathermy VERSUS no intervention</NAME>
<DICH_DATA CI_END="21.30471922660121" CI_START="0.8813905303352564" EFFECT_SIZE="4.333333333333333" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="2" LOG_CI_END="1.3284758150377034" LOG_CI_START="-0.05483161986335489" LOG_EFFECT_SIZE="0.6368220975871743" MODIFIED="2008-10-09 12:54:13 +1300" MODIFIED_BY="[Empty name]" ORDER="37" O_E="0.0" SE="0.8125616347431193" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="15" VAR="0.6602564102564104" WEIGHT="26.118500604594924"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="11.382285311114009" CI_START="2.008973543078256" DF="0" EFFECT_SIZE="4.781914893617022" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="8" I2="0.0" ID="CMP-002.03.02" LOG_CI_END="1.0562294675391715" LOG_CI_START="0.30297421739992664" LOG_EFFECT_SIZE="0.6796018424695489" MODIFIED="2009-02-14 08:45:07 +1300" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="4.0525649373448016E-4" STUDIES="1" TAU2="0.0" TOTAL_1="78" TOTAL_2="66" WEIGHT="73.88149939540509" Z="3.5366368434103856">
<NAME>Laparoscopic proximal tubal clamping VERSUS no intervention</NAME>
<DICH_DATA CI_END="11.382285311114009" CI_START="2.008973543078256" EFFECT_SIZE="4.781914893617022" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="8" LOG_CI_END="1.0562294675391715" LOG_CI_START="0.30297421739992664" LOG_EFFECT_SIZE="0.6796018424695489" MODIFIED="2008-10-09 12:54:31 +1300" MODIFIED_BY="[Empty name]" ORDER="38" O_E="0.0" SE="0.4424658626054158" STUDY_ID="STD-Moshin-2006" TOTAL_1="78" TOTAL_2="66" VAR="0.19577603957115472" WEIGHT="73.88149939540509"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.479908289397955E-33" CI_END="24.252761047879282" CI_START="0.03638600040745582" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.9393939393939396" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="100.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="1.3847611878702257" LOG_CI_START="-1.4390656799574555" LOG_EFFECT_SIZE="-0.027152246043614724" METHOD="MH" MODIFIED="2009-02-14 11:40:32 +1300" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.9699334899123886" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="50" TOTAL_2="15" WEIGHT="99.99999999999999" Z="0.03769170479335671">
<NAME>Ectopic pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.479908289397955E-33" CI_END="24.252761047879282" CI_START="0.03638600040745582" DF="0" EFFECT_SIZE="0.9393939393939396" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="100.0" ID="CMP-002.04.01" LOG_CI_END="1.3847611878702257" LOG_CI_START="-1.4390656799574555" LOG_EFFECT_SIZE="-0.027152246043614724" MODIFIED="2008-10-08 18:36:50 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.9699334899123886" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="15" WEIGHT="99.99999999999999" Z="0.03769170479335671">
<NAME>Laparoscopic proximal tubal occlusion by diathermy VERSUS no intervention</NAME>
<DICH_DATA CI_END="24.252761047879282" CI_START="0.03638600040745582" EFFECT_SIZE="0.9393939393939394" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.3847611878702257" LOG_CI_START="-1.4390656799574555" LOG_EFFECT_SIZE="-0.027152246043614773" MODIFIED="2008-09-12 14:07:58 +1200" MODIFIED_BY="[Empty name]" ORDER="46" O_E="0.0" SE="1.6587298803304127" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="15" VAR="2.751384815900945" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.0915787059211324" CI_START="0.0072778350934126195" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.15" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="0.49018030731625833" LOG_CI_START="-2.137997789204896" LOG_EFFECT_SIZE="-0.8239087409443188" METHOD="MH" MODIFIED="2009-05-28 11:02:40 +1200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="0.0" P_Z="0.21912432675217997" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="23" TOTAL_2="2" WEIGHT="100.0" Z="1.2288599931154693">
<NAME>Miscarriage rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.0915787059211324" CI_START="0.0072778350934126195" DF="0" EFFECT_SIZE="0.15" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="0.0" ID="CMP-002.05.01" LOG_CI_END="0.49018030731625833" LOG_CI_START="-2.137997789204896" LOG_EFFECT_SIZE="-0.8239087409443188" MODIFIED="2009-05-28 11:02:40 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.21912432675217997" STUDIES="1" TAU2="0.0" TOTAL_1="23" TOTAL_2="2" WEIGHT="100.0" Z="1.2288599931154693">
<NAME>Laparoscopic proximal tubal occlusion by diathermy VERSUS no intervention</NAME>
<DICH_DATA CI_END="3.0915787059211324" CI_START="0.0072778350934126195" EFFECT_SIZE="0.15" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="0.49018030731625833" LOG_CI_START="-2.137997789204896" LOG_EFFECT_SIZE="-0.8239087409443188" MODIFIED="2009-05-28 11:02:40 +1200" MODIFIED_BY="[Empty name]" ORDER="42" O_E="0.0" SE="1.5438048235879214" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="23" TOTAL_2="2" VAR="2.3833333333333333" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2009-05-28 11:02:21 +1200" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="6.286314364414075" CI_START="0.6171670596678851" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.9696969696969697" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.7983960953128983" LOG_CI_START="-0.20959726178296226" LOG_EFFECT_SIZE="0.2943994167649681" METHOD="MH" MODIFIED="2009-02-14 11:40:37 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.25226173619487124" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="32" TOTAL_2="32" WEIGHT="100.0" Z="1.1448731281153885">
<NAME>Clinical pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.286314364414075" CI_START="0.6171670596678851" DF="0" EFFECT_SIZE="1.9696969696969697" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" I2="0.0" ID="CMP-003.01.01" LOG_CI_END="0.7983960953128983" LOG_CI_START="-0.20959726178296226" LOG_EFFECT_SIZE="0.2943994167649681" MODIFIED="2008-10-08 18:57:42 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.25226173619487124" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="32" WEIGHT="100.0" Z="1.1448731281153885">
<NAME>Ultrasound guided aspiration of hydrosalpinges just after oocyte retrieval VERSUS no aspiration</NAME>
<DICH_DATA CI_END="6.286314364414075" CI_START="0.6171670596678851" EFFECT_SIZE="1.9696969696969697" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" LOG_CI_END="0.7983960953128983" LOG_CI_START="-0.20959726178296226" LOG_EFFECT_SIZE="0.2943994167649681" MODIFIED="2008-09-12 12:44:48 +1200" MODIFIED_BY="[Empty name]" ORDER="37" O_E="0.0" SE="0.5921002876056982" STUDY_ID="STD-Hammadieh-2008" TOTAL_1="32" TOTAL_2="32" VAR="0.35058275058275057" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="8.269992427890845" CI_START="0.9330177082984257" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="2.7777777777777777" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="0.9175051119072349" LOG_CI_START="-0.03011011344180948" LOG_EFFECT_SIZE="0.44369749923271273" METHOD="MH" MODIFIED="2009-02-14 11:40:37 +1300" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="0.06644499809566065" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="32" TOTAL_2="32" WEIGHT="100.0" Z="1.8354097639287834">
<NAME>Biochemical pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="8.269992427890845" CI_START="0.9330177082984257" DF="0" EFFECT_SIZE="2.7777777777777777" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="7" I2="0.0" ID="CMP-003.02.01" LOG_CI_END="0.9175051119072349" LOG_CI_START="-0.03011011344180948" LOG_EFFECT_SIZE="0.44369749923271273" MODIFIED="2008-10-08 18:57:22 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.06644499809566065" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="32" WEIGHT="100.0" Z="1.8354097639287834">
<NAME>Ultrasound guided aspiration of hydrosalpinges just after oocyte retrieval VERSUS no aspiration</NAME>
<DICH_DATA CI_END="8.269992427890845" CI_START="0.9330177082984259" EFFECT_SIZE="2.7777777777777777" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="7" LOG_CI_END="0.9175051119072349" LOG_CI_START="-0.030110113441809368" LOG_EFFECT_SIZE="0.44369749923271273" MODIFIED="2008-09-12 12:45:41 +1200" MODIFIED_BY="[Empty name]" ORDER="38" O_E="0.0" SE="0.5566338741410459" STUDY_ID="STD-Hammadieh-2008" TOTAL_1="32" TOTAL_2="32" VAR="0.3098412698412698" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="6.286314364414075" CI_START="0.6171670596678851" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.9696969696969697" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="0.7983960953128983" LOG_CI_START="-0.20959726178296226" LOG_EFFECT_SIZE="0.2943994167649681" METHOD="MH" MODIFIED="2009-02-14 11:40:37 +1300" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="0.0" P_Z="0.25226173619487124" Q="0.0" RANDOM="NO" SCALE="50.39" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="32" TOTAL_2="32" WEIGHT="100.0" Z="1.1448731281153885">
<NAME>Pregnancy rate - any definition</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.286314364414075" CI_START="0.6171670596678851" DF="0" EFFECT_SIZE="1.9696969696969697" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" I2="0.0" ID="CMP-003.03.01" LOG_CI_END="0.7983960953128983" LOG_CI_START="-0.20959726178296226" LOG_EFFECT_SIZE="0.2943994167649681" MODIFIED="2008-10-09 12:57:04 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.25226173619487124" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="32" WEIGHT="100.0" Z="1.1448731281153885">
<NAME>Ultrasound guided aspiration of hydrosalpinges just after oocyte retrieval VERSUS no aspiration</NAME>
<DICH_DATA CI_END="6.286314364414075" CI_START="0.6171670596678851" EFFECT_SIZE="1.9696969696969697" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" LOG_CI_END="0.7983960953128983" LOG_CI_START="-0.20959726178296226" LOG_EFFECT_SIZE="0.2943994167649681" MODIFIED="2008-10-09 12:57:04 +1300" MODIFIED_BY="[Empty name]" ORDER="39" O_E="0.0" SE="0.5921002876056982" STUDY_ID="STD-Hammadieh-2008" TOTAL_1="32" TOTAL_2="32" VAR="0.35058275058275057" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-003.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2009-05-24 06:43:25 +1200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="32" TOTAL_2="34" WEIGHT="0.0" Z="0.0">
<NAME>Ectopic pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment
</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.04.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-10-08 18:56:09 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="34" WEIGHT="0.0" Z="0.0">
<NAME>Ultrasound guided aspiration of hydrosalpinges just after oocyte retrieval VERSUS no aspiration</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2008-09-03 15:15:34 +1200" MODIFIED_BY="[Empty name]" ORDER="34" O_E="0.0" SE="0.0" STUDY_ID="STD-Hammadieh-2008" TOTAL_1="32" TOTAL_2="34" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="17.653059126646802" CI_START="0.08851157121212207" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-003.05" LOG_CI_END="1.2468199758258927" LOG_CI_START="-1.05299994980978" LOG_EFFECT_SIZE="0.09691001300805642" METHOD="MH" MODIFIED="2009-05-28 11:02:21 +1200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="0.0" P_Z="0.8688036705155074" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="6" WEIGHT="100.0" Z="0.16517826732421156">
<NAME>Miscarriage rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="17.653059126646802" CI_START="0.08851157121212207" DF="0" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-003.05.01" LOG_CI_END="1.2468199758258927" LOG_CI_START="-1.05299994980978" LOG_EFFECT_SIZE="0.09691001300805642" MODIFIED="2009-05-28 11:02:21 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8688036705155074" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="6" WEIGHT="100.0" Z="0.16517826732421156">
<NAME>Ultrasound guided aspiration of hydrosalpinges just after oocyte retrieval VERSUS no aspiration</NAME>
<DICH_DATA CI_END="17.653059126646802" CI_START="0.08851157121212207" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2468199758258927" LOG_CI_START="-1.05299994980978" LOG_EFFECT_SIZE="0.09691001300805642" MODIFIED="2009-05-28 11:02:21 +1200" MODIFIED_BY="[Empty name]" ORDER="39" O_E="0.0" SE="1.3509256086106296" STUDY_ID="STD-Hammadieh-2008" TOTAL_1="10" TOTAL_2="6" VAR="1.825" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-003.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2009-05-28 11:02:21 +1200" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="32" TOTAL_2="34" WEIGHT="0.0" Z="0.0">
<NAME>Surgical complication rate</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.06.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2009-05-28 11:02:21 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="34" WEIGHT="0.0" Z="0.0">
<NAME>Ultrasound guided aspiration of hydrosalpinges just after oocyte retrieval VERSUS no aspiration</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-05-28 11:02:21 +1200" MODIFIED_BY="[Empty name]" ORDER="36" O_E="0.0" SE="0.0" STUDY_ID="STD-Hammadieh-2008" TOTAL_1="32" TOTAL_2="34" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2009-05-28 11:02:20 +1200" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.706965942740529" CI_START="0.7376317208506153" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.65359477124183" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.5690185960247616" LOG_CI_START="-0.13216041530832337" LOG_EFFECT_SIZE="0.21842909035821909" METHOD="MH" MODIFIED="2009-02-14 11:40:49 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.22203921477833055" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="1.2211236884116763">
<NAME>Ongoing pregnancy rate</NAME>
<GROUP_LABEL_1>Tubal occlusion</GROUP_LABEL_1>
<GROUP_LABEL_2>Salpingectomy</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours salpingectomy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours tubal occlusion</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.706965942740529" CI_START="0.7376317208506153" DF="0" EFFECT_SIZE="1.65359477124183" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="17" I2="0.0" ID="CMP-004.01.01" LOG_CI_END="0.5690185960247616" LOG_CI_START="-0.13216041530832337" LOG_EFFECT_SIZE="0.21842909035821909" MODIFIED="2008-10-08 19:13:18 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.22203921477833055" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="1.2211236884116763">
<NAME>Laparoscopic proximal tubal occlusion by diathermy VERSUS laparoscopic salpingectomy</NAME>
<DICH_DATA CI_END="3.706965942740529" CI_START="0.7376317208506153" EFFECT_SIZE="1.65359477124183" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="17" LOG_CI_END="0.5690185960247616" LOG_CI_START="-0.13216041530832337" LOG_EFFECT_SIZE="0.21842909035821909" MODIFIED="2008-09-03 14:22:04 +1200" MODIFIED_BY="[Empty name]" ORDER="28" O_E="0.0" SE="0.41187602214913804" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="50" VAR="0.16964185762139725" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.6319424486469238" CI_END="2.1439322009226487" CI_START="0.7586301034890601" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="OR" EFFECT_SIZE="1.2753240793851097" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="43" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="0.33121104723773653" LOG_CI_START="-0.11996992788713201" LOG_EFFECT_SIZE="0.10562055967530229" METHOD="MH" MODIFIED="2009-02-14 11:40:49 +1300" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.42664393247476884" P_Q="0.0" P_Z="0.3588035772607526" Q="0.0" RANDOM="NO" SCALE="10.52" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="128" TOTAL_2="110" WEIGHT="100.0" Z="0.9176472608724844">
<NAME>Clinical pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.5891975141750905" CI_START="0.7357145962492113" DF="0" EFFECT_SIZE="1.625" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="20" I2="0.0" ID="CMP-004.02.01" LOG_CI_END="0.5549973582931369" LOG_CI_START="-0.13329062766335065" LOG_EFFECT_SIZE="0.21085336531489315" MODIFIED="2008-10-08 19:13:27 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.22980976601870717" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="37.99472295514512" Z="1.2008490936013043">
<NAME>Laparoscopic proximal tubal occlusion by diathermy VERSUS laparoscopic salpingectomy</NAME>
<DICH_DATA CI_END="3.5891975141750905" CI_START="0.7357145962492113" EFFECT_SIZE="1.625" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="20" LOG_CI_END="0.5549973582931369" LOG_CI_START="-0.13329062766335065" LOG_EFFECT_SIZE="0.21085336531489315" MODIFIED="2008-10-08 19:12:38 +1300" MODIFIED_BY="[Empty name]" ORDER="43" O_E="0.0" SE="0.40430377003131995" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="50" VAR="0.16346153846153844" WEIGHT="37.99472295514512"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.1160454719836386" CI_START="0.532047555083847" DF="0" EFFECT_SIZE="1.061054579093432" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="23" I2="0.0" ID="CMP-004.02.02" LOG_CI_END="0.3255249960755242" LOG_CI_START="-0.2740495481796095" LOG_EFFECT_SIZE="0.025737723947957345" MODIFIED="2009-02-14 08:47:14 +1300" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.8663713785233316" STUDIES="1" TAU2="0.0" TOTAL_1="78" TOTAL_2="60" WEIGHT="62.005277044854886" Z="0.16826935854890085">
<NAME>Laparoscopic proximal tubal clamping VERSUS laparoscopic salpingectomy</NAME>
<DICH_DATA CI_END="2.1160454719836386" CI_START="0.532047555083847" EFFECT_SIZE="1.061054579093432" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="23" LOG_CI_END="0.3255249960755242" LOG_CI_START="-0.2740495481796095" LOG_EFFECT_SIZE="0.025737723947957345" MODIFIED="2008-10-08 19:16:55 +1300" MODIFIED_BY="[Empty name]" ORDER="44" O_E="0.0" SE="0.35219305523732597" STUDY_ID="STD-Moshin-2006" TOTAL_1="78" TOTAL_2="60" VAR="0.12403994815740213" WEIGHT="62.005277044854886"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.6319424486469238" CI_END="2.1439322009226487" CI_START="0.7586301034890601" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="OR" EFFECT_SIZE="1.2753240793851097" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="43" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="0.33121104723773653" LOG_CI_START="-0.11996992788713201" LOG_EFFECT_SIZE="0.10562055967530229" METHOD="MH" MODIFIED="2009-02-14 11:40:49 +1300" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.42664393247476884" P_Q="0.0" P_Z="0.3588035772607526" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="128" TOTAL_2="110" WEIGHT="100.0" Z="0.9176472608724844">
<NAME>Pregnancy rate - any definition</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.5891975141750905" CI_START="0.7357145962492113" DF="0" EFFECT_SIZE="1.625" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="20" I2="0.0" ID="CMP-004.03.01" LOG_CI_END="0.5549973582931369" LOG_CI_START="-0.13329062766335065" LOG_EFFECT_SIZE="0.21085336531489315" MODIFIED="2008-10-09 13:01:50 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.22980976601870717" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="37.99472295514512" Z="1.2008490936013043">
<NAME>Laparoscopic proximal tubal occlusion by diathermy VERSUS laparoscopic salpingectomy</NAME>
<DICH_DATA CI_END="3.5891975141750905" CI_START="0.7357145962492113" EFFECT_SIZE="1.625" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="20" LOG_CI_END="0.5549973582931369" LOG_CI_START="-0.13329062766335065" LOG_EFFECT_SIZE="0.21085336531489315" MODIFIED="2008-10-09 13:01:50 +1300" MODIFIED_BY="[Empty name]" ORDER="40" O_E="0.0" SE="0.40430377003131995" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="50" VAR="0.16346153846153844" WEIGHT="37.99472295514512"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.1160454719836386" CI_START="0.532047555083847" DF="0" EFFECT_SIZE="1.061054579093432" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="23" I2="0.0" ID="CMP-004.03.02" LOG_CI_END="0.3255249960755242" LOG_CI_START="-0.2740495481796095" LOG_EFFECT_SIZE="0.025737723947957345" MODIFIED="2009-02-14 08:47:46 +1300" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.8663713785233316" STUDIES="1" TAU2="0.0" TOTAL_1="78" TOTAL_2="60" WEIGHT="62.005277044854886" Z="0.16826935854890085">
<NAME>Laparoscopic proximal tubal clamping VERSUS laparoscopic salpingectomy</NAME>
<DICH_DATA CI_END="2.1160454719836386" CI_START="0.532047555083847" EFFECT_SIZE="1.061054579093432" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="23" LOG_CI_END="0.3255249960755242" LOG_CI_START="-0.2740495481796095" LOG_EFFECT_SIZE="0.025737723947957345" MODIFIED="2008-10-09 13:02:02 +1300" MODIFIED_BY="[Empty name]" ORDER="41" O_E="0.0" SE="0.35219305523732597" STUDY_ID="STD-Moshin-2006" TOTAL_1="78" TOTAL_2="60" VAR="0.12403994815740213" WEIGHT="62.005277044854886"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="76.94865126062035" CI_START="0.12173455031059666" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="3.0606060606060606" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="1.8862010120141053" LOG_CI_START="-0.9145861442045954" LOG_EFFECT_SIZE="0.4858074339047551" METHOD="MH" MODIFIED="2009-02-14 11:40:49 +1300" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.49655083860245386" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.6799267639891967">
<NAME>Ectopic pregnancy rate</NAME>
<GROUP_LABEL_1>Tubal occlusion</GROUP_LABEL_1>
<GROUP_LABEL_2>Salpingectomy</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours tubal occlusion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours salpingectomy</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="76.94865126062035" CI_START="0.12173455031059666" DF="0" EFFECT_SIZE="3.0606060606060606" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-004.04.01" LOG_CI_END="1.8862010120141053" LOG_CI_START="-0.9145861442045954" LOG_EFFECT_SIZE="0.4858074339047551" MODIFIED="2008-10-08 19:14:51 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.49655083860245386" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.6799267639891967">
<NAME>Laparoscopic proximal tubal occlusion by diathermy VERSUS laparoscopic salpingectomy</NAME>
<DICH_DATA CI_END="76.94865126062035" CI_START="0.12173455031059666" EFFECT_SIZE="3.0606060606060606" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.8862010120141053" LOG_CI_START="-0.9145861442045954" LOG_EFFECT_SIZE="0.4858074339047551" MODIFIED="2008-09-03 15:00:13 +1200" MODIFIED_BY="[Empty name]" ORDER="30" O_E="0.0" SE="1.6451962396828856" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="50" VAR="2.7066706670667067" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="9.018127909520077" CI_START="0.20209294193710198" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.35" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-004.05" LOG_CI_END="0.9551163908735012" LOG_CI_START="-0.6944488538834891" LOG_EFFECT_SIZE="0.13033376849500614" METHOD="MH" MODIFIED="2009-05-28 11:02:20 +1200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="0.0" P_Z="0.7567759044101356" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="23" TOTAL_2="20" WEIGHT="100.0" Z="0.3097173549594583">
<NAME>Miscarriage rate</NAME>
<GROUP_LABEL_1>Tubal occlusion</GROUP_LABEL_1>
<GROUP_LABEL_2>Salpingectomy</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours tubal occlusion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours salpingectomy</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="9.018127909520077" CI_START="0.20209294193710198" DF="0" EFFECT_SIZE="1.35" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="0.0" ID="CMP-004.05.01" LOG_CI_END="0.9551163908735012" LOG_CI_START="-0.6944488538834891" LOG_EFFECT_SIZE="0.13033376849500614" MODIFIED="2009-05-28 11:02:20 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.7567759044101356" STUDIES="1" TAU2="0.0" TOTAL_1="23" TOTAL_2="20" WEIGHT="100.0" Z="0.3097173549594583">
<NAME>Laparoscopic proximal tubal occlusion by diathermy VERSUS laparoscopic salpingectomy</NAME>
<DICH_DATA CI_END="9.018127909520077" CI_START="0.20209294193710198" EFFECT_SIZE="1.35" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9551163908735012" LOG_CI_START="-0.6944488538834891" LOG_EFFECT_SIZE="0.13033376849500614" MODIFIED="2009-05-28 11:02:20 +1200" MODIFIED_BY="[Empty name]" ORDER="31" O_E="0.0" SE="0.9689627902499088" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="23" TOTAL_2="20" VAR="0.9388888888888889" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2009-09-07 04:48:27 +1200" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Surgical treatment (all types) VERSUS no surgical treatment</NAME>
<DICH_OUTCOME CHI2="15.937354702705724" CI_END="2.7855372559253966" CI_START="1.6501564779452138" CI_STUDY="95" CI_TOTAL="95" DF="16" EFFECT_MEASURE="OR" EFFECT_SIZE="2.1439618344138096" ESTIMABLE="YES" EVENTS_1="254" EVENTS_2="103" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.444908971423936" LOG_CI_START="0.21752512862964596" LOG_EFFECT_SIZE="0.33121705002679097" METHOD="MH" MODIFIED="2009-09-07 04:47:21 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.45734161747236335" P_Q="0.0" P_Z="1.1301928352197518E-8" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1186" TOTAL_2="855" WEIGHT="600.0" Z="5.709935069620642">
<NAME>Salpingectomy (all methods) VERSUS no surgical treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.9508128427104295" CI_END="3.817368820899812" CI_START="1.2639440287840236" DF="2" EFFECT_SIZE="2.1965747259864905" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="23" I2="0.0" ID="CMP-005.01.01" LOG_CI_END="0.5817641219987406" LOG_CI_START="0.10172784251562947" LOG_EFFECT_SIZE="0.34174598225718505" MODIFIED="2009-09-07 04:46:47 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6216324029106075" P_Z="0.005260015656111928" STUDIES="3" TAU2="0.0" TOTAL_1="196" TOTAL_2="133" WEIGHT="100.0" Z="2.7906633132253194">
<NAME>Ongoing pregnancy rate</NAME>
<DICH_DATA CI_END="9.657284194330876" CI_START="0.9688439519648329" EFFECT_SIZE="3.0588235294117645" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="6" LOG_CI_END="0.9848550120010728" LOG_CI_START="-0.013746167488022439" LOG_EFFECT_SIZE="0.48555442225652523" MODIFIED="2009-05-28 11:03:16 +1200" MODIFIED_BY="[Empty name]" ORDER="38" O_E="0.0" SE="0.5865832759874552" STUDY_ID="STD-Dechaud-1998" TOTAL_1="30" TOTAL_2="30" VAR="0.344079939668175" WEIGHT="18.961818961818963"/>
<DICH_DATA CI_END="16.57791028564947" CI_START="0.6763428313542315" EFFECT_SIZE="3.3484848484848486" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="2" LOG_CI_END="1.2195297850436218" LOG_CI_START="-0.16983310875713767" LOG_EFFECT_SIZE="0.524848338143242" MODIFIED="2009-05-28 11:12:33 +1200" MODIFIED_BY="[Empty name]" ORDER="39" O_E="0.0" SE="0.8161186412758086" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="15" VAR="0.6660496366378719" WEIGHT="11.325611325611325"/>
<DICH_DATA CI_END="3.5430886942842443" CI_START="0.8891329690611663" EFFECT_SIZE="1.7749019607843137" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="15" LOG_CI_END="0.5493820241807895" LOG_CI_START="-0.05103328581128034" LOG_EFFECT_SIZE="0.24917436918475458" MODIFIED="2009-05-24 05:25:50 +1200" MODIFIED_BY="[Empty name]" ORDER="40" O_E="0.0" SE="0.3526869251930598" STUDY_ID="STD-Strandell-1999" TOTAL_1="116" TOTAL_2="88" VAR="0.12438806720213494" WEIGHT="69.71256971256972"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.1702652507665245" CI_END="3.8637550594953747" CI_START="1.4912554807125975" DF="2" EFFECT_SIZE="2.4003845334869798" ESTIMABLE="YES" EVENTS_1="83" EVENTS_2="32" I2="52.04141991609801" ID="CMP-005.01.02" LOG_CI_END="0.5870095867700307" LOG_CI_START="0.17355205281510508" LOG_EFFECT_SIZE="0.3802808197925679" MODIFIED="2009-09-07 04:46:53 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.12429068353331452" P_Z="3.116909877092227E-4" STUDIES="3" TAU2="0.0" TOTAL_1="226" TOTAL_2="169" WEIGHT="100.0" Z="3.605384590167148">
<NAME>Clinical pregnancy rate</NAME>
<DICH_DATA CI_END="21.30471922660121" CI_START="0.8813905303352564" EFFECT_SIZE="4.333333333333333" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="2" LOG_CI_END="1.3284758150377034" LOG_CI_START="-0.05483161986335489" LOG_EFFECT_SIZE="0.6368220975871743" MODIFIED="2009-05-24 05:27:39 +1200" MODIFIED_BY="[Empty name]" ORDER="41" O_E="0.0" SE="0.8125616347431193" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="15" VAR="0.6602564102564104" WEIGHT="8.048899633002243"/>
<DICH_DATA CI_END="11.129516901982804" CI_START="1.824954006849494" EFFECT_SIZE="4.506756756756757" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="8" LOG_CI_END="1.0464763133592767" LOG_CI_START="0.2612519236839066" LOG_EFFECT_SIZE="0.6538641185215917" MODIFIED="2009-05-24 05:27:54 +1200" MODIFIED_BY="[Empty name]" ORDER="42" O_E="0.0" SE="0.46124469341872876" STUDY_ID="STD-Moshin-2006" TOTAL_1="60" TOTAL_2="66" VAR="0.21274666720693708" WEIGHT="20.484236632137982"/>
<DICH_DATA CI_END="2.9232939711647976" CI_START="0.8528306823861413" EFFECT_SIZE="1.5789473684210527" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="22" LOG_CI_END="0.46587249090828886" LOG_CI_START="-0.06913718337462188" LOG_EFFECT_SIZE="0.19836765376683346" MODIFIED="2009-05-24 05:28:00 +1200" MODIFIED_BY="[Empty name]" ORDER="43" O_E="0.0" SE="0.3142673310143813" STUDY_ID="STD-Strandell-1999" TOTAL_1="116" TOTAL_2="88" VAR="0.0987639553429027" WEIGHT="71.46686373485977"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.342136562529732" CI_END="3.858634025330341" CI_START="1.6008643622187966" DF="3" EFFECT_SIZE="2.4853872330074047" ESTIMABLE="YES" EVENTS_1="96" EVENTS_2="38" I2="30.909588936277082" ID="CMP-005.01.03" LOG_CI_END="0.5864335895802766" LOG_CI_START="0.20435453664424402" LOG_EFFECT_SIZE="0.39539406311226033" MODIFIED="2009-09-07 04:47:00 +1200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.22681121963601725" P_Z="4.9806550463604525E-5" STUDIES="4" TAU2="0.0" TOTAL_1="256" TOTAL_2="199" WEIGHT="100.00000000000001" Z="4.056532895200252">
<NAME>Pregnancy rate - any definition</NAME>
<DICH_DATA CI_END="9.657284194330876" CI_START="0.9688439519648329" EFFECT_SIZE="3.0588235294117645" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="6" LOG_CI_END="0.9848550120010728" LOG_CI_START="-0.013746167488022439" LOG_EFFECT_SIZE="0.48555442225652523" MODIFIED="2009-05-24 05:30:42 +1200" MODIFIED_BY="[Empty name]" ORDER="44" O_E="0.0" SE="0.5865832759874552" STUDY_ID="STD-Dechaud-1998" TOTAL_1="30" TOTAL_2="30" VAR="0.344079939668175" WEIGHT="12.909730445269007"/>
<DICH_DATA CI_END="21.30471922660121" CI_START="0.8813905303352564" EFFECT_SIZE="4.333333333333333" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="2" LOG_CI_END="1.3284758150377034" LOG_CI_START="-0.05483161986335489" LOG_EFFECT_SIZE="0.6368220975871743" MODIFIED="2009-05-24 05:30:48 +1200" MODIFIED_BY="[Empty name]" ORDER="49" O_E="0.0" SE="0.8125616347431193" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="15" VAR="0.6602564102564104" WEIGHT="7.009808386571407"/>
<DICH_DATA CI_END="11.129516901982804" CI_START="1.824954006849494" EFFECT_SIZE="4.506756756756757" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="8" LOG_CI_END="1.0464763133592767" LOG_CI_START="0.2612519236839066" LOG_EFFECT_SIZE="0.6538641185215917" MODIFIED="2009-05-24 05:30:58 +1200" MODIFIED_BY="[Empty name]" ORDER="50" O_E="0.0" SE="0.46124469341872876" STUDY_ID="STD-Moshin-2006" TOTAL_1="60" TOTAL_2="66" VAR="0.21274666720693708" WEIGHT="17.83977689915792"/>
<DICH_DATA CI_END="2.9232939711647976" CI_START="0.8528306823861413" EFFECT_SIZE="1.5789473684210527" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="22" LOG_CI_END="0.46587249090828886" LOG_CI_START="-0.06913718337462188" LOG_EFFECT_SIZE="0.19836765376683346" MODIFIED="2009-05-24 05:31:04 +1200" MODIFIED_BY="[Empty name]" ORDER="51" O_E="0.0" SE="0.3142673310143813" STUDY_ID="STD-Strandell-1999" TOTAL_1="116" TOTAL_2="88" VAR="0.0987639553429027" WEIGHT="62.24068426900167"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.25175399419384836" CI_END="2.752504458054386" CI_START="0.1496650159279151" DF="2" EFFECT_SIZE="0.6418361345050362" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" I2="0.0" ID="CMP-005.01.04" LOG_CI_END="0.43972803104319064" LOG_CI_START="-0.8248797037654558" LOG_EFFECT_SIZE="-0.1925758363611326" MODIFIED="2009-09-07 04:47:06 +1200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.8817232995992036" P_Z="0.5505535328910087" STUDIES="3" TAU2="0.0" TOTAL_1="196" TOTAL_2="133" WEIGHT="100.0" Z="0.5969308793095615">
<NAME>Ectopic pregnancy rate</NAME>
<DICH_DATA CI_END="8.235307327498598" CI_START="0.012621821467408088" EFFECT_SIZE="0.3224043715846995" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9156798109309462" LOG_CI_START="-1.8988779671075169" LOG_EFFECT_SIZE="-0.49159907808828524" MODIFIED="2009-05-24 05:38:00 +1200" MODIFIED_BY="[Empty name]" ORDER="52" O_E="0.0" SE="1.6532851711054914" STUDY_ID="STD-Dechaud-1998" TOTAL_1="30" TOTAL_2="30" VAR="2.733351856997314" WEIGHT="33.16488646543206"/>
<DICH_DATA CI_END="24.252761047879282" CI_START="0.03638600040745582" EFFECT_SIZE="0.9393939393939394" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.3847611878702257" LOG_CI_START="-1.4390656799574555" LOG_EFFECT_SIZE="-0.027152246043614773" MODIFIED="2009-05-24 05:38:25 +1200" MODIFIED_BY="[Empty name]" ORDER="53" O_E="0.0" SE="1.6587298803304127" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="15" VAR="2.751384815900945" WEIGHT="16.602730048513337"/>
<DICH_DATA CI_END="5.463028882236056" CI_START="0.10417264787069859" EFFECT_SIZE="0.7543859649122807" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7374334965721674" LOG_CI_START="-0.9822462967579771" LOG_EFFECT_SIZE="-0.12240640009290486" MODIFIED="2009-05-24 05:38:30 +1200" MODIFIED_BY="[Empty name]" ORDER="54" O_E="0.0" SE="1.0101484231543925" STUDY_ID="STD-Strandell-1999" TOTAL_1="116" TOTAL_2="88" VAR="1.0203998368013056" WEIGHT="50.23238348605461"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.11221252544819049" CI_END="2.3846009664338954" CI_START="0.30756774997104724" DF="2" EFFECT_SIZE="0.8564031491212875" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" I2="0.0" ID="CMP-005.01.05" LOG_CI_END="0.37741571562993037" LOG_CI_START="-0.5120592044489228" LOG_EFFECT_SIZE="-0.06732174440949622" MODIFIED="2009-09-07 04:47:12 +1200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.945438670085934" P_Z="0.7667048453178144" STUDIES="3" TAU2="0.0" TOTAL_1="196" TOTAL_2="133" WEIGHT="100.0" Z="0.2966878355768051">
<NAME>Miscarriage rate</NAME>
<DICH_DATA CI_END="16.76330729896324" CI_START="0.05965409940685434" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.224359706417746" LOG_CI_START="-1.224359706417746" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-05-28 11:03:34 +1200" MODIFIED_BY="[Empty name]" ORDER="55" O_E="0.0" SE="1.4383899044561523" STUDY_ID="STD-Dechaud-1998" TOTAL_1="30" TOTAL_2="30" VAR="2.068965517241379" WEIGHT="12.33662489653712"/>
<DICH_DATA CI_END="6.91837780703944" CI_START="0.04918461917930323" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="0.840004274797777" LOG_CI_START="-1.3081706868645129" LOG_EFFECT_SIZE="-0.23408320603336794" MODIFIED="2009-05-28 11:03:43 +1200" MODIFIED_BY="[Empty name]" ORDER="56" O_E="0.0" SE="1.2618486061179863" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="15" VAR="1.5922619047619049" WEIGHT="18.84853034590287"/>
<DICH_DATA CI_END="3.068628780777452" CI_START="0.2671707764132308" EFFECT_SIZE="0.9054545454545454" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.48694435398704466" LOG_CI_START="-0.5732110474560972" LOG_EFFECT_SIZE="-0.04313334673452634" MODIFIED="2009-05-28 11:04:20 +1200" MODIFIED_BY="[Empty name]" ORDER="57" O_E="0.0" SE="0.622740530661575" STUDY_ID="STD-Strandell-1999" TOTAL_1="116" TOTAL_2="88" VAR="0.38780576852866006" WEIGHT="68.81484475756001"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="81.52215966183218" CI_START="0.18320608759329335" DF="0" EFFECT_SIZE="3.8646288209606987" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-005.01.06" LOG_CI_END="1.9112756763564749" LOG_CI_START="-0.7370600996406002" LOG_EFFECT_SIZE="0.5871077883579374" MODIFIED="2009-09-07 04:47:21 +1200" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.38484374221011663" STUDIES="1" TAU2="0.0" TOTAL_1="116" TOTAL_2="88" WEIGHT="99.99999999999999" Z="0.8690062118662348">
<NAME>Surgical complication rate</NAME>
<DICH_DATA CI_END="81.52215966183218" CI_START="0.18320608759329343" EFFECT_SIZE="3.8646288209606987" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9112756763564749" LOG_CI_START="-0.7370600996405999" LOG_EFFECT_SIZE="0.5871077883579374" MODIFIED="2009-05-24 05:46:17 +1200" MODIFIED_BY="[Empty name]" ORDER="58" O_E="0.0" SE="1.5556455442941999" STUDY_ID="STD-Strandell-1999" TOTAL_1="116" TOTAL_2="88" VAR="2.4200330594823973" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.8193456331488957" CI_END="8.034636978068562" CI_START="2.110107858153089" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="OR" EFFECT_SIZE="4.117517531818154" ESTIMABLE="YES" EVENTS_1="72" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="0.9049662591972787" LOG_CI_START="0.3243046548254297" LOG_EFFECT_SIZE="0.6146354570113541" METHOD="MH" MODIFIED="2009-09-07 04:47:50 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5884979832212365" P_Q="0.0" P_Z="3.3352481730591326E-5" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="278" TOTAL_2="126" WEIGHT="400.0" Z="4.149278513659458">
<NAME>Tubal occlusion (all methods) VERSUS no surgical treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="59.573686497810925" CI_START="0.8731152197579721" DF="0" EFFECT_SIZE="7.212121212121212" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="1" I2="0.0" ID="CMP-005.02.01" LOG_CI_END="1.7750544756422226" LOG_CI_START="-0.05892844128497393" LOG_EFFECT_SIZE="0.8580630171786244" MODIFIED="2009-09-07 04:47:30 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.06665233082207438" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="15" WEIGHT="100.0" Z="1.8340112054627595">
<NAME>Ongoing pregnancy rate</NAME>
<DICH_DATA CI_END="59.573686497810876" CI_START="0.8731152197579726" EFFECT_SIZE="7.212121212121212" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="1" LOG_CI_END="1.7750544756422224" LOG_CI_START="-0.0589284412849737" LOG_EFFECT_SIZE="0.8580630171786244" MODIFIED="2009-05-24 06:32:44 +1200" MODIFIED_BY="[Empty name]" ORDER="59" O_E="0.0" SE="1.0772906437648877" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="15" VAR="1.1605551311433664" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.011369271946217396" CI_END="10.009329762172282" CI_START="2.173962974696834" DF="1" EFFECT_SIZE="4.664752116082226" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="10" I2="0.0" ID="CMP-005.02.02" LOG_CI_END="1.000404997525723" LOG_CI_START="0.3372521432361151" LOG_EFFECT_SIZE="0.668828570380919" MODIFIED="2009-09-07 04:47:35 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9150850670660647" P_Z="7.702354336478663E-5" STUDIES="2" TAU2="0.0" TOTAL_1="128" TOTAL_2="81" WEIGHT="100.00000000000001" Z="3.953477396044004">
<NAME>Clinical pregnancy rate</NAME>
<DICH_DATA CI_END="21.30471922660121" CI_START="0.8813905303352564" EFFECT_SIZE="4.333333333333333" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="2" LOG_CI_END="1.3284758150377034" LOG_CI_START="-0.05483161986335489" LOG_EFFECT_SIZE="0.6368220975871743" MODIFIED="2009-05-24 06:33:25 +1200" MODIFIED_BY="[Empty name]" ORDER="60" O_E="0.0" SE="0.8125616347431193" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="15" VAR="0.6602564102564104" WEIGHT="26.118500604594924"/>
<DICH_DATA CI_END="11.382285311114009" CI_START="2.008973543078256" EFFECT_SIZE="4.781914893617022" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="8" LOG_CI_END="1.0562294675391715" LOG_CI_START="0.30297421739992664" LOG_EFFECT_SIZE="0.6796018424695489" MODIFIED="2009-05-24 06:33:42 +1200" MODIFIED_BY="[Empty name]" ORDER="61" O_E="0.0" SE="0.4424658626054158" STUDY_ID="STD-Moshin-2006" TOTAL_1="78" TOTAL_2="66" VAR="0.19577603957115472" WEIGHT="73.88149939540509"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.479908289397955E-33" CI_END="24.252761047879282" CI_START="0.03638600040745582" DF="0" EFFECT_SIZE="0.9393939393939396" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="100.0" ID="CMP-005.02.03" LOG_CI_END="1.3847611878702257" LOG_CI_START="-1.4390656799574555" LOG_EFFECT_SIZE="-0.027152246043614724" MODIFIED="2009-09-07 04:47:43 +1200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.9699334899123886" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="15" WEIGHT="99.99999999999999" Z="0.03769170479335671">
<NAME>Ectopic pregnancy rate</NAME>
<DICH_DATA CI_END="24.252761047879282" CI_START="0.03638600040745582" EFFECT_SIZE="0.9393939393939394" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.3847611878702257" LOG_CI_START="-1.4390656799574555" LOG_EFFECT_SIZE="-0.027152246043614773" MODIFIED="2009-05-24 06:36:02 +1200" MODIFIED_BY="[Empty name]" ORDER="64" O_E="0.0" SE="1.6587298803304127" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="15" VAR="2.751384815900945" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="9.28174293356215" CI_START="0.08603463664434706" DF="0" EFFECT_SIZE="0.8936170212765957" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="0.0" ID="CMP-005.02.04" LOG_CI_END="0.9676295360630318" LOG_CI_START="-1.065326671138666" LOG_EFFECT_SIZE="-0.04884856753781702" MODIFIED="2009-09-07 04:47:50 +1200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.9249587280684952" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="15" WEIGHT="100.0" Z="0.09418937085937425">
<NAME>Miscarriage rate</NAME>
<DICH_DATA CI_END="9.281742933562146" CI_START="0.0860346366443471" EFFECT_SIZE="0.8936170212765957" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="0.9676295360630317" LOG_CI_START="-1.0653266711386657" LOG_EFFECT_SIZE="-0.04884856753781702" MODIFIED="2009-05-28 11:05:22 +1200" MODIFIED_BY="[Empty name]" ORDER="65" O_E="0.0" SE="1.1941685394058015" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="15" VAR="1.4260385005065854" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.18939031794259398" CI_END="4.966175216309078" CI_START="1.0963053471340913" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="OR" EFFECT_SIZE="2.3333333333333335" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-005.03" LOG_CI_END="0.6960220382418556" LOG_CI_START="0.03993153234733318" LOG_EFFECT_SIZE="0.36797678529459443" METHOD="MH" MODIFIED="2009-09-07 04:48:27 +1200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9096502495506837" P_Q="0.0" P_Z="0.027910509362807277" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="160" TOTAL_2="160" WEIGHT="300.0" Z="2.1985419384812186">
<NAME>Aspiration of hydro salpingeal fluid (all methods) VERSUS no surgical treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.286314364414075" CI_START="0.6171670596678851" DF="0" EFFECT_SIZE="1.9696969696969697" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" I2="0.0" ID="CMP-005.03.01" LOG_CI_END="0.7983960953128983" LOG_CI_START="-0.20959726178296226" LOG_EFFECT_SIZE="0.2943994167649681" MODIFIED="2009-09-07 04:47:57 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.25226173619487124" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="32" WEIGHT="100.0" Z="1.1448731281153885">
<NAME>Clinical pregnancy rate</NAME>
<DICH_DATA CI_END="6.286314364414075" CI_START="0.6171670596678851" EFFECT_SIZE="1.9696969696969697" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" LOG_CI_END="0.7983960953128983" LOG_CI_START="-0.20959726178296226" LOG_EFFECT_SIZE="0.2943994167649681" MODIFIED="2009-05-24 06:42:17 +1200" MODIFIED_BY="[Empty name]" ORDER="66" O_E="0.0" SE="0.5921002876056982" STUDY_ID="STD-Hammadieh-2008" TOTAL_1="32" TOTAL_2="32" VAR="0.35058275058275057" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="8.269992427890845" CI_START="0.9330177082984257" DF="0" EFFECT_SIZE="2.7777777777777777" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="7" I2="0.0" ID="CMP-005.03.02" LOG_CI_END="0.9175051119072349" LOG_CI_START="-0.03011011344180948" LOG_EFFECT_SIZE="0.44369749923271273" MODIFIED="2009-09-07 04:48:04 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.06644499809566065" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="32" WEIGHT="100.0" Z="1.8354097639287834">
<NAME>Biochemical pregnancy rate</NAME>
<DICH_DATA CI_END="8.269992427890845" CI_START="0.9330177082984259" EFFECT_SIZE="2.7777777777777777" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="7" LOG_CI_END="0.9175051119072349" LOG_CI_START="-0.030110113441809368" LOG_EFFECT_SIZE="0.44369749923271273" MODIFIED="2009-05-24 06:44:24 +1200" MODIFIED_BY="[Empty name]" ORDER="71" O_E="0.0" SE="0.5566338741410459" STUDY_ID="STD-Hammadieh-2008" TOTAL_1="32" TOTAL_2="32" VAR="0.3098412698412698" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.03.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2009-09-07 04:48:09 +1200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="32" WEIGHT="0.0" Z="0.0">
<NAME>Ectopic pregnancy rate</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-05-24 06:44:42 +1200" MODIFIED_BY="[Empty name]" ORDER="68" O_E="0.0" SE="0.0" STUDY_ID="STD-Hammadieh-2008" TOTAL_1="32" TOTAL_2="32" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="24.006254434760407" CI_START="0.17791659763993245" DF="0" EFFECT_SIZE="2.066666666666667" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-005.03.04" LOG_CI_END="1.3803244047380165" LOG_CI_START="-0.7497835351808337" LOG_EFFECT_SIZE="0.31527043477859146" MODIFIED="2009-09-07 04:48:14 +1200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.5617959739022298" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="32" WEIGHT="100.0" Z="0.58017594881118">
<NAME>Miscarriage rate</NAME>
<DICH_DATA CI_END="24.006254434760407" CI_START="0.17791659763993245" EFFECT_SIZE="2.066666666666667" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3803244047380165" LOG_CI_START="-0.7497835351808337" LOG_EFFECT_SIZE="0.31527043477859146" MODIFIED="2009-05-28 11:05:42 +1200" MODIFIED_BY="[Empty name]" ORDER="69" O_E="0.0" SE="1.25123594811269" STUDY_ID="STD-Hammadieh-2008" TOTAL_1="32" TOTAL_2="32" VAR="1.5655913978494622" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.03.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2009-09-07 04:48:27 +1200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="32" WEIGHT="0.0" Z="0.0">
<NAME>Surgical complication rate</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-05-28 11:05:52 +1200" MODIFIED_BY="[Empty name]" ORDER="70" O_E="0.0" SE="0.0" STUDY_ID="STD-Hammadieh-2008" TOTAL_1="32" TOTAL_2="32" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2009-09-07 04:49:13 +1200" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube</NAME>
<DICH_OUTCOME CHI2="1.6830885898284254" CI_END="2.041690879103656" CI_START="0.8829578635432681" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="OR" EFFECT_SIZE="1.3426567009586408" ESTIMABLE="YES" EVENTS_1="83" EVENTS_2="63" I2="0.0" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="0.3099899886509943" LOG_CI_START="-0.054060021300444495" LOG_EFFECT_SIZE="0.1279649836752749" METHOD="MH" MODIFIED="2009-09-07 04:49:13 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7937872857252322" P_Q="0.0" P_Z="0.16824348706698222" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="278" TOTAL_2="260" WEIGHT="400.0" Z="1.3778698114539278">
<NAME>Tubal occlusion (all methods) VERSUS Salpingectomy (all methods)</NAME>
<GROUP_LABEL_1>Tubal occlusion</GROUP_LABEL_1>
<GROUP_LABEL_2>Salpingectomy</GROUP_LABEL_2>
<GRAPH_LABEL_1>
Tubal occlusion 
</GRAPH_LABEL_1>
<GRAPH_LABEL_2>
Salpingectomy 
</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.706965942740529" CI_START="0.7376317208506153" DF="0" EFFECT_SIZE="1.65359477124183" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="17" I2="0.0" ID="CMP-006.01.01" LOG_CI_END="0.5690185960247616" LOG_CI_START="-0.13216041530832337" LOG_EFFECT_SIZE="0.21842909035821909" MODIFIED="2009-09-07 04:48:57 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.22203921477833055" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="1.2211236884116763">
<NAME>Ongoing pregnancy rate</NAME>
<DICH_DATA CI_END="3.706965942740529" CI_START="0.7376317208506153" EFFECT_SIZE="1.65359477124183" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="17" LOG_CI_END="0.5690185960247616" LOG_CI_START="-0.13216041530832337" LOG_EFFECT_SIZE="0.21842909035821909" MODIFIED="2009-05-24 09:48:10 +1200" MODIFIED_BY="[Empty name]" ORDER="72" O_E="0.0" SE="0.41187602214913804" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="50" VAR="0.16964185762139725" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.6319424486469238" CI_END="2.1439322009226487" CI_START="0.7586301034890601" DF="1" EFFECT_SIZE="1.2753240793851097" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="43" I2="0.0" ID="CMP-006.01.02" LOG_CI_END="0.33121104723773653" LOG_CI_START="-0.11996992788713201" LOG_EFFECT_SIZE="0.10562055967530229" MODIFIED="2009-09-07 04:49:03 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.42664393247476884" P_Z="0.3588035772607526" STUDIES="2" TAU2="0.0" TOTAL_1="128" TOTAL_2="110" WEIGHT="100.0" Z="0.9176472608724844">
<NAME>Clinical pregnancy rate</NAME>
<DICH_DATA CI_END="3.5891975141750905" CI_START="0.7357145962492113" EFFECT_SIZE="1.625" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="20" LOG_CI_END="0.5549973582931369" LOG_CI_START="-0.13329062766335065" LOG_EFFECT_SIZE="0.21085336531489315" MODIFIED="2009-05-24 09:50:16 +1200" MODIFIED_BY="[Empty name]" ORDER="73" O_E="0.0" SE="0.40430377003131995" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="50" VAR="0.16346153846153844" WEIGHT="37.99472295514512"/>
<DICH_DATA CI_END="2.1160454719836386" CI_START="0.532047555083847" EFFECT_SIZE="1.061054579093432" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="23" LOG_CI_END="0.3255249960755242" LOG_CI_START="-0.2740495481796095" LOG_EFFECT_SIZE="0.025737723947957345" MODIFIED="2009-05-24 09:50:22 +1200" MODIFIED_BY="[Empty name]" ORDER="74" O_E="0.0" SE="0.35219305523732597" STUDY_ID="STD-Moshin-2006" TOTAL_1="78" TOTAL_2="60" VAR="0.12403994815740213" WEIGHT="62.005277044854886"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="8.2145947674557" CI_START="0.012995679373418273" DF="0" EFFECT_SIZE="0.32673267326732675" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-006.01.03" LOG_CI_END="0.9145861442045954" LOG_CI_START="-1.8862010120141055" LOG_EFFECT_SIZE="-0.48580743390475506" MODIFIED="2009-09-07 04:49:08 +1200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.49655083860245386" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.00000000000001" Z="0.6799267639891967">
<NAME>Ectopic pregnancy rate</NAME>
<DICH_DATA CI_END="8.2145947674557" CI_START="0.012995679373418273" EFFECT_SIZE="0.32673267326732675" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9145861442045954" LOG_CI_START="-1.8862010120141055" LOG_EFFECT_SIZE="-0.48580743390475506" MODIFIED="2009-05-24 09:52:14 +1200" MODIFIED_BY="[Empty name]" ORDER="78" O_E="0.0" SE="1.6451962396828856" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="50" VAR="2.7066706670667067" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="9.586551876924666" CI_START="0.24479742783580316" DF="0" EFFECT_SIZE="1.5319148936170213" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="0.0" ID="CMP-006.01.04" LOG_CI_END="0.981662426763436" LOG_CI_START="-0.6111931497723341" LOG_EFFECT_SIZE="0.185234638495551" MODIFIED="2009-09-07 04:49:13 +1200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.6484963914893094" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.4558520251160055">
<NAME>Miscarriage rate</NAME>
<DICH_DATA CI_END="9.586551876924666" CI_START="0.24479742783580316" EFFECT_SIZE="1.5319148936170213" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.981662426763436" LOG_CI_START="-0.6111931497723341" LOG_EFFECT_SIZE="0.185234638495551" MODIFIED="2009-05-28 11:06:43 +1200" MODIFIED_BY="[Empty name]" ORDER="79" O_E="0.0" SE="0.935651250419379" STUDY_ID="STD-Kontoravdis-2006" TOTAL_1="50" TOTAL_2="50" VAR="0.8754432624113475" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2009-09-07 04:51:06 +1200" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2009-09-07 04:47:22 +1200" MODIFIED_BY="[Empty name]" NO="1" REF_ID="CMP-005.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: Surgical treatment (all types) VERSUS no surgical treatment: Salpingectomy (all methods) VERSUS no surgical treatment. Outcomes: Ongoing pregnancy rate, Clinical pregnancy rate, Pregnancy rate according to any definition, Ectopic pregnancy rate, Miscarriage rate, Surgical complication rate.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqkAAAOgCAMAAAApgB+JAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2009-09-07 04:47:51 +1200" MODIFIED_BY="[Empty name]" NO="2" REF_ID="CMP-005.02" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>
<I>Forest plot of comparison: Surgical treatment (all types) VERSUS no surgical treatment: Tubal occlusion (all methods) VERSUS no surgical treatment. </I>Outcomes: Ongoing pregnancy rate, Clinical pregnancy rate, Ectopic pregnancy rate, Miscarriage rate, Surgical complication rate.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqkAAAIgCAMAAACRRwDlAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2009-09-07 04:48:28 +1200" MODIFIED_BY="[Empty name]" NO="3" REF_ID="CMP-005.03" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>
<I>Forest plot of comparison: Surgical treatment (all types) VERSUS no surgical treatment: Aspiration of hydro salpingeal fluid (all methods) VERSUS no surgical treatment. </I>Outcomes: Ongoing pregnancy rate, Clinical pregnancy rate, Ectopic pregnancy rate, Miscarriage rate, Surgical complication rate.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqkAAAKACAMAAACIWxELAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2009-09-07 04:49:15 +1200" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-006.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>
<I>Forest plot of comparison: Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube:</I> Tubal occlusion (all methods) VERSUS Salpingectomy (all methods). Outcomes: Ongoing pregnancy rate, Clinical pregnancy rate, Ectopic pregnancy rate, Miscarriage rate.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAtAAAAIgCAMAAACbG663AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2009-09-07 04:50:44 +1200" MODIFIED_BY="[Empty name]" NO="5" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAfMAAAEZCAMAAAC0DjydAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2009-09-07 04:51:06 +1200" MODIFIED_BY="[Empty name]" NO="6" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Methodological quality summary: review authors' judgements about each methodological quality item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAW0AAAGACAIAAADpuaQpAAAVMUlEQVR42u3dvY4cRRfG8ZFICDbY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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2009-06-08 14:59:04 +1200" MODIFIED_BY="jane clarke">
<APPENDIX ID="APP-01" MODIFIED="2009-06-08 14:58:38 +1200" MODIFIED_BY="jane clarke" NO="1">
<TITLE MODIFIED="2008-09-23 13:07:29 +1200" MODIFIED_BY="[Empty name]">Search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2009-06-08 14:58:38 +1200" MODIFIED_BY="jane clarke">
<P>
<B>Database: Cochrane Menstrual Disorders and Subfertility Group (MDSG) trials register </B>
</P>
<P>Keywords CONTAINS "IVF" or "ICSI" or "in-vitro fertilisation " or "in-vitro fertilisation procedure" or "in-vitro fertilisation procedure failure" or "in-vitro fertilisation techniques" or "in vitro fertilization" or "intracytoplasmic sperm injection" or "intracytoplasmic sperm injection techniques" or Title CONTAINS "IVF" or "ICSI" or "in-vitro fertilisation " or "in-vitro fertilisation procedure" or "in-vitro fertilisation procedure failure" or "in-vitro fertilisation techniques" or "in vitro fertilization" or "intracytoplasmic sperm injection" or "intracytoplasmic sperm injection techniques"<B>
<BR/>
</B>AND<B>
<BR/>
</B>Keywords CONTAINS "tubal anastomosis"or "tubal disorders" or "tubal factor" or "tubal occlusion" or "tubal patency" or "tubal reconstruction" or "tubal subfertility" or "tuboplasty" or "tube drainage" or  "Fallopian tube obstruction"or "Fallopian Tube Fixation" or "falloscopy" or "salpingectomy" or "Salpingolysis" or "*Salpingostomy-" or"salpingotomy" or "hydrosalpingies" or "Hydrosalpinx" or "hydrosalpinges" or "hydrotubation" or "Aspiration" or Title CONTAINS "tubal anastomosis"or "tubal disorders" or "tubal factor" or "tubal occlusion" or "tubal patency" or "tubal reconstruction" or "tubal subfertility" or "tuboplasty" or "tube drainage" or  "Fallopian tube obstruction"or "Fallopian Tube Fixation" or "falloscopy" or "salpingectomy" or "Salpingolysis" or "*Salpingostomy-" or"salpingotomy" or "hydrosalpingies" or "Hydrosalpinx" or "hydrosalpinges" or "hydrotubation" or "Aspiration"</P>
<P>
<B>Database: Cochrane Central Register of Controlled Trials </B>
</P>
<P>1     (in vitro fertilisation or in vitro fertilization).tw. (1148)<BR/>2     (ivf or icsi).tw. (1793)<BR/>3     intracytoplasmic sperm injections.tw. (0)<BR/>4     exp reproductive techniques, assisted/ or exp embryo transfer/ or exp fertilization in vitro/ or exp<BR/>sperm injections, intracytoplasmic/ or exp zygote intrafallopian transfer/ (1740)<BR/>5     (ART or embryo transfer or et).tw. (4591)<BR/>6     or/1-5 (6699)<BR/>7     exp Fallopian Tube Diseases/ (94)<BR/>8     Fallopian Tube Disease$.tw. (0)<BR/>9     salping$.tw. (204)<BR/>10     (fallopian adj3 disease$).tw. (0)<BR/>11     (tub$ adj5 adhesion$).tw. (33)<BR/>12     (tub$ adj3 occlusion$).tw. (94)<BR/>13     (tub$ adj5 block$).tw. (121)<BR/>14     hydrosalpin$.tw. (29)<BR/>15     (surg$ adj5 tub$).tw. (307)<BR/>16     (aspirat$ adj5 hydrosalpin$).tw. (2)<BR/>17     essure$.tw. (1)<BR/>18     (clip$ adj5 hydrosalpin$).tw. (1)<BR/>19     hysteroscop$.tw. (326)<BR/>20     or/7-19 (1063)<BR/>21     6 and 20 (67)<BR/>22     limit 21 to yr="2004 - 2008" (15)<BR/>23     from 22 keep 1-15 (15)</P>
<P>
<B>Database: Ovid MEDLINE(R)</B> </P>
<P>1     (in vitro fertilisation or in vitro fertilization).tw. (12679)<BR/>2     (ivf or icsi).tw. (13008)<BR/>3     intracytoplasmic sperm injections.tw. (15)<BR/>4     exp reproductive techniques, assisted/ or exp embryo transfer/ or exp fertilization in vitro/ or exp<BR/>sperm injections, intracytoplasmic/ or exp zygote intrafallopian transfer/ (41350)<BR/>5     (ART or embryo transfer or et).tw. (137241)<BR/>6     or/1-5 (174789)<BR/>7     exp Fallopian Tube Diseases/ (5463)<BR/>8     Fallopian Tube Disease$.tw. (11)<BR/>9     salping$.tw. (5123)<BR/>10     (fallopian adj3 disease$).tw. (37)<BR/>11     (tub$ adj5 adhesion$).tw. (669)<BR/>12     (tub$ adj3 occlusion$).tw. (967)<BR/>13     (tub$ adj5 block$).tw. (2032)<BR/>14     hydrosalpin$.tw. (532)<BR/>15     (surg$ adj5 tub$).tw. (6164)<BR/>16     (aspirat$ adj5 hydrosalpin$).tw. (13)<BR/>17     essure$.tw. (56)<BR/>18     (clip$ adj5 hydrosalpin$).tw. (4)<BR/>19     hysteroscop$.tw. (3330)<BR/>20     or/7-19 (21124)<BR/>21     6 and 20 (1119)<BR/>22     randomised controlled trial.pt. (263468)<BR/>23     controlled clinical trial.pt. (79901)<BR/>24     randomized.ab. (172034)<BR/>25     placebo.ab. (109112)<BR/>26     cross-over studies/ (22777)<BR/>27     (crossover or cross-over or cross over).tw. (41720)<BR/>28     clinical trials as topic.sh. (142719)<BR/>29     randomly.ab. (124831)<BR/>30     trial.ti. (76577)<BR/>31     or/22-30 (623968)<BR/>32     humans.sh. (10628562)<BR/>33     31 and 32 (564390)<BR/>34     33 and 21 (68)<BR/>35     limit 34 to yr="2004 - 2008" (21)<BR/>36     from 35 keep 1-21 (21)</P>
<P>
<B>Database: EMBASE </B>
</P>
<P>1     exp embryo transfer/ or exp fertilization in vitro/ or exp intracytoplasmic sperm injection/ (24650)<BR/>2     (in vitro fertilisation or in vitro fertilization).tw. (11070)<BR/>3     (ivf or icsi or et or embryo transfer).tw. (143156)<BR/>4     intracytoplasmic sperm injection.tw. (3040)<BR/>5     or/1-4 (155969)<BR/>6     (tub$ adj3 disease$).tw. (4190)<BR/>7     (fallopian adj5 disease).tw. (42)<BR/>8     (tub$ adj5 adhesion$).tw. (573)<BR/>9     (tub$ adj5 occlusion$).tw. (886)<BR/>10     (tub$ adj5 block$).tw. (1619)<BR/>11     (fallopian adj3 adhesion$).tw. (12)<BR/>12     (fallopian$ adj3 block$).tw. (30)<BR/>13     (fallopian adj3 adhesion$).tw. (12)<BR/>14     hydrosalpin$.tw. (505)<BR/>15     (surg$ adj5 tub$).tw. (3324)<BR/>16     (surg$ adj5 fallopian$).tw. (121)<BR/>17     salping$.tw. (4367)<BR/>18     (aspirat$ adj5 hydrosalpin$).tw. (12)<BR/>19     (clip$ adj5 hydrosalpin$).tw. (1)<BR/>20     essure$.tw. (64)<BR/>21     exp uterine tube disease/ or exp hydrosalpinx/ or exp salpingitis/ or exp tuboovarian abscess/ or exp<BR/>uterine tube abscess/ or exp uterine tube occlusion/ (4002)<BR/>22     or/6-21 (16567)<BR/>23     22 and 5 (1137)<BR/>24     Controlled study/ or randomised controlled trial/ (2734301)<BR/>25     double blind procedure/ (70094)<BR/>26     single blind procedure/ (7722)<BR/>27     crossover procedure/ (20517)<BR/>28     drug comparison/ (81252)<BR/>29     placebo/ (116586)<BR/>30     random$.ti,ab,hw,tn,mf. (415876)<BR/>31     latin square.ti,ab,hw,tn,mf. (1107)<BR/>32     crossover.ti,ab,hw,tn,mf. (35368)<BR/>33     cross-over.ti,ab,hw,tn,mf. (11959)<BR/>34     placebo$.ti,ab,hw,tn,mf. (167040)<BR/>35     ((doubl$ or singl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).ti,ab,hw,tn,mf. (115237)<BR/>36     (comparative adj5 trial$).ti,ab,hw,tn,mf. (15269)<BR/>37     (clinical adj5 trial$).ti,ab,hw,tn,mf. (576643)<BR/>38     or/24-37 (3243356)<BR/>39     nonhuman/ (3097648)<BR/>40     animal/ not (human/ and animal/) (14472)<BR/>41     or/39-40 (3101342)<BR/>42     38 not 41 (1915335)<BR/>43     42 and 23 (297)<BR/>44     limit 43 to yr="2006 - 2008" (61)<BR/>45     from 44 keep 1-61 (61)</P>
<P>
<B>Database: CINAHL - Cumulative Index to Nursing &amp; Allied Health</B>
</P>
<P>1     (in vitro fertilisation or in vitro fertilization).tw. (376)<BR/>2     (ivf or icsi).tw. (316)<BR/>3     intracytoplasmic sperm injections.tw. (0)<BR/>4     exp reproductive techniques, assisted/ or exp embryo transfer/ or exp fertilization in vitro/ or exp<BR/>sperm injections, intracytoplasmic/ or exp zygote intrafallopian transfer/ (1002)<BR/>5     (ART or embryo transfer or et).tw. (45441)<BR/>6     or/1-5 (46463)<BR/>7     exp Fallopian Tube Diseases/ (152)<BR/>8     Fallopian Tube Disease$.tw. (1)<BR/>9     salping$.tw. (134)<BR/>10     (fallopian adj3 disease$).tw. (1)<BR/>11     (tub$ adj5 adhesion$).tw. (9)<BR/>12     (tub$ adj3 occlusion$).tw. (63)<BR/>13     (tub$ adj5 block$).tw. (53)<BR/>14     hydrosalpin$.tw. (13)<BR/>15     (surg$ adj5 tub$).tw. (184)<BR/>16     (aspirat$ adj5 hydrosalpin$).tw. (0)<BR/>17     essure$.tw. (25)<BR/>18     (clip$ adj5 hydrosalpin$).tw. (0)<BR/>19     hysteroscop$.tw. (172)<BR/>20     or/7-19 (736)<BR/>21     6 and 20 (37)<BR/>22     exp clinical trials/ (61758)<BR/>23     Clinical trial.pt. (32434)<BR/>24     (clinic$ adj trial$1).tw. (14019)<BR/>25     ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$3 or mask$3)).tw. (8276)<BR/>26     Randomi?ed control$ trial$.tw. (12024)<BR/>27     Random assignment/ (18434)<BR/>28     Random$ allocat$.tw. (1272)<BR/>29     Placebo$.tw. (11470)<BR/>30     Placebos/ (4474)<BR/>31     Quantitative studies/ (4044)<BR/>32     Allocat$ random$.tw. (74)<BR/>33     or/22-32 (85043)<BR/>34     33 and 21 (4)<BR/>35     from 34 keep 1-4 (4)<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2009-06-08 14:14:40 +1200" MODIFIED_BY="jane clarke" NO="2">
<TITLE MODIFIED="2008-09-23 13:00:07 +1200" MODIFIED_BY="[Empty name]">Items of data extraction</TITLE>
<APPENDIX_BODY MODIFIED="2009-06-08 14:14:40 +1200" MODIFIED_BY="jane clarke">
<P>The following characteristics were assessed:<BR/>(1) Trial characteristics<BR/>(a) Study design:<BR/>(i) Randomised controlled trial<BR/>(ii) Patient recruitement.<BR/>(iii) Patient sampling<BR/>(iv) Patient in- and exclusion criteria<BR/>(v) Duration of follow-up<BR/>(vi) Type of follow-up</P>
<P>(c) Size of study:<I>
<BR/>
</I>(i) Number of women recruited<BR/>(ii) Number of women randomised<BR/>(iii) Number of women excluded<BR/>(iv) Number of women withdrawn and lost to follow-up<BR/>(v) Number of women analysed</P>
<P>(d) Study setting:<I>
<BR/>
</I>(i) Single-centre or multicentre<BR/>(ii) Location<BR/>(iii) Timing and duration<BR/>
</P>
<P>(e) Criteria for surgical treatment prior to IVF:<I>
<BR/>
</I>(i) Tubal disease<BR/>(ii) Hydrosalpinx<BR/>(iii) Either of the above plus previous failed IVF</P>
<P>(2) Characteristics of the study participants<BR/>(a) Baseline characteristics<BR/>(i) Age<BR/>(ii) Primary or secondary infertility<BR/>(iii) Duration of infertility<BR/>(iv) Investigative work-up - baseline follicle-stimulating hormone (FSH), semen analysis, diagnosis of tubal pathology, confirmatory test of ovulation<BR/>(v) Other contributory causes to infertility than tubal disease<BR/>(vi) Previous treatments - IVF and other treatments<BR/>
</P>
<P>(b) Treatment characteristics<BR/>(i) IVF protocol<BR/>(ii) Time from surgery to IVF<I>
<BR/>
</I>(iii) Proportion undergoing intracytoplasmic sperm injection (ICSI)<BR/>(iv) Number of oocytes retrieved at IVF<BR/>(iii) Fertilisation rate<BR/>(iv) Number of embryos transferred</P>
<P>(3) Interventions<I>
<BR/>
</I>(a) Timing of surgical intervention<BR/>(b) Nature of surgical intervention<BR/>(c) Absence of other interventions in treatment and control group</P>
<P>(4) Outcomes<I>
<B>
<BR/>
</B>
</I>(a) Primary<BR/>(i) Live birth rate<BR/>(b) Secondary<BR/>(i) Ongoing pregnancy rate<BR/>(ii) Viable pregnancy rate<BR/>(iii) Clinical pregnancy rate<BR/>(iv) Biochemical pregnancy rate<BR/>(v) Ectopic pregnancy rate<BR/>(vi) Miscarriage rate<BR/>(vii) Multiple pregnancy rate<BR/>(viii) Surgical complication rate<BR/>(ix) Ovarian response to IVF<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2009-06-08 14:59:04 +1200" MODIFIED_BY="jane clarke" NO="3">
<TITLE MODIFIED="2008-10-07 20:21:42 +1300" MODIFIED_BY="[Empty name]">Assessment of risk of bias</TITLE>
<APPENDIX_BODY MODIFIED="2009-06-08 14:59:04 +1200" MODIFIED_BY="jane clarke">
<P>Risk of the following bias were assessed, according to the following terms:</P>
<P>(1) Studysize bias - was a power calculation performed and adhered to?<BR/>(2) Selection bias - was allocation concealment was not performed by any of the following methods: central computer randomisation, on site assignment, or sealed opaque envelopes?<BR/>(3) Detection bias - were both the physician performing IVF and the outcome assessor blinded? And was the length of follow-up was adequate to detect the stated outcome measure(s)? Blinding of patient blinding was not applied as a quality criterion; as this sham tubal surgical intervention is not ethical and less relevant as patients cannot influence the occurrence or the detection of pregnancy.<BR/>(4) Attrition bias - was loss to follow-up of patients accounted for and dealt with an intention-to-treat analysis?<BR/>(5) Selective reporting bias -were there no suggestions of selective reporting?<BR/>(7) Funding bias - Was there no source of funding of the trial, or was this stated?</P>
<P>All quality items were scored with yes (suggesting the absence or a low risk of bias), no or unclear (suggesting a risks of bias of the certain item).</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>